Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017044	s-tshrab	— (—)	9392	14799	100.00%	Distribution not available
3017044	s-tshrab	IU/l (iu/l)	3300	5814	0.58%
3017044	s-tsh-abr	mU/l (iu/l)	944	2399	0.00%
3017044	s-tshrab	U/l (iu/l)	715	1216	0.00%
3017044	s-tshrab	IU/L (iu/l)	489	693	0.00%
3017044	s-tsh-reseptori,vasta-aineet	— (—)	438	501	100.00%	Distribution not available
3017044	s-tsh-abr	— (—)	223	313	100.00%	Distribution not available
3017044	s-tsh-reseptori,vasta-aineet	IU/l (iu/l)	187	293	0.00%
3017044	tsh-reseptori,vasta-aineet	IU/l (iu/l)	89	105	0.00%
3017044	s-tshrab	IU/l______ (iu/l)	76	141	0.00%
3017044	tsh-reseptori,vasta-aineet	— (—)	66	71	100.00%	Distribution not available
3017044	s-tsh-reseptori,vasta-aineet	IU/l______ (iu/l)	64	93	0.00%
3017044	s-tsh-reseptori,vasta-aineet	IU/L (iu/l)	36	39	0.00%
3017044	s-tshrab	IU/ml (iu/l)	16	16	0.00%	Distribution not available
3017044	tsh-reseptori,vasta-aineet	IU/L (iu/l)	13	16	0.00%
3017044	s-tsh-abr	IU/ml (iu/l)	6	6	0.00%	Distribution not available
3017044	s-tshrab	U/L (iu/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Graves disease, strict definition

2980

1131

72.61

307.65

3.7

1.6

21.90

8.53

iu/l

0.56

2071

392

Thyroiditis, ILD-related definition

914

1533

6.98

307.65

2.3

2.1

3.39

7.58

iu/l

0.62

405

657

Carbimazole or st.post thyroidectomy, condition for graves disease

4477

2150

36.55

307.65

3.1

1.5

19.22

10.06

iu/l

0.44

2609

734

Benign thyroid growths and nodules

2175

1671

13.73

307.65

1.9

1.1

11.66

2.01

iu/l

0.99

766

420

Thyroiditis

661

506

16.38

307.65

2.2

1.4

3.27

16.74

iu/l

0.44

265

158

Autoimmune hyperthyroidism

1513

507

63.54

307.65

4.1

1.4

5.84

2.18

iu/l

21.37

1029

156

Metabolic disorders

2883

7462

2.38

307.65

2.4

1.8

8.58

10.48

iu/l

0.16

1350

2929

Hypothyroidism, strict autoimmune

2148

3880

3.76

307.65

2.0

1.5

33.97

2.92

iu/l

0.87

1037

1292

Hypothyroidism (congenital or acquired)

1730

1139

9.36

307.65

2.8

2.0

4.73

3.22

iu/l

6.07

928

506

Hypothyroidism, levothyroxine purchases

1722

1138

9.34

307.65

2.8

2.0

4.73

3.22

iu/l

6.10

929

506

Hypothyreosis and Thyroxine purchase for inclusion criteria

4517

7167

4.39

307.65

2.6

1.7

24.17

4.39

iu/l

1.35

2348

2475

Thyrotoxicosis, other and/or unspecified

5562

1130

108.38

307.65

2.8

1.1

17.38

1.99

iu/l

1.37

2941

313

Disorders of the thyroid gland

6860

3848

12.93

307.65

2.5

1.2

18.10

4.93

iu/l

1.10

3309

1039

Disorders of thyroid, IBD co-morbidities

5125

700

92.62

307.65

2.7

1.3

19.55

2.09

iu/l

1.42

2682

219

Endocrine, nutritional and metabolic diseases

2935

2273

6.83

307.65

2.4

1.2

5.64

2.01

iu/l

1.59

1431

615

Hypothyroidism, other/unspecified

4389

3684

8.42

307.65

2.6

1.2

24.52

5.07

iu/l

1.20

2289

995

Graves ophthalmopathy

528

294

38.69

307.65

5.7

2.0

6.08

3.87

iu/l

2.99

377

121

Graves ophthalmopathy, strict

498

265

43.41

307.65

5.8

1.9

6.08

4.09

iu/l

2.11

359

105

Thyrotoxicosis with toxic multinodular goitre

1152

365

58.42

307.65

1.9

1.5

19.87

22.46

iu/l

0.04

391

114

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

5109

3218

22.01

307.65

2.7

1.6

12.07

11.47

iu/l

0.03

2392

1256

Thyrotoxicosis with diffuse goitre

3573

778

96.39

307.65

3.5

1.1

19.52

2.05

iu/l

1.24

2400

216

Subacute thyroiditis

299

152

24.26

307.65

1.9

1.2

2.68

1.60

iu/l

4.21

109

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1454

1572

11.90

307.65

3.4

1.9

9.25

8.46

iu/l

0.05

894

637

Other metabolic disorders

1473

1685

11.01

307.65

3.3

1.9

9.22

8.13

iu/l

0.07

901

682

Used for control exclusion in common control thyroid runs

4442

3196

7.40

307.65

2.4

1.2

6.64

8.99

iu/l

0.18

2096

866

Hypothyroidism and >3 levothyroxin purchases

1722

1138

9.34

307.65

2.8

2.0

4.73

3.22

iu/l

6.10

929

506

Autoimmune diseases

3261

7134

2.38

307.65

2.5

1.7

7.83

10.38

iu/l

0.27

1595

2484

Nontoxic multinodular goitre

821

952

9.38

307.65

1.7

1.2

14.08

2.07

iu/l

0.56

291

246

Hypothyroidism, drug reimbursement

1159

745

12.48

307.65

3.1

1.9

13.42

3.19

iu/l

1.07

667

338

Thyrotoxicosis

6245

1944

62.68

307.65

2.7

1.4

18.34

10.73

iu/l

0.38

3193

644

Disorders of orbit

649

456

21.62

307.65

4.9

1.9

5.64

15.91

iu/l

0.41

424

195

Disorders of lacrimal system and orbit in diseases classified elsewhere

530

266

42.31

307.65

5.7

1.9

6.06

4.10

iu/l

2.05

379

109

Nontoxic goitre/thyroid nodule

1214

3902

3.31

299.17

1.8

2.0

10.67

9.49

iu/l

0.05

418

1610

Hypothyroidism, strict autoimmune, 3 medication purchases required

2306

6921

2.30

264.49

1.9

1.7

32.36

4.41

iu/l

0.80

1094

2403

Other and/or unspecified nontoxic goitre

313

348

9.78

259.31

1.7

1.2

2.60

2.00

iu/l

0.72

Autoimmune thyroiditis

183

24.95

243.18

2.5

1.2

3.68

1.65

iu/l

2.74

Hypothyroidism due to medicaments and other exogenous substances

145

45.48

232.65

2.8

1.2

5.52

1.45

iu/l

4.91

Amiodarone users

417

725

6.29

232.37

1.5

1.8

11.72

12.40

iu/l

0.02

101

269

Disorders of eyelid, lacrimal system and orbit

2438

9241

1.98

194.69

2.7

1.8

5.18

13.05

iu/l

1.51

1089

3674

Neurological diseases, wide definition

694

913

3.91

181.41

2.1

1.3

3.65

2.00

iu/l

3.47

310

294

Autoimmune diseases related-to ILD

2358

10503

1.91

176.15

2.0

3.57

17.97

iu/l

1.99

943

4332

Antihypertensive medication - note that there are other indications

1798

4393

2.19

173.23

2.4

2.0

3.84

14.37

iu/l

0.48

818

1858

Thyrotoxicosis with toxic single thyroid nodule

114

33.57

163.37

2.5

1.3

4.60

2.42

iu/l

1.09

Anaemias

603

1107

3.60

154.17

2.2

2.0

16.81

3.24

iu/l

0.55

246

490

Depression medications

715

1165

3.16

138.85

2.1

2.0

3.68

3.20

iu/l

0.57

330

514

Thyroiditis, unspecified

113

19.38

136.24

2.5

1.2

2.23

1.44

iu/l

1.78

Nontoxic diffuse goitre

132

119

12.28

127.41

1.8

1.2

2.60

1.58

iu/l

1.85

Nontoxic single thyroid nodule

201

327

6.50

119.02

1.6

1.2

3.27

1.88

iu/l

1.32

Abnormalities of heart beat

1024

4578

2.23

118.54

2.2

2.0

3.88

7.85

iu/l

0.49

432

1910

Cardiac arrhythmias

1653

5702

1.90

114.36

2.1

11.99

9.52

iu/l

0.15

677

2526

Non-invasive ventilation

707

2480

2.53

107.06

2.4

2.1

2.71

11.14

iu/l

0.64

421

1102

Exophthalmic conditions

104

15.15

105.79

3.0

1.7

2.74

3.93

iu/l

0.56

Headache

1761

7741

1.79

105.42

2.0

2.1

16.62

15.42

iu/l

0.04

685

3321

Abnormalities of breathing

2205

7519

1.70

104.86

2.0

10.28

13.65

iu/l

0.16

937

3154

Other heart diseases, wide

2279

8402

1.67

101.19

2.0

13.89

16.41

iu/l

0.12

904

3620

Atrial fibrillation and flutter with reimbursement

639

1565

2.65

97.91

1.8

2.0

14.29

15.74

iu/l

0.03

229

665

Other heart diseases

1237

4174

1.97

95.74

2.0

2.1

16.09

8.06

iu/l

0.44

499

1897

Symptoms and signs involving the circulatory and respiratory systems

2414

7531

1.63

94.20

2.1

2.0

12.15

13.64

iu/l

0.07

1039

3157

Atrial fibrillation and flutter

765

2142

2.36

93.51

1.9

2.1

12.02

12.50

iu/l

0.01

292

942

Pain in joint

1406

4727

1.86

91.25

2.1

2.0

3.54

15.93

iu/l

0.66

555

2006

Other disorders of lacrimal gland

1006

5151

2.00

88.71

2.3

1.8

6.00

13.16

iu/l

0.79

435

2079

Medical observation and evaluation for suspected diseases and conditions

1490

4234

1.83

87.83

2.0

7.74

8.19

iu/l

0.03

582

1785

Malaise and fatigue

1271

5470

1.86

87.27

1.9

2.0

10.25

10.48

iu/l

0.01

478

2289

Pain in throat and chest

1995

7267

1.65

84.77

2.0

17.33

7.45

iu/l

0.59

796

3049

General symptoms and signs

2490

8030

1.57

84.48

1.9

2.1

12.05

15.94

iu/l

0.20

1011

3422

Other arrhythmias

1552

6782

1.74

83.74

2.0

10.30

12.66

iu/l

0.14

599

2907

Disorder of thyroid, unspecified

17.27

83.51

2.6

1.3

2.71

1.34

iu/l

1.87

Mood [affective] disorders

2447

10199

1.56

83.48

2.0

7.57

16.70

iu/l

0.79

972

4248

Mood disorders

2450

10205

1.55

83.14

2.0

7.58

16.67

iu/l

0.79

972

4254

Mood disorders, excluding more controls

2219

8279

1.60

82.91

2.0

8.04

16.22

iu/l

0.55

867

3466

Disorders of lacrimal system

1150

6176

1.87

82.90

2.3

1.8

5.85

14.06

iu/l

1.00

488

2471

Anxiety disorders, excluding more controls

2019

8044

1.63

82.78

2.0

12.08

16.46

iu/l

0.21

783

3400

Infections, IBD-co-morbidities

268

485

3.97

81.94

1.7

1.3

3.94

2.11

iu/l

1.05

110

161

Depression

2309

10010

1.56

80.77

2.0

7.82

15.44

iu/l

0.62

925

4194

Anxiety disorders

2212

9822

1.57

78.45

2.0

11.33

14.66

iu/l

0.18

867

4160

Anxiety (asthma-related co-morbidities)

1618

7421

1.69

78.39

2.0

2.1

9.25

15.85

iu/l

0.36

628

3247

Neurotic, stress-related and somatoform disorders

2197

9787

1.57

78.30

2.0

11.40

14.67

iu/l

0.18

860

4154

Visual disturbances

1222

6923

1.80

78.12

2.3

2.0

4.02

9.98

iu/l

1.15

502

2819

Visual disturbances and blindness

1287

7394

1.77

77.96

2.2

2.0

4.06

9.60

iu/l

1.14

520

3009

Oral corticosteroids

2482

9633

1.53

76.90

2.0

16.87

15.12

iu/l

0.08

985

4019

Other soft tissue disorders, not elsewhere classified

2211

8150

1.56

75.09

1.9

2.1

9.62

18.41

iu/l

0.55

852

3424

All anxiety disorders

1664

7958

1.65

74.52

2.0

2.1

9.04

14.12

iu/l

0.28

650

3482

Examination and observation for other reasons

1315

4224

1.78

73.60

1.9

2.0

23.09

8.21

iu/l

0.49

410

1780

Diplopia

391

1461

2.79

73.37

2.7

2.0

4.16

7.80

iu/l

0.46

176

601

Disorders of other endocrine glands

1143

6363

1.80

73.32

1.9

2.0

10.51

8.81

iu/l

0.09

466

2648

Lower back pain or/and sciatica

2520

10543

1.50

72.97

2.0

21.20

13.88

iu/l

0.30

988

4383

Any reimbursement code in KELA

1430

4167

1.75

72.47

2.2

2.1

7.65

14.18

iu/l

0.48

649

1825

Disorders of calcium metabolism

217

588

3.91

70.17

2.3

1.8

3.80

3.68

iu/l

0.08

105

215

Low back pain

1861

8026

1.59

69.73

2.0

18.96

16.64

iu/l

0.06

706

3379

Heart failure and antihypertensive medication

481

1254

2.55

69.60

1.8

1.9

6.21

4.12

iu/l

0.40

161

471

Disorders of mineral metabolism

260

799

3.42

69.14

2.2

1.8

4.14

3.68

iu/l

0.35

123

292

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1075

3748

1.86

68.96

2.8

2.1

3.28

10.63

iu/l

1.18

496

1755

Cardiodefibrillation

666

3235

2.10

67.25

1.7

1.8

4.55

6.60

iu/l

0.44

218

1165

ILD medications: prednisolone, methylprednisolone, prednisone

2477

9357

1.49

66.91

2.0

16.61

15.26

iu/l

0.06

967

3944

Other obstetric conditions, not elsewhere classified

1085

3840

1.83

66.69

2.7

2.1

3.26

10.49

iu/l

1.20

498

1800

Malignant neoplasm of thyroid gland, including Hilmo

280

924

3.22

66.67

2.5

2.1

3.96

9.72

iu/l

0.48

147

391

Other disorders of thyroid

11.16

65.77

2.6

1.5

2.65

102.71

iu/l

0.48

Dyspnoea

2032

9719

1.53

65.29

1.9

2.0

12.49

10.93

iu/l

0.09

801

4010

Episodal and paroxysmal disorders

2477

8568

1.48

64.53

2.0

2.1

8.86

14.59

iu/l

0.37

995

3601

Dorsalgia

2284

8146

1.50

64.12

2.0

18.95

16.47

iu/l

0.08

897

3422

Malignant neoplasm of endocrine gland, including Hilmo

291

1004

3.06

63.93

2.5

2.1

4.10

9.11

iu/l

0.45

150

430

First line medication for Crohn's disease

2499

9233

1.47

63.58

2.0

13.44

15.35

iu/l

0.09

979

3923

ILD medications

2558

9516

1.46

63.44

2.1

2.0

16.34

15.06

iu/l

0.06

1002

4006

Migraine

1416

6836

1.64

62.04

2.0

2.1

22.58

14.63

iu/l

0.20

564

3008

Inflammatory bowel disease treatment related agents

2576

9934

1.45

61.88

2.0

16.21

14.76

iu/l

0.07

1027

4144

Pain in limb

1919

8044

1.53

61.63

1.9

2.1

7.51

18.59

iu/l

0.77

732

3386

Asthma, excluding more controls

1683

5483

1.60

61.34

2.0

63.35

6.51

iu/l

1.07

676

2384

Other disorders of fluid, electrolyte and acid-base balance

643

3022

2.04

60.18

1.7

3.15

11.64

iu/l

0.78

222

1099

Type 1 diabetes

597

2911

2.10

60.17

2.1

2.0

7.15

5.58

iu/l

0.17

273

1228

Vocal cord dysfunction

381

1345

2.57

59.96

2.2

2.1

4.77

16.52

iu/l

0.45

167

612

Other headache syndromes

1087

6418

1.72

59.36

1.9

2.1

10.80

9.59

iu/l

0.05

419

2763

Disorders of lipoprotein metabolism and other lipidaemias

1571

6062

1.59

59.24

1.9

1.8

12.91

12.38

iu/l

0.02

575

2320

Malignant neoplasm of thyroid gland

252

840

3.19

59.05

2.6

2.1

3.52

10.41

iu/l

0.53

135

356

Diseases of the eye and adnexa

1781

5793

1.56

58.52

2.3

1.9

6.99

14.07

iu/l

0.72

791

2473

General examination and investigation of persons without complaint and reported diagnosis

1340

4230

1.66

58.15

1.9

2.0

10.95

8.20

iu/l

0.15

554

1783

Malignant neoplasm of endocrine gland

260

891

3.09

57.95

2.5

2.1

3.68

9.93

iu/l

0.51

138

379

Other antidepressants

2193

7622

1.48

57.72

1.9

2.0

8.18

18.26

iu/l

0.66

873

3162

Asthma

1727

5772

1.56

57.59

2.0

62.06

6.40

iu/l

1.08

691

2480

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1391

7684

1.60

56.08

1.8

1.9

10.39

12.51

iu/l

0.12

522

3058

Type 1 diabetes, wide definition, subgroup 1

519

2470

2.15

56.04

2.2

2.1

7.30

5.90

iu/l

0.13

252

1064

Pure hypercholesterolaemia

1406

5614

1.61

55.66

1.9

1.8

7.95

13.20

iu/l

0.36

529

2111

Other specific joint derangements/joint disorders

1765

7295

1.53

55.22

2.1

3.65

16.09

iu/l

1.13

708

3111

Depression or dysthymia

1381

4699

1.62

55.12

2.0

11.11

12.90

iu/l

0.09

544

1943

Asthma (mode)

1695

5830

1.54

54.23

2.0

61.75

8.54

iu/l

1.01

697

2509

Pain, not elsewhere classified

709

3820

1.90

53.73

1.8

2.1

36.43

4.08

iu/l

0.74

256

1655

Asthma, unspecified (mode), excluding more controls

1184

5187

1.66

53.68

1.9

2.0

41.05

6.70

iu/l

1.05

460

2250

Benzodiazepine use

2258

10703

1.44

53.42

1.9

2.0

12.73

15.84

iu/l

0.17

836

4485

Type 1 diabetes, wide definition

528

2579

2.09

53.16

2.3

2.1

7.20

5.84

iu/l

0.13

257

1106

Hypocalcemia

115

241

5.32

52.92

2.7

1.9

4.32

3.60

iu/l

0.38

Recurrent or chronic depression

951

3829

1.75

52.49

2.0

2.1

14.45

12.52

iu/l

0.07

367

1674

Codeine

2105

7865

1.46

52.01

2.0

2.1

11.17

17.14

iu/l

0.31

845

3433

Persons encountering health services in other circumstances, wide

2455

8960

1.42

51.83

2.0

4.10

17.21

iu/l

1.48

988

3720

Strabismus

666

3552

1.91

51.81

2.7

2.0

4.32

7.21

iu/l

0.59

306

1526

Opioids

2212

7966

1.45

51.69

1.9

2.1

7.35

16.97

iu/l

0.69

868

3477

Other anxiety disorders

1221

6556

1.61

50.68

2.0

2.1

3.80

16.15

iu/l

0.97

443

2902

Asthma (only as main-diagnosis), excluding more controls

1519

5483

1.55

49.86

2.0

71.90

6.51

iu/l

1.20

638

2384

Cardiovascular diseases

1495

5155

1.56

49.84

2.1

2.2

3.87

15.61

iu/l

0.71

637

2357

Symptoms and signs involving the skin and subcutaneous tissue

1635

10449

1.50

49.70

2.0

14.49

15.78

iu/l

0.05

610

4344

Other dorsopathies, not elsewhere classified

2230

8155

1.43

49.54

2.0

6.80

16.45

iu/l

0.72

900

3425

Sleep disorders (combined)

2397

8939

1.41

49.28

2.0

12.98

16.96

iu/l

0.17

976

3676

Congenital iodine-deficiency syndrome/hypothyroidism

113

7.13

49.26

2.1

1.2

3.76

1.53

iu/l

1.63

Tramadol

1705

6906

1.50

49.12

1.8

2.1

13.85

12.46

iu/l

0.06

610

3003

Parasetamol

1555

5152

1.54

49.10

2.0

2.1

7.28

16.76

iu/l

0.46

652

2250

Insulin, fast-acting

757

4273

1.80

49.07

2.1

2.0

6.45

6.86

iu/l

0.04

346

1731

Asthma, unspecified (mode)

1204

5465

1.61

49.06

1.9

2.0

40.80

6.57

iu/l

1.06

463

2344

Neurological diseases

1904

6542

1.48

48.88

2.0

2.1

6.51

15.45

iu/l

0.56

810

2775

Paroxysmal tachycardia

524

2167

2.05

48.52

1.9

2.1

3.81

11.93

iu/l

0.51

191

969

Other strabismus

569

2946

1.97

48.38

2.8

2.1

4.37

5.46

iu/l

0.26

270

1293

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

784

2159

1.85

48.23

2.1

3.66

35.68

iu/l

0.82

329

968

Codeine or tramadol medication

2478

9736

1.39

47.59

1.9

2.0

10.17

15.01

iu/l

0.29

965

4101

Other special examinations and investigations of persons without complaint or reported diagnosis

1315

4234

1.59

47.54

2.1

2.0

7.93

8.19

iu/l

0.02

577

1785

Asthma (only as main-diagnosis)

1556

5772

1.52

47.53

1.9

2.0

71.03

6.40

iu/l

1.20

646

2480

Cardiovascular diseases (excluding rheumatic etc)

1534

5829

1.52

47.01

2.0

2.2

16.73

14.44

iu/l

0.07

665

2625

Disorders of ocular muscles, binocular movement, accommodation and refraction

1173

7444

1.59

46.87

2.4

2.0

3.96

8.98

iu/l

1.06

511

3140

Insulin, fast-acting or short human

760

4354

1.77

46.82

2.1

2.0

6.42

6.79

iu/l

0.04

348

1759

Exclusions for E4_PCOS_BROAD

442

2130

2.13

46.46

1.8

2.1

20.39

6.37

iu/l

0.39

184

913

Sciatica+with lumbago

1171

6623

1.59

46.33

2.0

23.93

11.18

iu/l

0.54

474

2789

Gastro-oesophageal reflux disease

1463

8293

1.51

45.35

1.9

2.0

9.31

13.17

iu/l

0.26

576

3424

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2333

8946

1.40

45.21

2.0

10.55

17.22

iu/l

0.33

896

3716

Sub-endpoint used in defining T1D endpoints

605

3220

1.88

45.09

2.1

2.0

7.06

5.37

iu/l

0.19

278

1341

Persons encountering health services for specific procedures and health care

2357

10113

1.39

44.64

1.9

2.1

6.54

11.52

iu/l

0.71

914

4265

Follow-up examination after treatment for conditions other than malignant neoplasms

963

3899

1.67

44.41

1.9

2.0

12.67

8.54

iu/l

0.17

363

1665

Other functional intestinal disorders

1020

5794

1.62

44.40

1.8

2.0

5.69

13.18

iu/l

0.85

393

2412

Asthma, including avohilmo

2560

10373

1.37

44.36

1.9

2.0

46.83

6.63

iu/l

1.14

1006

4285

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

142

253

4.00

44.28

1.9

1.3

10.75

2.02

iu/l

0.66

Hypertension, essential

1613

6201

1.49

43.90

2.0

6.91

8.24

iu/l

0.11

653

2665

Hypertensive diseases (excluding secondary)

1141

4198

1.60

43.71

2.1

14.80

8.15

iu/l

0.33

483

1909

Heart failure, not strict

1396

6250

1.52

43.48

1.8

1.9

10.63

12.95

iu/l

0.12

502

2493

Autoimmune diseases excluding thyroid diseases

1654

6120

1.48

43.45

1.5

1.4

14.67

9.31

iu/l

0.24

500

1787

Nausea and vomiting

636

3451

1.83

43.31

1.9

2.0

5.62

8.04

iu/l

0.23

229

1447

Dysphagia

546

2902

1.92

43.26

1.9

18.62

11.41

iu/l

0.17

199

1170

Behavioural syndromes associated with physiological disturbances and physical factors

2091

10198

1.40

42.82

2.0

4.98

18.09

iu/l

1.60

858

4233

Diseases of oesophagus, stomach and duodenum

2276

9784

1.39

42.74

1.9

2.0

14.26

16.58

iu/l

0.11

898

4081

Fever of other and unknown origin

1182

6679

1.55

42.38

1.8

2.0

3.59

10.30

iu/l

1.34

458

2825

Other pulmonary diagnosis

1687

5825

1.47

41.85

2.0

11.51

6.38

iu/l

0.43

704

2507

Sleep disorders

2030

10085

1.40

41.55

2.0

5.06

18.23

iu/l

1.59

838

4190

Vertical strabismus

130

358

3.90

41.55

3.6

2.0

6.36

19.00

iu/l

0.40

155

Excluding asthma or asthma-COPD overlap

1682

5825

1.46

41.10

2.1

2.0

11.47

6.38

iu/l

0.43

709

2507

Selective serotonin reuptake inhibitors

2048

7644

1.40

40.83

2.0

8.44

18.23

iu/l

0.63

838

3170

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2184

10232

1.38

40.82

2.0

15.44

16.00

iu/l

0.02

867

4214

Disturbances of skin sensation

704

4120

1.74

40.65

2.1

4.11

6.86

iu/l

0.69

283

1827

Other diseases of intestines

2308

9444

1.37

40.64

2.0

6.91

17.28

iu/l

0.88

916

4032

Other nutritional deficiencies

1557

9914

1.45

40.56

2.0

17.31

16.53

iu/l

0.02

644

4159

Any gastric operation

1769

6235

1.44

39.63

2.1

6.85

19.90

iu/l

0.83

734

2715

GASTRO-related operations

1769

6235

1.44

39.63

2.1

6.85

19.90

iu/l

0.83

734

2715

Mechanical strabismus

17.96

39.35

9.0

2.4

6.80

4.59

iu/l

0.69

Care involving use of rehabilitation procedures

1349

8274

1.48

39.28

1.9

2.0

17.91

11.00

iu/l

0.27

592

3420

Pain (limb, back, neck, head abdominally)

1410

4759

1.50

39.21

2.0

7.42

15.82

iu/l

0.36

586

2015

Insulin, intermediate and long-acting

1033

6455

1.56

38.96

2.0

1.9

5.68

7.24

iu/l

0.23

427

2531

Insomnia

2009

10179

1.39

38.94

2.1

2.0

5.09

17.32

iu/l

1.46

833

4238

Hypo-osmolality and hyponatraemia

353

1656

2.16

38.91

1.7

3.34

3.59

iu/l

0.28

129

582

Oedema, not elsewhere classified

680

3888

1.74

38.80

1.9

2.0

3.85

9.49

iu/l

0.60

266

1589

Asthma (diagnoses ohter than nonallergic)

1896

11094

1.39

38.80

1.9

2.0

70.86

5.78

iu/l

1.40

736

4592

Symptoms and signs involving cognition, perception, emotional state and behaviour

2047

9995

1.38

38.51

1.9

2.0

12.61

12.07

iu/l

0.03

794

4162

ILD differential diagnosis

1665

5830

1.44

38.43

2.0

11.59

8.54

iu/l

0.21

701

2509

Intestinal infectious diseases, including avohilmo, including avohilmo

2425

10083

1.35

38.41

1.9

2.0

14.62

16.11

iu/l

0.07

941

4171

Abdominal and pelvic pain

1998

7241

1.40

38.36

2.0

10.51

17.31

iu/l

0.35

802

3020

COPD differential diagnosis

1665

5836

1.44

38.23

2.0

11.59

8.53

iu/l

0.21

701

2513

Symptoms and signs involving the digestive system and abdomen

2000

7241

1.40

38.16

2.0

10.36

17.31

iu/l

0.36

805

3020

Sleep apnoea, including avohilmo

2075

9195

1.38

37.71

1.9

2.0

14.37

11.64

iu/l

0.13

856

3772

Migraine with aura

697

4157

1.71

37.54

2.0

2.2

14.08

8.63

iu/l

0.19

285

1906

Any mental disorder

2251

8327

1.36

37.50

2.0

13.00

16.18

iu/l

0.15

904

3474

Psychiatric diseases

1978

7184

1.39

36.98

2.0

10.18

18.36

iu/l

0.44

817

2970

Viral hepatitis, IBD co-morbidity

195

4.63

36.96

1.9

1.4

2.76

2.10

iu/l

0.77

Bronchitis

2354

10586

1.34

36.81

2.0

7.24

17.07

iu/l

0.89

922

4391

Acute upper respiratory infections of multiple and unspecified sites

1694

8857

1.41

36.45

2.1

2.0

8.19

17.19

iu/l

0.61

693

3694

Chronic lower respiratory diseases

2557

10211

1.33

36.08

1.9

2.0

42.65

6.58

iu/l

1.04

1043

4220

Hypertension

1612

6425

1.43

35.91

2.0

11.69

8.12

iu/l

0.23

661

2764

Diabetes mellitus

2205

9482

1.35

35.90

2.0

7.35

16.05

iu/l

0.69

917

3946

Oxycodone

755

3943

1.66

35.89

1.6

1.9

3.87

14.35

iu/l

1.02

219

1604

Abnormal results of function studies

242

1018

2.47

35.79

1.8

2.0

3.71

9.45

iu/l

0.52

419

Cardiomyopathy

307

1420

2.20

35.78

1.6

1.8

101.58

3.74

iu/l

0.74

547

Hypertensive diseases

1612

6432

1.43

35.73

2.0

11.69

8.11

iu/l

0.23

661

2768

Cystitis

1867

8077

1.39

35.55

2.0

7.85

16.44

iu/l

0.55

740

3390

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

681

4043

1.69

35.45

2.0

2.2

3.22

22.07

iu/l

0.93

271

1836

Asthma, hospital admission 2, infections

1274

8572

1.46

35.39

1.9

2.0

94.49

5.37

iu/l

1.23

486

3539

Asthma-related infections

1274

8572

1.46

35.39

1.9

2.0

94.49

5.37

iu/l

1.23

486

3539

Acute upper respiratory infections

2208

9888

1.35

35.34

2.0

10.86

17.50

iu/l

0.40

884

4042

Insulin, combination of fast acting with intermediate-acting or long-acting

1149

7044

1.49

35.10

2.0

1.9

5.41

6.93

iu/l

0.25

472

2774

Autoimmune diseases excluding thyroid diseases, strict definition

1251

4598

1.49

34.68

1.3

2.04

9.46

iu/l

1.10

352

1267

Symptoms and signs concerning food and fluid intake

257

1121

2.35

34.65

1.9

2.0

3.30

4.14

iu/l

0.93

449

Disorders of parathyroid gland

466

2503

1.88

34.63

1.8

1.9

4.09

6.51

iu/l

0.48

181

944

Dermatitis and eczema

2363

10593

1.33

34.47

1.9

2.0

13.57

15.02

iu/l

0.06

925

4384

Conjunctivitis (acute, non atopic), including avohilmo

2110

9507

1.35

34.17

2.0

3.90

13.52

iu/l

2.33

830

3938

2394

9183

1.33

34.08

2.0

10.62

8.37

iu/l

0.17

938

3798

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2040

10261

1.35

33.65

2.0

8.26

11.35

iu/l

0.29

809

4240

Insulin medication

1147

6486

1.48

33.23

2.0

5.41

11.39

iu/l

0.81

472

2583

Diabetes, varying definitions

2172

9475

1.34

33.06

2.0

7.43

16.05

iu/l

0.68

899

3948

Dorsopathies

2154

8172

1.34

32.87

2.0

6.82

16.44

iu/l

0.71

882

3431

Heart failure,strict

878

3933

1.58

32.80

1.7

1.8

8.53

11.94

iu/l

0.29

289

1476

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1061

6919

1.50

32.72

2.1

2.0

3.94

10.75

iu/l

1.26

445

2885

Non-small cell lung cancer, including Hilmo

280

1214

2.21

32.46

1.5

1.8

3.57

11.02

iu/l

0.73

443

Nerve, nerve root and plexus disorders

2205

10028

1.33

32.30

1.9

2.0

14.37

15.03

iu/l

0.03

901

4107

Other disorders of eye and adnexa

365

1879

2.00

32.27

2.2

2.1

4.78

6.53

iu/l

0.26

149

826

Symptoms and signs involving speech and voice

724

4531

1.62

32.25

2.1

2.0

3.62

11.08

iu/l

0.95

298

1840

Generalized anxiety disorder

453

2499

1.85

32.13

1.9

2.2

2.86

5.72

iu/l

0.84

164

1196

Bipolar affective disorders

461

2560

1.84

32.09

1.9

2.2

19.78

5.79

iu/l

0.39

186

1192

Cardiomyopathies, Primary/intrinsic

210

869

2.47

31.94

1.6

1.8

140.58

3.83

iu/l

0.74

336

Non-small cell lung cancer

198

788

2.54

31.88

1.5

1.8

3.42

11.53

iu/l

0.51

293

Migraine, single triptan purchase ok & required. ICD-code if available is included

1757

8778

1.37

31.54

2.1

20.19

14.30

iu/l

0.25

755

3731

Triptan medication for migraine, single purchase ok

1757

8778

1.37

31.54

2.1

20.19

14.30

iu/l

0.25

755

3731

Type 1 diabetes, definitions combined

253

1145

2.27

31.31

2.2

3.42

8.21

iu/l

0.53

120

507

Dizziness and giddiness

1540

8686

1.39

31.30

2.0

11.19

10.16

iu/l

0.06

553

3600

Insulin, fast-acting (human)

326

1635

2.04

30.97

2.2

2.1

10.25

6.99

iu/l

0.20

154

704

Sleep apnoea

1886

8872

1.35

30.85

1.9

2.0

15.45

11.13

iu/l

0.19

771

3634

Osteoporosis

573

3133

1.71

30.78

1.9

23.48

11.03

iu/l

0.38

226

1177

Type 1 diabetes, strict (exclude DM2)

251

1141

2.26

30.75

2.2

3.43

8.21

iu/l

0.52

119

506

Type 1 diabetes, strict definition, subgroup 1

211

893

2.44

30.70

2.2

2.3

3.24

3.66

iu/l

0.48

108

411

Lung cancer and mesothelioma

348

1501

2.00

30.68

1.5

1.9

3.40

4.22

iu/l

1.13

562

Other intervertebral disc disorders

1664

7258

1.38

30.65

1.9

2.0

7.81

11.55

iu/l

0.30

687

3042

COPD/asthma related infections

2149

8148

1.33

30.57

2.0

16.28

8.79

iu/l

0.35

870

3433

COPD/asthma/ILD related infections

2149

8148

1.33

30.57

2.0

16.28

8.79

iu/l

0.35

870

3433

Covid-19 confirmed case

738

4695

1.59

30.39

1.8

2.0

3.81

7.09

iu/l

0.89

282

1888

Papillary adenocarcinoma of thyroid gland

168

646

2.74

30.39

2.5

2.1

3.55

12.80

iu/l

0.54

266

Dental caries

487

2626

1.78

30.25

2.2

2.0

5.90

15.71

iu/l

0.83

193

1081

Other diseases of upper respiratory tract

2221

8829

1.32

30.05

2.1

2.0

7.25

17.32

iu/l

0.77

903

3631

1867

8148

1.35

30.05

1.9

2.0

48.19

8.79

iu/l

0.69

703

3433

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1867

8148

1.35

30.05

1.9

2.0

48.19

8.79

iu/l

0.69

703

3433

Malignant melanoma of skin, including Hilmo

294

1436

2.10

30.02

1.6

1.9

3.75

9.42

iu/l

0.69

566

Voice disturbances

604

3687

1.67

29.90

2.1

2.0

3.68

7.53

iu/l

0.88

264

1522

983

6634

1.49

29.72

1.9

2.1

20.95

5.77

iu/l

0.65

368

2817

Diseases of the digestive system

850

5568

1.53

29.71

2.0

1.9

4.89

6.73

iu/l

0.41

347

2197

Personality disorders, excluding more controls

596

3622

1.67

29.66

1.9

2.2

2.95

3.98

iu/l

3.68

225

1644

Cardiomyopathy (excluding other)

215

933

2.35

29.43

1.6

1.9

138.53

3.90

iu/l

0.74

355

Irritable bowel syndrome

669

4207

1.62

29.32

2.1

15.93

11.06

iu/l

0.15

257

1859

Type 1 diabetes, strict definition

215

936

2.37

29.30

2.3

3.24

3.64

iu/l

0.46

109

426

Gastrointestinal diseases

1313

4636

1.43

29.24

2.1

7.97

23.39

iu/l

0.72

568

2058

362

1925

1.93

29.07

2.3

2.1

2.77

6.35

iu/l

0.74

151

875

Disorders of conjunctiva

1831

10696

1.34

28.95

2.1

2.0

34.40

11.05

iu/l

0.41

755

4441

Malignant melanoma, including Hilmo

342

1785

1.96

28.91

1.5

1.9

3.66

8.37

iu/l

0.72

701

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2066

9981

1.32

28.59

1.9

2.1

3.92

17.53

iu/l

1.74

818

4174

Constipation

1778

9033

1.34

28.55

1.9

2.0

4.98

13.14

iu/l

1.52

681

3705

Soft tissue disorders

2094

8181

1.32

28.34

2.0

2.1

6.22

18.37

iu/l

1.00

848

3436

Myalgia

590

3632

1.65

28.27

2.0

2.1

3.47

10.78

iu/l

0.81

206

1612

Malignant melanoma

309

1571

2.01

28.25

1.5

1.9

3.60

8.92

iu/l

0.72

621

Ocular pain

242

1129

2.22

28.19

2.2

2.1

4.65

8.66

iu/l

0.39

104

490

Panic disorder

395

2182

1.85

28.13

2.0

2.2

3.15

6.10

iu/l

0.72

149

1043

Other disorders of urethra and urinary system

1523

7789

1.37

28.10

1.9

2.0

9.75

10.76

iu/l

0.06

597

3287

Adjustment and management of implanted device

317

1630

1.98

27.94

1.6

1.8

2.71

5.52

iu/l

1.08

572

Other disorders of eyelid

809

5049

1.53

27.84

2.2

1.7

4.05

15.58

iu/l

1.32

327

1884

Provisional assignment of new diseases of uncertain etiology

1113

7783

1.43

27.75

1.8

2.0

3.72

10.77

iu/l

1.48

410

3252

Symptoms and signs involving the nervous and musculoskeletal systems

1177

8383

1.42

27.74

2.0

10.55

13.18

iu/l

0.14

486

3428

Syncope and collapse

844

4690

1.52

27.64

1.8

2.0

10.13

4.41

iu/l

0.38

327

1923

Codes for special purposes

1113

7788

1.43

27.64

1.8

2.0

3.72

10.77

iu/l

1.48

410

3253

Phobic anxiety disorders

351

1874

1.91

27.62

2.2

2.3

28.83

6.38

iu/l

0.48

137

893

Intestinal infectious diseases

1955

11126

1.32

27.55

1.9

2.0

12.72

15.66

iu/l

0.15

774

4594

Use of hypnotics and sedatives

2136

9404

1.31

27.50

2.1

2.0

12.51

12.59

iu/l

0.00

859

3887

Other joint disorders

1868

7365

1.33

27.10

2.0

2.1

6.70

16.02

iu/l

0.67

803

3129

Persons encountering health services for examination and investigation

1200

4234

1.43

26.90

2.0

8.35

8.19

iu/l

0.01

505

1785

Maternal care for other conditions predominantly related to pregnancy

601

3671

1.63

26.90

2.1

2.2

3.13

12.77

iu/l

1.47

266

1690

Osteopathies and chondropathies

1134

7362

1.42

26.85

2.0

21.84

11.30

iu/l

0.48

430

2985

Caries of dentine

420

2314

1.78

26.29

2.2

2.0

5.85

13.08

iu/l

0.53

169

958

Diseases of pulp and periapical tissues, including avohilmo

2133

8528

1.30

26.28

2.0

3.83

19.35

iu/l

1.65

843

3513

Malignant melanoma of skin

246

1185

2.13

26.18

1.6

1.9

3.72

8.94

iu/l

0.51

461

Heart failure, strict

929

4404

1.48

26.18

1.7

1.8

8.22

7.28

iu/l

0.09

308

1620

Other reaction to severe stress, and adjustment disorders

860

5862

1.49

25.85

2.1

4.90

9.83

iu/l

0.69

354

2617

Implicit Sepsis

1440

7845

1.36

25.77

1.8

2.0

11.30

10.03

iu/l

0.07

545

3158

Haemorrhage from respiratory passages

581

3211

1.62

25.57

1.8

1.9

3.77

3.82

iu/l

0.04

199

1255

Other/unspecified dorsalgia

786

5208

1.51

25.55

1.9

2.0

3.45

9.29

iu/l

1.14

286

2208

Persons encountering health services in other circumstances

861

5829

1.48

25.35

1.9

2.0

4.38

10.38

iu/l

0.95

370

2445

Migraine with aura and triptan purchases

455

2704

1.72

25.24

2.0

2.3

18.89

5.72

iu/l

0.38

198

1269

Diseases of the musculoskeletal system and connective tissue

1150

4080

1.43

25.12

2.0

2.1

8.26

21.62

iu/l

0.53

495

1777

Chronic inflammatory disorders of orbit

11.64

24.97

2.6

1.8

1.41

5.53

iu/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

1454

9708

1.35

24.89

1.9

2.0

16.37

17.21

iu/l

0.03

560

4034

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1809

9362

1.31

24.88

1.8

2.0

11.49

9.69

iu/l

0.11

714

3883

Hard cardiovascular diseases

1550

6852

1.35

24.81

1.9

2.0

21.22

11.36

iu/l

0.41

618

2778

Cough

804

5081

1.49

24.72

1.8

2.0

3.66

7.43

iu/l

0.52

295

2113

Abnormal findings on examination of blood, without diagnosis

784

4778

1.50

24.63

2.0

1.9

4.99

8.80

iu/l

0.68

294

1876

Complications of surgical and medical care, not elsewhere classified

2013

10455

1.29

24.63

1.9

2.0

7.63

17.33

iu/l

0.81

776

4331

Diabetes medication

2147

9819

1.29

24.55

2.0

7.46

15.70

iu/l

0.66

890

4059

Other diseases of urinary system

1981

8612

1.30

24.51

2.0

11.69

15.70

iu/l

0.20

791

3588

All-cause Heart Failure

905

4329

1.47

24.50

1.7

1.8

8.35

7.37

iu/l

0.09

302

1586

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1846

8414

1.31

24.48

1.9

2.0

7.47

11.04

iu/l

0.31

771

3482

Abnormal findings on diagnostic imaging of lung

812

5231

1.48

24.46

1.7

1.9

5.20

10.99

iu/l

0.69

278

2010

Subjective visual disturbances

559

3526

1.61

24.31

2.1

2.0

3.89

7.68

iu/l

0.80

212

1457

Implicit Sepsis, including avohilmo

1596

8639

1.33

24.16

1.8

2.0

14.40

8.70

iu/l

0.38

610

3537

Pacemaker

561

3281

1.61

24.14

1.6

1.8

3.07

11.90

iu/l

0.94

196

1155

Percutaneous Coronary Intervention

1426

6440

1.36

24.13

1.8

1.9

24.23

12.83

iu/l

0.42

566

2546

Obesity and other hyperalimentation

1386

9759

1.35

23.77

2.0

19.09

16.65

iu/l

0.07

561

4115

Obesity

1380

9731

1.35

23.67

2.0

19.15

16.70

iu/l

0.07

559

4098

Coronary revascularization (ANGIO or CABG)

1423

6444

1.35

23.47

1.8

1.9

24.31

12.83

iu/l

0.42

564

2547

Non-ischemic cardiomyopathy

533

2632

1.63

23.46

1.7

1.8

7.02

6.25

iu/l

0.09

169

968

Factors influencing health status and contact with health services

470

1385

1.72

23.41

2.0

1.9

16.48

4.01

iu/l

0.51

190

592

Ischemic heart diseases

1511

6769

1.34

23.32

1.9

2.0

17.66

12.35

iu/l

0.20

613

2701

Other systemic involvement of connective tissue (FG)

553

3446

1.60

23.31

1.9

2.0

35.84

6.10

iu/l

0.72

196

1419

Other inflammation of eyelid, including avohilmo

984

7024

1.42

23.12

2.3

1.9

5.85

18.81

iu/l

0.97

398

2964

Type 2 diabetes, wide definition

1447

6842

1.34

23.11

1.9

2.0

9.75

10.97

iu/l

0.07

562

2766

Other specified and unspecified strabismus

117

4.97

23.03

4.2

2.1

5.81

4.59

iu/l

0.26

Spondylopathies

1439

6376

1.34

22.82

1.8

1.9

21.68

11.64

iu/l

0.48

567

2619

Condition for Implicit Sepsis (Organ dysfunction codes)

1655

8797

1.31

22.80

1.8

2.0

12.39

8.60

iu/l

0.25

641

3620

Diseases of the respiratory system

1307

4816

1.37

22.77

2.1

2.0

8.06

8.09

iu/l

0.00

540

2067

Asthma/COPD (KELA code 203)

1948

10200

1.28

22.69

1.9

2.0

51.84

6.59

iu/l

1.02

801

4216

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

681

4559

1.52

22.65

2.0

2.2

3.22

6.50

iu/l

1.06

271

2045

Chronic apical periodontitis

2285

10204

1.26

22.59

2.0

4.29

16.73

iu/l

1.56

908

4243

COPD (mode)

496

2387

1.64

22.54

1.7

1.9

23.97

4.15

iu/l

0.55

169

927

Major coronary heart disease event

1494

6755

1.33

22.41

1.8

1.9

23.43

12.47

iu/l

0.42

590

2664

Emergency coronary revascularization (for ACS)

1492

6816

1.33

22.23

1.8

1.9

23.54

12.78

iu/l

0.40

586

2671

Diabetes mellitus in pregnancy

888

3942

1.45

22.21

2.4

2.2

3.94

12.13

iu/l

1.28

429

1821

Dental pulpitis, including avohilmo

1928

9691

1.28

22.09

2.1

2.0

7.76

16.64

iu/l

0.71

821

4067

Type 2 diabetes

1976

8985

1.28

22.07

2.0

7.88

11.39

iu/l

0.31

805

3746

Hyperkinetic disorders, excluding more controls

330

1730

1.82

22.04

2.0

2.4

2.71

3.61

iu/l

2.92

134

828

Cerebrovascular diseases (FINNGEN)

567

2540

1.58

21.90

1.9

2.1

14.32

10.93

iu/l

0.10

216

1132

Migraine without aura

526

3358

1.59

21.83

1.9

2.2

3.45

9.42

iu/l

0.88

208

1573

Diseases of the skin and subcutaneous tissue

1981

7795

1.28

21.83

2.0

3.90

17.82

iu/l

1.34

803

3289

Somatoform disorder

374

2192

1.74

21.83

1.8

2.1

49.81

6.22

iu/l

0.71

133

986

ILD medications: immunosuppressive drugs

1266

8583

1.35

21.68

2.3

2.0

4.91

9.11

iu/l

0.83

510

3644

Adrenocortical insufficiency

110

407

2.84

21.59

2.2

2.0

67.25

18.34

iu/l

0.36

167

Neoplasms

1570

6282

1.32

21.58

2.0

2.1

7.49

15.89

iu/l

0.49

641

2835

Implicit viral Sepsis, including avohilmo

569

3695

1.56

21.51

1.9

5.38

5.54

iu/l

0.02

207

1447

Viral Sepsis

392

2336

1.70

21.39

1.9

6.23

6.57

iu/l

0.03

147

911

Hypoparathyroidism

109

404

2.84

21.35

2.2

2.0

5.93

18.98

iu/l

0.42

157

Conjunctivitis

1654

10345

1.30

21.31

2.1

2.0

37.76

11.05

iu/l

0.43

678

4327

Asthma-related pneumonia

673

4531

1.50

21.27

1.8

1.9

169.43

3.86

iu/l

1.15

247

1814

Exclusions for E4_PCOS_CONSORTIUM

1705

8267

1.30

21.25

1.9

2.1

11.19

15.91

iu/l

0.24

701

3560

Influenza and pneumonia

2167

10680

1.26

21.25

1.9

2.0

45.94

8.31

iu/l

0.79

814

4496

Functional dyspepsia

580

3810

1.54

21.13

2.1

2.0

3.21

12.22

iu/l

1.03

224

1601

Lumbar disc prolapse

1241

6859

1.35

21.12

1.9

2.0

9.48

11.98

iu/l

0.14

501

2886

Non-rheumatic valve diseases

747

3644

1.48

21.05

1.9

15.58

10.27

iu/l

0.17

261

1468

Asthma-related pneumonia or sepsis

673

4542

1.49

21.02

1.8

1.9

169.43

3.86

iu/l

1.15

247

1816

Asthma, hospital admissions 3, pneumonia

673

4542

1.49

21.02

1.8

1.9

169.43

3.86

iu/l

1.15

247

1816

Missing teeth due to accident, extraction or parodontitis

1130

7463

1.36

21.00

2.0

1.9

4.49

14.00

iu/l

1.66

450

2928

Any operation in hilmo

4.27

20.87

2.2

1.8

3.77

4.33

iu/l

0.21

Nutritional anaemias

937

6428

1.40

20.84

2.0

1.9

4.32

12.99

iu/l

1.35

349

2563

Implicit viral Sepsis

389

2332

1.69

20.77

1.9

6.27

6.57

iu/l

0.03

146

910

Valvular heart disease excluding rheumatic fever

749

3669

1.47

20.75

1.9

15.52

10.23

iu/l

0.17

262

1480

Asthma, hospital admissions , main diagnosis only

1658

11268

1.29

20.62

1.9

2.0

75.90

5.76

iu/l

1.41

685

4634

Other and unspecified disorders of orbit

8.09

20.57

1.9

1.8

2.04

2.72

iu/l

0.75

Nonorganic sleeping disorders, excluding more controls

453

2831

1.63

20.55

1.9

2.2

3.06

3.92

iu/l

1.92

171

1293

Complications of procedures, not elsewhere classified

1609

10085

1.29

20.48

2.0

8.34

13.06

iu/l

0.38

637

4169

Dilated cardiomyopathy

189

906

2.13

20.45

1.7

1.9

156.91

10.61

iu/l

0.69

337

Concussion

1007

5676

1.39

20.42

1.9

2.1

5.55

16.83

iu/l

0.71

407

2451

Hyperlipidaemia, other/unspecified

573

3385

1.54

20.31

1.6

1.7

51.32

13.75

iu/l

0.82

195

1193

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

382

1870

1.70

20.27

1.5

1.9

3.32

8.33

iu/l

0.81

713

Hyperparathyroidism

365

2143

1.71

20.26

1.7

1.9

3.43

7.02

iu/l

0.68

135

817

Finngen Rheumatological endpoints

1939

8717

1.27

20.21

1.9

2.1

10.96

13.25

iu/l

0.11

752

3723

Clear cell adenocarcinoma of kidney

100

364

2.85

20.11

1.7

1.9

3.11

20.23

iu/l

0.54

144

Benign neoplasms

1929

8308

1.27

20.08

2.0

2.1

6.40

15.28

iu/l

0.70

772

3560

Other inflammation of eyelid

299

1687

1.81

19.98

2.3

1.8

12.48

7.01

iu/l

0.27

112

692

Chronic rhinitis, nasopharyngitis and pharyngitis

682

4682

1.47

19.97

1.9

2.0

3.42

8.86

iu/l

0.75

237

2003

Weight loss

218

1114

2.01

19.91

1.9

2.0

3.37

8.98

iu/l

0.55

445

Iron deficiency anaemia

818

5695

1.42

19.85

2.0

4.33

9.22

iu/l

0.92

304

2299

Other symptoms and signs involving the nervous and musculoskeletal systems

841

6004

1.42

19.84

2.0

3.20

10.50

iu/l

1.31

370

2491

Other and unspecified iron deficiency

671

4589

1.48

19.83

2.0

4.53

6.80

iu/l

0.53

248

1864

Hypopituitarism

151

673

2.30

19.71

1.6

2.1

49.43

4.04

iu/l

0.46

289

Excessive, frequent and irregular menstruation

972

3741

1.40

19.68

2.1

67.25

5.93

iu/l

0.64

400

1636

Malignant neoplasm of bronchus and lung, including Hilmo

339

1644

1.74

19.64

1.5

1.8

3.35

9.03

iu/l

0.78

608

Heartburn

250

1344

1.90

19.58

2.1

2.0

2.98

3.92

iu/l

1.75

578

Disease of hard tissues of teeth, NOS

953

3578

1.41

19.57

2.0

1.9

3.38

19.13

iu/l

1.72

381

1452

Certain infectious and parasitic diseases

2000

7976

1.26

19.53

2.0

2.1

7.88

15.68

iu/l

0.53

797

3419

Chronic sinusitis

861

6180

1.41

19.52

2.1

2.0

3.18

11.14

iu/l

1.39

335

2616

Maternal care for other known or suspected fetal problems

648

2741

1.51

19.50

2.4

2.2

13.61

6.44

iu/l

0.30

312

1303

Triptan medication for migraine, min. 3 purchases

1370

7859

1.32

19.35

2.0

2.2

14.51

15.88

iu/l

0.05

577

3500

Undetermined asthma, excluding more controls

273

1519

1.83

19.04

1.8

2.0

3.08

3.80

iu/l

0.88

101

664

Conduction disorders

470

2396

1.59

19.00

1.6

1.9

3.19

4.02

iu/l

1.94

161

939

Nonischemic cardiomyopathy

175

838

2.13

19.00

1.7

1.9

178.55

11.30

iu/l

0.70

315

Cardiomyopathy, other and unspecified

141

620

2.33

18.99

1.5

1.9

169.34

3.91

iu/l

0.49

239

Abnormal weight loss

198

996

2.04

18.95

1.9

2.0

3.55

9.77

iu/l

0.53

393

Hypokalaemia

230

1216

1.93

18.93

1.7

1.8

3.44

3.55

iu/l

0.08

453

Obesity related asthma

688

4783

1.46

18.91

1.8

2.0

37.05

3.95

iu/l

0.74

273

1992

Type1 diabetes, definitions combined, early onset

168

794

2.17

18.88

2.3

2.2

3.01

3.61

iu/l

0.71

354

Dronedarone medication

201

3.48

18.86

1.3

1.6

2.83

3.72

iu/l

0.50

Mycoses, including avohilmo

1855

11283

1.26

18.85

2.0

15.99

15.01

iu/l

0.03

739

4669

Other disorders affecting eyelid function

5.55

18.81

5.2

1.9

6.18

4.00

iu/l

0.50

Coeliac disease

274

1539

1.82

18.69

2.4

2.0

4.43

7.25

iu/l

0.37

142

667

Other disorders of adrenal gland

123

516

2.48

18.66

2.2

2.0

61.60

14.75

iu/l

0.39

218

Other symptoms and signs involving cognitive functions and awareness

807

5108

1.41

18.65

1.8

1.9

13.55

13.56

iu/l

0.00

316

1988

Other and unspecified dermatitis

1055

7888

1.35

18.64

1.9

2.0

26.93

10.83

iu/l

0.44

388

3306

Fibromyalgia

256

1416

1.86

18.48

1.9

2.2

3.06

8.81

iu/l

0.64

104

652

Dermatitis

1237

9259

1.32

18.43

1.9

2.0

23.15

15.88

iu/l

0.19

466

3843

Caries of dentine, including avohilmo

1415

5558

1.31

18.43

1.9

2.0

3.58

15.33

iu/l

1.75

562

2239

Personality disorders

596

4056

1.49

18.39

1.9

2.2

2.95

6.70

iu/l

1.12

225

1843

Diabetes, insulin treatment (Kela reimbursement)

1912

9113

1.26

18.31

1.9

2.0

7.43

10.66

iu/l

0.29

792

3726

Pregnancy examination and test

421

1621

1.64

18.27

2.6

2.1

3.62

12.21

iu/l

0.88

185

783

Other maternal disorders predominantly related to pregnancy

1384

6689

1.31

18.23

2.2

2.1

7.70

12.93

iu/l

0.48

631

2900

Cholecystectomy

1377

9076

1.30

18.13

1.9

2.0

3.62

12.51

iu/l

2.06

538

3749

All pneumoniae

2032

10686

1.24

17.93

1.9

2.0

48.72

8.35

iu/l

0.80

763

4482

Excessive vomiting in pregnancy

229

1238

1.91

17.87

2.0

2.2

2.90

3.94

iu/l

1.11

102

572

Non-small cell lung cancer, adenocarcinoma

121

512

2.43

17.86

1.5

1.8

3.65

16.02

iu/l

0.51

191

Spondylosis

951

5475

1.37

17.86

1.9

20.21

10.78

iu/l

0.35

373

2183

Poisoning by drugs, medicaments and biological substances

505

3344

1.53

17.84

2.1

2.2

3.37

7.37

iu/l

0.90

196

1497

Complications of the puerperium, not elsewhere classified

146

675

2.27

17.81

2.3

3.24

3.68

iu/l

0.53

311

False labour

770

3390

1.43

17.74

2.3

2.2

3.19

8.32

iu/l

1.19

336

1592

Thyrotropin deficiency

130

4.22

17.71

1.7

2.0

1.93

4.67

iu/l

1.82

Disorders of adult personality and behaviour

623

4310

1.46

17.67

1.9

2.2

2.99

6.50

iu/l

1.11

242

1960

Dental caries, including avohilmo

1278

4989

1.32

17.64

1.9

2.0

3.49

12.72

iu/l

1.71

504

2033

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

865

3946

1.39

17.55

1.9

2.1

9.63

8.33

iu/l

0.07

384

1805

Primary adrenocortical insufficiency

113

4.45

17.53

2.2

2.0

150.37

3.62

iu/l

0.51

Undetermined asthma

273

1560

1.78

17.45

1.8

2.0

3.08

3.77

iu/l

0.83

101

676

Primary hyperparathyroidism

238

1317

1.85

17.14

1.7

2.0

3.61

8.55

iu/l

0.56

516

Non-small cell lung cancer, adenocarcinoma, helper endpoint

121

522

2.38

17.12

1.5

1.9

3.65

15.63

iu/l

0.50

196

Iron deficiency

109

452

2.53

17.10

2.3

2.54

4.18

iu/l

2.47

204

Poisoning by medicine

462

3033

1.55

17.04

2.1

2.2

3.04

7.72

iu/l

0.99

180

1360

Diaphragmatic hernia

644

4511

1.44

17.03

2.0

1.9

15.40

6.20

iu/l

0.44

238

1777

Pneumonias (Asthma/COPD co-morbidities)

2010

10677

1.24

17.01

1.9

2.0

49.36

8.35

iu/l

0.80

752

4476

Benign neoplasm of colon, rectum, anus and anal canal

1068

6830

1.33

17.00

1.9

10.62

14.02

iu/l

0.18

357

2667

Candidiasis, including avohilmo

676

4783

1.43

16.99

1.9

2.1

3.46

6.55

iu/l

0.96

281

2032

Malignant neoplasm of respiratory system and intrathoracic organs

327

1629

1.69

16.89

1.5

1.8

3.29

9.17

iu/l

0.81

606

Shoulder lesions

1377

6419

1.29

16.89

1.8

2.0

3.57

14.02

iu/l

1.68

540

2671

Diseases of oral cavity, salivary glands and jaws

958

3631

1.37

16.88

2.0

1.9

9.82

19.01

iu/l

0.51

376

1464

Malignant neoplasm of urinary organs, including Hilmo

180

911

2.01

16.87

1.6

1.8

2.87

10.61

iu/l

0.59

339

Malignant neoplasm of bronchus and lung

291

1418

1.74

16.83

1.5

1.8

3.33

9.95

iu/l

0.77

518

Acute pharyngitis

323

1934

1.68

16.81

2.2

3.92

3.67

iu/l

0.20

139

872

Diseases of salivary glands

672

4758

1.43

16.80

1.8

2.0

12.06

5.61

iu/l

0.31

253

2010

Implicit fungal Sepsis, including avohilmo

157

760

2.12

16.78

1.7

2.0

16.40

11.95

iu/l

0.11

293

Diseases of arteries, arterioles and capillaries (FINNGEN)

377

1609

1.63

16.77

1.8

2.0

4.81

15.51

iu/l

0.46

140

684

Complications of medical and surgical care

1420

10051

1.28

16.76

2.0

9.40

12.39

iu/l

0.19

540

4148

Chronic diseases of tonsils and adenoids

1593

7976

1.27

16.75

2.1

2.0

12.97

16.32

iu/l

0.14

657

3373

Later onset COPD, excluding more controls

311

1404

1.71

16.69

1.8

3.88

4.03

iu/l

0.10

104

505

Chronic gastritis

463

3055

1.53

16.59

1.9

6.10

9.49

iu/l

0.39

167

1174

All influenza

451

2959

1.54

16.56

2.2

2.0

4.19

5.68

iu/l

0.35

161

1211

Arthropathies

1815

7370

1.25

16.49

2.0

2.1

6.77

16.02

iu/l

0.66

769

3129

Other retinal disorders

1088

6285

1.32

16.46

1.9

6.63

12.97

iu/l

0.68

413

2427

STROKE

985

4958

1.35

16.46

1.8

2.0

9.74

10.93

iu/l

0.06

361

2020

Dental operations

1011

3873

1.35

16.45

1.9

2.0

3.78

14.97

iu/l

1.53

412

1552

Osteoporosis with pathological fracture (FG)

166

827

2.06

16.44

2.2

1.8

3.53

4.09

iu/l

0.42

305

Pain in thoracic spine

332

2036

1.66

16.44

2.0

2.1

3.14

6.89

iu/l

0.81

126

888

Abnormal involuntary movements

268

1553

1.76

16.43

2.1

2.0

37.89

7.50

iu/l

0.49

102

641

Non-selective monoamine reuptake inhibitors

674

4601

1.42

16.23

1.8

1.9

3.32

14.33

iu/l

1.30

264

1869

Systemic connective tissue disorders

691

4948

1.41

16.20

1.8

2.0

29.76

10.46

iu/l

0.52

244

2019

Problems related to lifestyle

219

1203

1.86

16.11

2.2

2.1

63.97

8.12

iu/l

0.44

529

Diverticular disease of intestine

1209

5801

1.31

16.05

1.8

1.9

3.64

14.82

iu/l

1.69

417

2362

Persons encountering health services for specific procedures, not carried out

189

993

1.95

16.01

1.9

2.0

3.65

3.99

iu/l

0.19

426

Polycystic ovarian syndrome, consortium definition

1785

8279

1.25

15.88

2.0

2.1

46.37

10.36

iu/l

0.67

734

3575

Cholelithiasis

1609

8797

1.26

15.86

1.9

2.0

7.27

11.90

iu/l

0.45

636

3636

Disorders of gallbladder, biliary tract and pancreas

1862

9416

1.24

15.83

1.9

2.0

12.09

12.16

iu/l

0.00

751

3868

Disorders of synovium and tendon

1059

6864

1.32

15.78

2.0

2.1

10.06

14.24

iu/l

0.23

469

2904

Diseases of the ear and mastoid process

2300

9541

1.21

15.70

2.0

34.01

12.16

iu/l

0.48

929

4000

Malignant neoplasm of urinary organs

156

771

2.06

15.68

1.6

1.8

2.92

12.02

iu/l

0.58

286

Unspecified mental disorder

778

5708

1.38

15.67

1.8

2.1

13.58

6.14

iu/l

0.35

325

2426

All kidney diseases

1943

10655

1.23

15.58

1.9

2.0

12.14

15.98

iu/l

0.20

740

4466

Malignant neoplasm of kidney, except renal pelvis

146

706

2.11

15.58

1.6

1.8

3.06

12.88

iu/l

0.56

259

Other systemic involvement of connective tissue

557

3868

1.46

15.56

1.9

2.0

35.51

7.42

iu/l

0.67

198

1579

Agoraphobia

404

2.53

15.55

2.6

2.2

4.65

4.30

iu/l

0.08

201

Presence of other functional implants

993

5138

1.33

15.49

1.7

1.9

15.34

13.50

iu/l

0.07

374

1987

Spinal stenosis

819

4440

1.37

15.48

1.8

1.9

26.99

10.89

iu/l

0.53

306

1710

Disorders of choroid and retina

1403

7769

1.27

15.47

1.9

11.33

14.05

iu/l

0.16

562

3079

Abnormal findings on antenatal screening of mother

243

1400

1.78

15.42

2.5

2.4

2.65

3.81

iu/l

3.79

118

670

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1945

10615

1.23

15.39

1.8

2.0

50.49

8.49

iu/l

0.78

725

4448

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

147

720

2.11

15.38

2.3

2.0

4.66

11.99

iu/l

0.44

289

Special screening examination for infectious and parasitic diseases

495

2431

1.50

15.35

2.1

4.05

3.83

iu/l

0.22

156

1090

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1151

8774

1.30

15.35

2.0

10.24

12.66

iu/l

0.12

450

3616

Presence of cardiac and vascular implants and grafts

626

3242

1.43

15.32

1.6

1.8

3.40

10.86

iu/l

0.77

218

1178

Ptosis of eyelid

201

1093

1.87

15.30

2.4

1.8

4.15

9.52

iu/l

0.48

425

Benign neoplasm of other and unspecified endocrine glands

261

1535

1.73

15.24

2.0

3.20

7.63

iu/l

0.64

636

Carpal tunnel syndrome

1184

7997

1.29

15.24

1.9

2.0

28.97

9.31

iu/l

0.68

480

3254

Cholelithiasis, broad definition with cholecystitis

1657

8901

1.25

15.22

1.9

2.0

8.53

11.81

iu/l

0.29

659

3669

Other CVD (FINNGEN)

190

762

1.93

15.21

1.9

2.0

19.51

4.30

iu/l

0.53

314

Dentofacial anomalies [including malocclusion]

1514

9499

1.26

15.17

2.1

41.37

10.10

iu/l

0.46

611

4062

Other chronic obstructive pulmonary disease, including avohilmo

815

4952

1.36

15.08

1.8

1.9

34.95

7.28

iu/l

0.69

288

1861

Benign neoplasm: Colon

885

6240

1.34

15.08

1.8

1.9

12.08

13.75

iu/l

0.07

293

2411

Obesity due to excess calories

1006

7714

1.32

15.07

2.0

2.1

25.22

11.45

iu/l

0.39

407

3313

Heart failure and coronary heart disease

607

2983

1.44

15.05

1.7

1.8

7.85

12.01

iu/l

0.24

205

1050

Hypothyroidism, autoimmune, DX-based

5.94

15.00

2.0

1.9

2.92

6.49

iu/l

0.94

Migraine without aura and triptan purchases

426

2832

1.53

14.97

2.0

2.3

3.52

9.60

iu/l

0.78

166

1345

Gingivitis and periodontal diseases

1846

7762

1.23

14.97

2.0

3.92

12.43

iu/l

1.99

737

3167

Cervicalgia

409

2693

1.54

14.92

1.9

2.0

2.92

6.45

iu/l

1.04

155

1126

Specific personality disorders

512

3534

1.47

14.83

1.9

2.2

2.99

5.24

iu/l

0.91

196

1624

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

159

808

2.00

14.82

1.6

1.8

2.96

11.55

iu/l

0.58

303

Early onset COPD, excluding more controls

304

1869

1.64

14.78

1.9

33.84

4.14

iu/l

0.56

115

766

Pneumonia, organism unspecified

1755

9814

1.23

14.69

1.8

2.0

52.37

8.77

iu/l

0.69

635

4120

Other specified/unspecified arthritis

508

3505

1.47

14.68

1.9

2.0

18.97

10.40

iu/l

0.23

199

1470

Irregular menses

1233

7283

1.28

14.67

2.1

2.2

58.52

8.17

iu/l

0.69

529

3234

Hyperkalaemia

408

2.43

14.55

1.5

1.7

3.61

3.68

iu/l

0.03

153

Cervical disc disorders

625

4485

1.41

14.48

2.0

1.9

3.77

7.21

iu/l

0.93

256

1814

Heart failure and bmi 25plus

501

2275

1.48

14.48

1.7

1.8

6.25

10.04

iu/l

0.34

167

870

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

508

3056

1.47

14.45

2.1

2.3

2.84

3.57

iu/l

2.42

215

1383

Acute sinusitis

1084

7657

1.30

14.44

2.1

2.0

10.81

18.61

iu/l

0.36

446

3268

Disturbance of activity and attention

327

2016

1.61

14.40

2.0

2.3

2.71

3.70

iu/l

2.96

133

929

Other diseases of hard tissues of teeth

928

3617

1.34

14.23

2.0

1.9

3.61

19.05

iu/l

1.68

363

1460

Inflammatory diseases of female pelvic organs

1546

8556

1.25

14.22

2.1

3.52

18.61

iu/l

1.72

617

3703

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

391

2495

1.54

14.20

1.5

1.9

2.82

10.19

iu/l

1.18

101

990

Symptoms and signs involving the urinary system

1342

8065

1.26

14.12

1.8

2.0

23.02

11.07

iu/l

0.40

487

3252

Schizophrenia or delusion, excluding more controls

542

3762

1.44

14.12

1.7

2.1

3.35

3.99

iu/l

0.59

227

1626

COPD-related respiratory insufficiency

168

885

1.93

14.09

1.8

8.55

11.24

iu/l

0.11

306

Allergic asthma (mode), excluding more controls

481

3231

1.47

14.03

2.0

2.1

118.50

3.92

iu/l

0.60

202

1459

Other neurological diseases

1246

7646

1.27

13.98

1.8

1.9

10.44

12.61

iu/l

0.13

465

3024

Disorders of sclera, cornea, iris and ciliary body

1036

8059

1.30

13.91

2.0

3.94

8.98

iu/l

1.15

425

3325

Gestational diabetes (for exclusion)

967

5101

1.32

13.90

2.3

2.2

49.66

10.12

iu/l

0.41

436

2358

Diseases of pulp and periapical tissues and dental caries

1120

4450

1.30

13.90

1.9

2.0

3.49

12.16

iu/l

1.46

444

1812

Menorrhagia

795

3287

1.36

13.86

2.0

2.1

20.08

6.35

iu/l

0.60

331

1428

Urinary track infection

1496

6021

1.25

13.85

2.1

12.58

18.82

iu/l

0.25

620

2650

Deforming dorsopathies

545

3853

1.43

13.80

1.9

2.0

3.78

5.64

iu/l

0.67

214

1617

Social phobias

201

1132

1.81

13.72

2.0

2.3

44.25

3.84

iu/l

0.48

539

Caries of enamel

1899

10282

1.21

13.69

2.1

2.0

3.72

12.02

iu/l

2.43

727

4328

Hyperkinetic disorders

335

2105

1.58

13.56

2.0

2.3

2.71

3.65

iu/l

2.84

134

968

Continuous positive airway pressure

278

1416

1.65

13.53

1.7

2.0

3.21

4.26

iu/l

1.89

581

Pain and other conditions associated with female genital organs and menstrual cycle

541

3196

1.43

13.53

2.0

2.2

3.87

3.91

iu/l

0.03

204

1451

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

626

4501

1.39

13.46

2.1

2.2

16.25

10.60

iu/l

0.17

232

2093

Implicit bacterial Sepsis, including avohilmo

721

4437

1.36

13.45

1.7

1.9

38.99

3.97

iu/l

0.79

259

1673

COPD

652

3854

1.38

13.45

1.8

1.9

18.67

3.96

iu/l

0.56

233

1425

Polyarthropathies

1224

6220

1.27

13.40

1.9

2.0

10.94

9.53

iu/l

0.07

450

2645

Trochanteric bursitis

324

2081

1.58

13.38

2.0

2.1

28.71

7.87

iu/l

0.37

123

869

Other specified and unspecified disorders of eyelid

122

3.74

13.36

3.5

1.7

5.69

58.91

iu/l

0.48

Stomatitis and related lesions

398

2672

1.51

13.33

2.1

4.42

5.78

iu/l

0.27

168

1133

Pain associated with micturition

246

1479

1.69

13.30

1.9

2.0

3.47

7.54

iu/l

0.55

104

621

Convulsions, not elsewhere classified

393

2595

1.51

13.30

2.0

2.1

2.84

3.92

iu/l

2.82

145

1113

Genitourinary diseases

923

3513

1.33

13.29

2.1

2.0

9.54

5.94

iu/l

0.25

400

1473

Other medical care

826

5246

1.33

13.26

1.7

2.0

5.39

11.06

iu/l

0.67

264

2083

Extrapyramidal and movement disorders

657

4827

1.37

13.24

1.8

1.9

28.80

5.63

iu/l

0.71

245

1903

Coxibs

459

1626

1.49

13.22

2.1

2.0

4.16

5.19

iu/l

0.31

185

699

Allergic asthma (mode)

481

3270

1.45

13.21

2.0

2.1

118.50

3.90

iu/l

0.60

202

1468

Intracranial trauma

1093

5781

1.28

13.15

1.9

2.1

5.29

16.61

iu/l

0.73

441

2492

Other and unspecified visual disturbances

220

1292

1.74

13.02

1.9

2.0

4.51

8.32

iu/l

0.41

535

Other arthrosis

896

4590

1.32

12.94

1.9

13.49

9.19

iu/l

0.17

323

1873

Excessive attrition of teeth

1233

9782

1.26

12.88

2.0

2.1

10.53

15.46

iu/l

0.24

457

4166

Other chronic obstructive pulmonary disease

621

3698

1.38

12.88

1.9

1.8

19.46

4.00

iu/l

0.56

221

1360

Other arthritis (FG)

568

4099

1.40

12.82

1.9

2.0

17.58

7.73

iu/l

0.31

220

1724

Delirium, not induced by alcohol and other psychoactive substances

187

1048

1.81

12.82

1.7

1.8

10.08

3.74

iu/l

0.44

368

Kela-code for severe mental illness

664

4916

1.36

12.77

1.7

2.1

14.02

4.96

iu/l

0.37

276

2080

Inflammatory disease of uterus

360

2395

1.53

12.75

2.0

2.2

3.50

8.80

iu/l

0.88

157

1107

Heterophoria

184

1034

1.82

12.75

2.4

2.1

4.20

8.61

iu/l

0.40

452

Bacterial pneumoniae

676

4393

1.36

12.73

1.8

1.9

37.53

6.99

iu/l

0.64

266

1755

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1047

8230

1.28

12.69

2.0

10.84

11.60

iu/l

0.03

413

3359

Nonorganic sleeping disorders

453

3152

1.46

12.66

1.9

2.1

3.06

5.48

iu/l

0.83

171

1412

Other gastritis (incl. Duodenitis)

368

2456

1.52

12.66

1.9

24.92

6.50

iu/l

0.41

146

961

Urticaria

631

4646

1.37

12.62

2.0

2.1

3.40

8.23

iu/l

1.28

257

2032

Bacterial pneumonia, not elsewhere classified

638

4118

1.37

12.57

1.8

1.9

40.49

7.17

iu/l

0.64

245

1651

Other noninfective gastroenteritis and colitis

460

3210

1.45

12.56

2.0

4.35

7.71

iu/l

0.58

156

1341

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1296

9535

1.25

12.52

2.0

2.1

9.67

14.18

iu/l

0.24

537

4057

Post-traumatic stress disorder

224

1339

1.71

12.48

2.1

2.3

8.12

3.77

iu/l

0.44

655

Follicular adenocarcinoma of thyroid gland, including Hilmo

4.07

12.47

2.3

2.4

3.65

5.44

iu/l

0.50

Urticaria and erythema

755

5728

1.33

12.33

2.0

2.1

3.40

10.53

iu/l

1.26

309

2480

Disorders of vestibular function (Vertigo)

845

6338

1.31

12.28

1.9

3.54

14.37

iu/l

1.78

309

2538

Paralytic strabismus

129

655

2.01

12.21

1.8

1.9

3.68

12.99

iu/l

0.51

254

Other extrapyramidal and movement disorders in other diseases

446

3115

1.45

12.21

1.8

2.0

41.03

5.81

iu/l

0.73

165

1248

Implicit bacterial Sepsis

635

4019

1.36

12.14

1.7

1.9

33.75

5.54

iu/l

0.54

228

1511

Disorder of lipoprotein metabolism, unspecified

184

1048

1.78

12.07

1.8

1.6

19.76

3.46

iu/l

0.47

366

Haemorrhoids and perianal venous thrombosis

588

4279

1.38

12.05

1.8

2.0

17.69

16.75

iu/l

0.02

213

1737

Abnormal findings on diagnostic imaging of other body structures

273

1728

1.60

12.04

1.9

2.0

29.70

7.27

iu/l

0.41

120

705

Other and unspecified effects of external causes

556

4051

1.39

11.92

1.9

2.1

3.18

6.80

iu/l

1.02

214

1796

Other symptoms and signs involving the circulatory and respiratory systems

128

654

2.00

11.89

1.9

2.0

3.32

4.11

iu/l

0.48

260

Type 2 diabetes, definitions combined, including avohilmo

1784

8596

1.21

11.80

1.9

2.0

8.32

10.00

iu/l

0.12

708

3592

Other disorders of skin and subcutaneous tissue

1320

9065

1.24

11.80

1.9

2.0

10.03

11.10

iu/l

0.06

514

3683

Paracetamol or NSAID medication

287

902

1.62

11.79

2.0

2.2

3.95

3.61

iu/l

0.23

123

409

Soft tissue disorders related to use, overuse and pressure

500

3586

1.41

11.77

1.9

2.0

19.93

11.50

iu/l

0.20

191

1468

Volume depletion

141

746

1.92

11.75

1.8

5.93

3.35

iu/l

0.65

263

Cervicobrachial syndrome

434

3041

1.44

11.70

2.0

20.58

6.19

iu/l

0.39

180

1296

Endometriosis

792

3507

1.33

11.69

2.0

2.1

3.48

6.10

iu/l

0.68

320

1542

Disorders of vitreous body and globe

893

6590

1.29

11.68

2.0

1.9

6.32

11.56

iu/l

0.60

339

2625

Contraceptive management

779

4153

1.32

11.66

2.3

2.0

43.51

7.45

iu/l

0.80

348

1830

Other acute lower respiratory infections

943

7060

1.28

11.61

2.0

3.79

7.06

iu/l

1.18

334

2914

Other diseases of the digestive system

464

3294

1.42

11.54

1.8

5.75

6.40

iu/l

0.08

164

1247

Primary gonarthrosis, bilateral

843

5466

1.30

11.52

1.8

1.9

27.12

10.00

iu/l

0.33

333

2067

Bacterial infection, other or unspecified, including avohilmo

983

6359

1.27

11.46

1.7

2.0

31.12

6.28

iu/l

0.70

335

2538

Elevated blood glucose level

157

869

1.84

11.45

2.3

2.1

4.52

10.49

iu/l

0.43

357

Disorders of lens

1072

5278

1.27

11.44

1.9

9.11

13.39

iu/l

0.25

414

2126

GI-bleeding

459

3259

1.42

11.40

1.8

5.61

6.38

iu/l

0.09

168

1232

AV-block

241

1273

1.63

11.34

1.6

1.8

3.16

4.04

iu/l

1.26

460

Non-small cell lung cancer, squamous

238

2.65

11.33

1.6

1.9

3.19

28.24

iu/l

0.51

Bacterial pneumonia (organism specified)

706

4853

1.33

11.30

1.8

1.9

39.70

6.69

iu/l

0.74

275

1897

Other and unspecified polyneuropathies, also in other diseases

281

1816

1.57

11.29

1.8

1.9

67.74

7.31

iu/l

0.46

694

Postmenopausal osteoporosis with pathological fracture

136

727

1.92

11.15

2.2

1.8

3.56

12.50

iu/l

0.49

258

Disorders of refraction and accommodation

571

4207

1.37

11.15

2.1

2.0

3.47

6.77

iu/l

0.91

221

1831

Other and unspecified anaemias

660

4676

1.33

11.07

1.9

29.92

7.49

iu/l

0.44

244

1761

Supervision of high-risk pregnancy

484

2073

1.42

11.07

2.6

2.1

36.22

10.65

iu/l

0.36

235

968

Pre-eclampsia or poor fetal growth

745

5718

1.31

10.99

2.3

2.2

46.70

19.27

iu/l

0.51

340

2561

Follicular adenocarcinoma of thyroid gland

5.10

10.97

2.1

2.2

2.22

6.28

iu/l

—

Bacterial Sepsis

730

4615

1.32

10.96

1.7

1.9

29.98

5.26

iu/l

0.54

261

1754

Certain infectious and parasitic diseases, including avohilmo

1365

5583

1.23

10.93

2.0

2.1

7.89

17.09

iu/l

0.47

563

2421

Polyuria

340

2305

1.49

10.90

1.9

29.81

7.31

iu/l

0.41

120

903

Myocarditis

404

2.23

10.89

1.6

2.0

33.10

4.21

iu/l

0.46

182

Coxarthrosis [arthrosis of hip](FG)

876

4709

1.29

10.88

1.8

1.9

39.92

7.25

iu/l

0.62

297

1876

Diabetic maculopathy, excluding more controls

178

1037

1.74

10.88

2.1

5.04

9.47

iu/l

0.35

418

Special screening examination for other diseases and disorders

216

1323

1.65

10.87

1.8

2.0

3.58

3.77

iu/l

0.07

115

550

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

336

2278

1.50

10.86

2.0

2.2

3.83

6.10

iu/l

0.50

121

1047

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1742

11414

1.19

10.84

2.0

4.23

16.68

iu/l

1.82

658

4743

Noninfective enteritis and colitis

842

6588

1.29

10.82

1.9

2.0

3.81

9.71

iu/l

1.11

303

2784

Rheumatism, unspecified

290

1910

1.54

10.82

2.0

2.1

22.70

17.66

iu/l

0.09

123

804

Adenomyosis (Endometriosis of uterus)

298

1971

1.53

10.81

1.9

2.0

3.11

8.10

iu/l

0.69

117

817

Ovarian cyst

814

3600

1.31

10.77

2.2

2.1

3.88

6.02

iu/l

0.53

362

1585

COPD, hospital admissions

621

3922

1.34

10.76

1.9

1.8

19.46

6.19

iu/l

0.45

221

1419

Emotionally unstable personality disorder

292

1929

1.54

10.76

1.9

2.3

3.20

3.78

iu/l

0.73

111

897

Substance use, excluding alcohol

360

2479

1.47

10.70

2.0

2.1

52.52

6.01

iu/l

0.51

132

1080

Disorders of vitreous body

866

6480

1.28

10.70

2.0

1.9

6.33

11.72

iu/l

0.60

329

2578

Type 2 diabetes, definitions combined

1756

8588

1.19

10.64

1.9

2.0

8.41

10.88

iu/l

0.18

693

3578

Cardiac murmurs and other cardiac sounds

188

1107

1.71

10.60

2.1

2.0

3.44

3.78

iu/l

0.29

460

Other anaemias

663

4717

1.32

10.60

1.9

29.81

7.45

iu/l

0.44

245

1775

Bleeding

1385

8009

1.22

10.59

1.9

10.79

12.99

iu/l

0.14

516

3206

Adverse effects, not elsewhere classified

405

2860

1.43

10.55

1.9

2.1

3.11

8.17

iu/l

1.00

154

1263

COPD, early/later onset

626

3956

1.34

10.54

1.8

19.38

6.16

iu/l

0.45

222

1432

Mouth breathing

621

4683

1.33

10.53

1.9

26.96

10.76

iu/l

0.46

268

1886

Other general symptoms and signs

116

594

1.98

10.50

1.9

2.2

3.96

4.21

iu/l

0.11

265

Polyneuropathies and other disorders of the peripheral nervous system

317

2137

1.50

10.48

1.8

1.9

59.57

6.71

iu/l

0.46

107

819

Maternal care for known or suspected abnormality of pelvic organs

609

3080

1.35

10.45

2.3

2.2

3.10

10.14

iu/l

1.38

276

1442

Acetic acid derivatives and related substances

439

1594

1.43

10.42

1.9

2.0

3.20

5.22

iu/l

0.83

168

685

Diseases of the myoneural junction and muscle

201

1225

1.66

10.40

1.7

2.0

4.69

8.88

iu/l

0.40

479

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

545

4048

1.36

10.40

1.9

2.0

3.23

11.94

iu/l

1.03

200

1664

Glucagon-like peptide-1 (GLP-1) analogues

545

4048

1.36

10.40

1.9

2.0

3.23

11.94

iu/l

1.03

200

1664

Procreative management

611

3787

1.34

10.36

2.1

2.0

30.57

9.17

iu/l

0.36

280

1659

Other and unspecified urticaria

399

2820

1.43

10.36

2.1

3.66

5.79

iu/l

0.57

153

1245

Anosmia

116

3.30

10.34

1.7

2.0

2.09

2.51

iu/l

0.64

Renal tubulo-interstitial diseases

1627

10013

1.20

10.31

1.8

2.0

10.38

12.82

iu/l

0.16

611

4158

Hypercalcemia

428

2.16

10.30

1.8

1.9

3.26

17.86

iu/l

0.52

164

Abnormal serum enzyme levels

366

2452

1.45

10.29

1.9

1.8

4.94

10.70

iu/l

0.70

119

913

Transient ischemic attack

791

4912

1.29

10.25

1.8

1.9

14.28

10.59

iu/l

0.16

287

1875

Left bundle-branch block

120

632

1.93

10.25

1.5

1.8

3.14

3.74

iu/l

0.38

237

Disorders of skin appendages

990

7918

1.25

10.24

2.1

3.45

10.24

iu/l

1.49

402

3380

Intracranial injury

1043

7848

1.24

10.23

1.9

2.0

5.03

11.00

iu/l

1.03

411

3207

Falls/tendency to fall

2087

8929

1.18

10.23

2.0

7.14

17.51

iu/l

0.83

855

3775

Non-small cell lung cancer, squamous, helper endpoint

252

2.50

10.12

1.6

1.8

3.19

29.06

iu/l

0.52

Type 2 diabetes, strict (exclude DM1)

1756

8629

1.19

10.11

1.9

2.0

8.43

10.84

iu/l

0.18

691

3596

All chronic kidney diseases

883

5573

1.27

10.11

1.8

1.9

6.91

7.58

iu/l

0.06

337

2221

Pregnancy hypertension

979

7044

1.25

9.98

2.2

2.1

23.97

18.60

iu/l

0.13

451

3087

Diseases of male genital organs

509

1861

1.38

9.91

1.8

3.53

13.81

iu/l

0.94

195

675

Hypertensive Heart Disease

309

1577

1.50

9.87

1.8

30.95

4.07

iu/l

0.48

558

Postpartum care and examination

338

1449

1.49

9.86

2.3

2.1

3.05

13.03

iu/l

0.94

179

706

Renal failure

669

4376

1.31

9.83

1.6

1.9

7.78

11.00

iu/l

0.23

226

1607

Statin medication

1287

5963

1.22

9.80

2.0

2.1

3.41

14.95

iu/l

1.84

559

2586

Coxarthrosis

787

3965

1.29

9.79

1.8

1.9

44.43

10.15

iu/l

0.56

265

1583

Bacterial infection, other or unspecified

866

5799

1.27

9.79

1.7

1.9

27.79

7.54

iu/l

0.47

286

2297

Other and unspecified nerve root and plexus disorders, also in other diseases

375

2648

1.43

9.78

2.1

3.38

5.87

iu/l

0.64

173

1135

KRA_PSY_EATING, excluding more controls

205

1266

1.63

9.77

1.8

2.4

6.58

3.89

iu/l

0.26

634

Temporomandibular joint disorders, including avohilmo

1012

7944

1.24

9.76

2.1

60.07

10.07

iu/l

0.50

408

3494

Other and unspecified tonsillitis

642

4084

1.32

9.71

2.0

2.1

3.65

24.14

iu/l

1.08

281

1817

Psychotic depression

115

610

1.92

9.66

1.9

2.2

74.63

3.97

iu/l

0.48

268

Injuries to the thorax

724

5648

1.29

9.62

1.8

1.9

18.84

6.28

iu/l

0.50

260

2246

COPD related to multimorbidity

521

3274

1.35

9.62

1.8

22.13

6.67

iu/l

0.44

187

1145

Senile cataract

944

4586

1.26

9.60

1.9

10.04

11.70

iu/l

0.08

363

1797

Rotator cuff syndrome

1026

5711

1.24

9.59

1.8

2.0

10.62

13.23

iu/l

0.12

409

2322

Diseases of inner ear

941

7252

1.25

9.53

1.9

3.53

13.02

iu/l

1.79

349

2905

Other disorders of bladder

177

1069

1.68

9.52

1.8

1.9

57.16

9.53

iu/l

0.42

413

Obsessive-compulsive disorder

159

935

1.73

9.52

2.0

2.3

2.56

3.83

iu/l

3.77

454

Benign neoplasm: Colon, unspecified

376

2669

1.42

9.51

1.9

1.8

4.14

6.44

iu/l

0.46

128

990

Malignant neoplasm, including Hilmo

1598

7843

1.19

9.49

1.8

2.0

4.38

12.34

iu/l

1.70

597

3392

Other diseases of intestine

254

1672

1.54

9.49

2.0

1.9

4.27

7.52

iu/l

0.44

660

Congenital malformations, deformations and chromosomal abnormalities

1156

9023

1.22

9.48

2.0

2.1

3.72

15.41

iu/l

1.32

478

3880

Recurrent aphthous stomatitis , including avohilmo

277

1860

1.51

9.46

1.9

2.0

3.83

6.66

iu/l

0.47

118

796

Chronic kidney disease

425

2961

1.39

9.45

1.7

1.8

10.88

6.14

iu/l

0.31

143

1063

Arthrosis

1211

5448

1.22

9.41

1.9

2.0

8.70

10.64

iu/l

0.13

491

2265

Sequelae of external causes of morbidity and mortality

433

3155

1.39

9.40

2.0

3.02

8.18

iu/l

1.03

176

1272

Enlarged lymph nodes

267

1780

1.52

9.39

1.7

2.1

26.12

4.10

iu/l

0.48

103

753

Malignant neoplasm, wide definition

1596

7836

1.19

9.39

1.8

2.0

4.37

12.37

iu/l

1.71

594

3384

Cervicocranial syndrome

212

1346

1.60

9.36

2.1

2.93

8.29

iu/l

0.74

580

Viral and other specified intestinal infections, including avohilmo

549

3990

1.33

9.35

2.1

2.2

3.81

4.94

iu/l

0.37

238

1780

Superficial injury of head

423

3069

1.39

9.35

1.7

2.0

3.18

5.64

iu/l

0.72

150

1254

Other diseases of anus and rectum

498

3696

1.35

9.34

1.9

2.0

3.43

11.46

iu/l

1.04

191

1503

Chronic periodontitis, including avohilmo

1818

9907

1.18

9.32

2.0

8.47

12.41

iu/l

0.34

729

4078

Other diseases of lip and oral mucosa

785

6221

1.27

9.31

2.0

13.77

11.57

iu/l

0.08

303

2564

Hypotension

241

1574

1.55

9.31

1.9

1.8

16.75

7.80

iu/l

0.32

569

Internal derangement of knee

643

4918

1.30

9.29

1.9

2.0

36.33

8.55

iu/l

0.41

242

2081

Asthma and allergy, excluding more controls

270

1786

1.51

9.29

2.0

2.2

192.61

3.76

iu/l

0.50

106

859

Aplastic and other anaemias

705

5035

1.29

9.28

1.9

28.49

7.14

iu/l

0.45

260

1918

Allergic conjunctivitis

1212

9672

1.21

9.26

2.1

49.82

10.00

iu/l

0.49

501

4120

Periodontitis

1820

9914

1.17

9.25

2.0

8.43

12.41

iu/l

0.34

734

4080

Localized swelling, mass and lump of skin and subcutaneous tissue

564

4292

1.32

9.18

1.8

2.0

37.73

6.88

iu/l

0.74

194

1801

Solid cancers, including Hilmo

1563

7685

1.19

9.17

1.9

2.0

4.37

12.52

iu/l

1.72

580

3325

DVT of lower extremities and pulmonary embolism

645

4973

1.30

9.16

1.8

1.9

28.86

7.17

iu/l

0.65

251

1928

Substance abuse, excluding more controls

893

5991

1.25

9.16

1.9

2.0

23.49

11.65

iu/l

0.27

325

2502

Tonsillectomy and adenotomy

1183

6793

1.22

9.15

2.1

3.39

18.49

iu/l

1.36

491

3057

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1064

7567

1.23

9.10

2.2

2.1

22.23

17.76

iu/l

0.11

493

3281

Other cataract

681

3930

1.30

9.10

1.8

1.9

3.34

11.04

iu/l

0.80

250

1528

Emotional disorders starting during childhood or adolecense, excluding more controls

102

514

1.97

9.10

2.2

2.4

2.82

3.76

iu/l

1.07

257

Pulmonary heart disease, diseases of pulmonary circulation

481

3581

1.35

9.07

1.7

1.9

37.61

7.85

iu/l

0.66

186

1371

Need for other prophylactic measures

110

589

1.91

9.05

2.5

2.0

3.54

13.62

iu/l

0.53

243

Acute bronchitis

694

5328

1.29

9.05

1.9

2.0

3.54

6.37

iu/l

0.92

251

2173

Suicide or other Intentional self-harm

455

3365

1.37

9.03

2.0

2.1

3.42

7.41

iu/l

0.89

169

1485

Acute tubulo-interstitial nephritis

1161

8105

1.21

8.98

1.8

2.0

10.76

13.11

iu/l

0.11

439

3333

Medical abortion

1454

6613

1.20

8.97

2.1

9.59

14.88

iu/l

0.35

594

2849

Exposure to unspecified factor

1929

11301

1.16

8.96

1.9

2.0

13.90

15.29

iu/l

0.06

701

4724

Viral and other specified intestinal infections

400

2829

1.39

8.96

2.1

2.2

3.67

5.30

iu/l

0.39

180

1254

Retention of urine

446

2646

1.37

8.95

1.6

1.8

3.38

7.05

iu/l

0.83

154

994

Hyperfunction of pituitary gland

114

621

1.88

8.94

1.7

2.1

1.92

4.08

iu/l

7.19

266

Ischaemic heart disease, wide definition

1220

6216

1.21

8.92

1.8

1.9

17.23

14.35

iu/l

0.10

463

2427

Single delivery by caesarean section

432

1790

1.40

8.89

2.4

2.1

3.20

12.25

iu/l

1.01

208

809

Malignant neoplasm

1542

7635

1.19

8.88

1.9

2.0

4.47

12.62

iu/l

1.68

585

3293

Asthma and allergy

270

1803

1.50

8.87

2.0

2.2

192.61

3.77

iu/l

0.50

106

855

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1154

9166

1.21

8.86

2.1

2.0

52.05

10.36

iu/l

0.49

478

3893

Injuries to the abdomen, lower back, lumbar spine and pelvis

695

5379

1.28

8.86

2.0

15.70

7.64

iu/l

0.28

252

2198

Non-allergic asthma (mode), excluding more controls

312

2151

1.45

8.83

2.0

27.86

3.92

iu/l

0.49

128

938

All influenza (not pneumonia)

238

1570

1.53

8.83

2.3

2.0

4.96

7.17

iu/l

0.27

666

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

140

813

1.76

8.82

1.8

2.1

2.72

10.54

iu/l

0.62

351

Dislocation, sprain and strain of joints and ligaments at neck level

309

2151

1.45

8.81

2.1

2.2

6.51

6.30

iu/l

0.02

131

963

Injuries to the neck

425

3124

1.37

8.78

2.1

5.70

5.48

iu/l

0.03

170

1373

Venous thromboembolism

853

6609

1.25

8.78

1.8

1.9

30.88

12.11

iu/l

0.61

321

2570

Malignant neoplasm

1540

7634

1.19

8.75

1.9

2.0

4.48

12.63

iu/l

1.68

584

3290

Obesity, other/unspecified

687

5403

1.28

8.74

2.0

2.1

26.23

10.82

iu/l

0.29

256

2376

Vitamin deficiency, wide

512

1.96

8.71

2.2

2.1

7.50

15.09

iu/l

0.30

211

Vitamin deficiency

512

1.96

8.71

2.2

2.1

7.50

15.09

iu/l

0.30

211

Persons encountering health services in circumstances related to reproduction

994

5427

1.23

8.70

2.1

2.0

17.65

7.74

iu/l

0.47

434

2278

Chronic laryngitis and laryngotracheitis

245

1633

1.52

8.70

2.2

2.0

4.60

7.03

iu/l

0.32

685

Wide developmental disorders, excluding more controls

302

2.25

8.69

1.9

2.3

2.27

4.41

iu/l

3.30

152

Polyarthrosis

361

2325

1.41

8.68

1.8

1.9

5.05

10.84

iu/l

0.61

130

919

Persistent mood disorders

348

2481

1.42

8.67

2.0

2.1

3.11

6.03

iu/l

0.75

124

1082

Sequelae with surgical and medical care as external cause

341

2424

1.42

8.64

1.9

2.0

3.14

6.24

iu/l

0.69

140

970

Propionic acid derivatives

456

1679

1.37

8.59

2.0

3.82

5.13

iu/l

0.48

202

716

Solid cancers

1502

7453

1.19

8.55

1.8

2.0

4.39

12.88

iu/l

1.72

560

3206

Other disorders of amniotic fluid and membranes

330

2259

1.43

8.52

2.3

2.2

3.36

6.96

iu/l

0.67

143

1079

Meniscus derangement

891

4770

1.25

8.52

1.9

30.50

8.95

iu/l

0.50

376

1952

Fenamates

259

1180

1.51

8.48

1.8

2.0

3.02

3.97

iu/l

1.88

106

507

Acute inflammation of orbit

4.36

8.44

1.9

1.8

1.36

4.57

iu/l

1.35

Autoimmune hepatitis, wide definition

380

2.10

8.42

2.2

1.7

4.27

2.81

iu/l

0.52

138

Other shoulder lesions

185

1169

1.61

8.40

2.0

2.1

3.93

4.18

iu/l

0.06

524

Gonarthrosis,primary

1441

7347

1.19

8.34

1.8

1.9

22.10

9.71

iu/l

0.40

557

2875

Spondylolisthesis/Spondylolysis

324

2299

1.42

8.32

1.9

2.0

4.09

7.00

iu/l

0.61

121

951

Hernia of abdominal wall, postoperative

298

2066

1.45

8.32

1.9

2.0

23.04

16.55

iu/l

0.12

120

867

Keratitis

634

4968

1.29

8.31

2.0

4.15

8.06

iu/l

0.95

269

2070

Oxicams

339

1353

1.43

8.31

1.7

2.0

3.74

5.63

iu/l

0.59

113

569

Blepharochalasis

461

3464

1.34

8.26

2.1

1.7

4.16

13.87

iu/l

0.84

175

1295

Entropion and trichiasis of eyelid

114

635

1.82

8.24

1.9

1.7

4.16

15.07

iu/l

0.50

214

Other external causes of accidental injury

1566

6673

1.18

8.23

2.0

2.1

8.40

20.70

iu/l

0.73

680

2856

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

193

1243

1.59

8.18

2.4

2.2

2.89

4.08

iu/l

2.28

578

Other (not insulin) diabetes medications

1785

9029

1.16

8.13

1.9

2.0

8.24

10.58

iu/l

0.18

713

3727

Gonarthrosis [arthrosis of knee](FG)

1228

5903

1.20

8.11

1.8

1.9

24.49

6.62

iu/l

0.56

497

2412

Any event in cancer register

1729

8684

1.17

8.10

1.9

2.1

12.52

16.25

iu/l

0.15

665

3739

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

126

728

1.76

8.09

2.0

10.40

12.12

iu/l

0.06

285

Other specified and unspecified personality disorders

179

1134

1.61

8.08

1.7

2.2

2.64

3.86

iu/l

2.19

508

Other problems related to primary support group, including family circumstances

242

1591

1.50

8.08

2.1

2.2

34.67

6.91

iu/l

0.41

736

Tinnitus

405

2997

1.36

8.07

2.1

2.0

37.28

6.45

iu/l

0.45

162

1244

Acute renal failure

295

2070

1.44

8.03

1.6

1.8

13.22

7.23

iu/l

0.28

102

754

Necrosis of pulp, including avohilmo

1096

9030

1.21

8.02

2.1

2.0

3.89

17.53

iu/l

1.58

489

3798

Persons with potential health hazards related to communicable diseases

757

6029

1.25

8.01

2.2

3.42

17.77

iu/l

1.11

388

2652

Other bacterial intestinal infections, including avohilmo

393

2897

1.37

8.01

1.8

2.0

3.67

5.74

iu/l

0.48

142

1191

Benign neoplasm: Adrenal gland

138

821

1.71

8.00

1.9

2.0

3.62

11.18

iu/l

0.53

325

Certain disorders involving the immune mechanism

309

2192

1.42

7.97

1.9

2.0

3.82

6.42

iu/l

0.51

124

923

Fall on same level

2185

10190

1.15

7.95

2.0

3.59

16.62

iu/l

1.74

885

4263

Conjunctivitis (acute, non atopic)

532

4088

1.31

7.89

2.2

2.0

3.56

6.95

iu/l

0.88

222

1743

Hypertensive heart and/or renal disease

328

1704

1.41

7.88

1.8

27.89

4.22

iu/l

0.48

608

Infections of the skin and subcutaneous tissue

1033

8441

1.21

7.88

1.9

2.0

17.94

11.20

iu/l

0.19

413

3499

Scleritis and episcleritis

129

758

1.74

7.86

2.1

2.2

3.94

11.10

iu/l

0.48

319

Viral pneumonia

206

1355

1.54

7.83

2.1

2.0

8.62

7.91

iu/l

0.04

564

Other disorders of conjunctiva

228

1533

1.51

7.82

2.3

1.9

4.40

7.80

iu/l

0.41

602

conjunctival haemorrhage

130

767

1.72

7.77

2.3

2.0

4.62

11.77

iu/l

0.44

299

Fracture of rib(s), sternum and thoracic spine

441

3322

1.34

7.77

1.6

1.9

31.64

5.73

iu/l

0.60

144

1293

Gonarthrosis

1032

4812

1.22

7.76

1.8

1.9

27.85

8.94

iu/l

0.49

427

1964

Schizophrenia, schizotypal and delusional disorders

546

4240

1.30

7.73

1.7

2.1

3.37

6.78

iu/l

0.91

226

1809

Endometriosis of pelvic peritoneum

366

2439

1.38

7.73

2.1

3.02

7.01

iu/l

0.76

157

1100

Pulmonary embolism

438

3303

1.34

7.66

1.7

1.9

40.66

8.20

iu/l

0.66

170

1275

Non-allergic asthma (mode)

312

2211

1.41

7.65

2.0

27.86

3.92

iu/l

0.49

128

949

Intermittent heterotropia

124

725

1.74

7.65

2.2

2.1

3.86

3.58

iu/l

0.15

325

Other disorders of ear

1614

8975

1.17

7.65

1.9

2.0

16.10

12.19

iu/l

0.16

624

3683

Pulmonary heart disease

438

3306

1.33

7.62

1.7

1.9

40.66

8.21

iu/l

0.66

170

1274

Impingement syndrome of shoulder

380

2814

1.36

7.56

2.0

3.76

13.66

iu/l

0.77

144

1150

Other complications of surgical and medical care, not elsewhere classified

185

1201

1.56

7.53

2.0

2.1

6.40

8.58

iu/l

0.18

516

Benign neoplasm: Pituitary gland, craniopharyngeal duct

104

582

1.83

7.53

2.2

2.1

2.35

4.16

iu/l

3.26

243

Restless leg syndrome

261

1817

1.45

7.53

1.8

2.0

3.16

6.90

iu/l

0.66

767

Maternal care related to the fetus and amniotic cavity and possible delivery problems

986

4775

1.22

7.51

2.3

2.1

3.51

11.75

iu/l

1.27

449

2154

Schizophrenia or delusion

542

4222

1.29

7.51

1.7

2.1

3.35

6.78

iu/l

0.91

227

1801

Mycoses

481

3690

1.31

7.49

1.9

2.0

33.19

7.42

iu/l

0.42

205

1506

Other abnormal products of conception

784

4162

1.25

7.48

2.2

3.49

14.04

iu/l

1.33

349

1961

Unspecified acute lower respiratory infection

241

1653

1.47

7.48

2.0

4.31

7.23

iu/l

0.41

704

Dipeptidyl peptidase 4 (DPP-4) inhibitors

819

5227

1.23

7.46

1.8

1.9

34.54

12.61

iu/l

0.45

290

1987

Other disorders of patella

321

2321

1.40

7.45

2.1

5.11

10.16

iu/l

0.57

146

1016

Other and unspecified nonorganic psychotic disorders

345

2525

1.38

7.42

1.7

2.2

2.86

5.94

iu/l

0.85

145

1123

Mental disorders, not otherwise specified

173

1112

1.58

7.39

2.2

2.1

8.04

3.69

iu/l

0.39

488

L01XE Protein kinase inhibitors

477

1.91

7.39

1.5

2.0

2.84

15.66

iu/l

0.55

196

Diagnoses used for exclusion with ILD

361

2663

1.37

7.35

1.8

1.9

4.50

6.03

iu/l

0.29

137

1053

Giant cell arteritis

360

2.05

7.32

1.8

4.03

20.88

iu/l

0.48

136

Premature rupture of membranes

501

2746

1.31

7.30

2.3

2.2

100.96

6.57

iu/l

0.48

206

1296

Disorders of psychological development

224

1409

1.49

7.30

2.0

2.2

3.21

7.30

iu/l

0.55

619

Polymyalgia rheumatica

199

1321

1.52

7.28

1.8

52.82

8.70

iu/l

0.43

478

Hyperhidrosis

396

2.00

7.27

2.4

2.3

2.66

4.45

iu/l

2.35

184

Noninfectious colitis NAS

241

1664

1.47

7.26

2.0

4.62

7.04

iu/l

0.31

721

Cutaneous abscess, furuncle and carbuncle

447

3415

1.32

7.20

2.0

3.24

5.39

iu/l

0.73

181

1461

Gonarthrosis, primary, with knee surgery

875

5604

1.22

7.18

1.9

33.63

8.79

iu/l

0.52

336

2124

Other disorders of glucose regulation and pancreatic internal secretion

139

853

1.65

7.18

2.2

2.1

5.66

10.53

iu/l

0.32

353

Charcot foot

140

2.73

7.17

2.3

2.0

8.73

5.59

iu/l

0.19

Speech and linguistic disorders, excluding more controls

142

820

1.65

7.16

2.0

2.4

3.05

3.77

iu/l

0.66

392

Other diseases of liver

312

2262

1.39

7.14

1.9

2.0

3.51

6.27

iu/l

0.58

125

962

Early onset COPD

304

2193

1.40

7.14

1.9

33.84

6.48

iu/l

0.50

115

849

Other eating disorders

128

772

1.69

7.13

1.8

2.4

2.11

3.62

iu/l

4.62

373

Coxarthrosis, primary

896

6145

1.22

7.13

1.9

39.45

10.60

iu/l

0.53

301

2330

Disorders of muscles

181

1184

1.55

7.12

1.9

2.1

3.71

4.13

iu/l

0.23

533

Postpartum haemorrhage

598

3911

1.27

7.11

2.3

2.1

3.81

14.28

iu/l

1.19

266

1795

Malignant neoplasm of skin, including Hilmo

832

4561

1.23

7.06

1.7

2.0

4.73

12.97

iu/l

1.02

243

1874

Atopic dermatitis

1203

8133

1.18

7.05

2.1

10.43

15.76

iu/l

0.25

478

3528

Other diseases of pericardium

358

2.02

7.04

1.7

1.8

3.26

3.89

iu/l

0.38

138

Female infertility

668

3202

1.26

7.01

2.5

2.1

3.62

6.21

iu/l

0.60

301

1451

Tobacco use

106

611

1.77

6.97

2.5

2.2

120.66

4.13

iu/l

0.49

266

Benign paroxysmal vertigo

505

3941

1.29

6.95

1.9

2.0

3.94

7.42

iu/l

0.79

188

1586

Coronary atherosclerosis

946

4953

1.21

6.89

1.8

1.9

12.76

14.20

iu/l

0.05

333

1868

Other necrotizing vasculopathies (FG)

100

569

1.79

6.85

1.8

1.9

4.10

3.95

iu/l

0.04

224

Schizoaffective disorder

146

919

1.62

6.85

1.6

2.2

2.62

4.00

iu/l

3.19

400

Other and unspecified disorders of vitreous body

707

5615

1.24

6.85

2.0

1.9

3.70

12.82

iu/l

1.42

263

2224

Other bacterial diseases, including avohilmo

1840

10058

1.15

6.85

1.8

2.0

22.99

8.15

iu/l

0.62

690

4216

Drug-induced adrenocortical insufficiency

199

2.40

6.81

2.2

2.0

4.28

4.86

iu/l

0.15

Manic episode

309

2.09

6.80

1.6

2.1

3.94

4.91

iu/l

0.33

136

Nonalcoholic fatty liver disease

181

1198

1.53

6.79

2.1

3.09

8.58

iu/l

0.66

521

Congenital malformations of the circulatory system

239

1621

1.45

6.78

2.3

2.1

3.27

7.21

iu/l

0.61

694

Complications predominantly related to the puerperium

594

4749

1.26

6.77

2.4

2.2

3.72

13.11

iu/l

1.38

272

2108

Brachial plexus disorders

189

1265

1.52

6.74

1.9

2.2

2.82

8.23

iu/l

0.73

570

Accidents

1541

6673

1.16

6.70

2.0

2.1

8.46

20.70

iu/l

0.73

674

2856

Hyperplasia of prostate

317

1290

1.39

6.70

1.6

1.7

3.50

19.53

iu/l

0.95

104

436

Other bacterial diseases

1623

9355

1.15

6.68

1.8

2.0

22.45

7.74

iu/l

0.52

586

3881

Fentanyl

147

929

1.60

6.67

1.6

1.9

3.51

10.14

iu/l

0.52

363

Lichen simplex chronicus and prurigo

112

664

1.72

6.66

2.0

2.50

12.67

iu/l

0.62

268

Mental and behavioural disorders due to sedatives or hypnotics

124

756

1.67

6.63

1.7

2.1

2.91

3.72

iu/l

0.93

329

Temporal arteritis

312

2.07

6.62

1.9

1.8

4.07

23.28

iu/l

0.49

120

Ovarian dysfunction

197

1337

1.50

6.62

2.2

2.3

3.93

3.74

iu/l

0.10

626

Other CVD

268

1918

1.41

6.62

1.9

1.8

15.34

7.19

iu/l

0.33

698

Benign neoplasm of meninges

178

1181

1.53

6.62

1.9

3.65

8.73

iu/l

0.52

479

Dissociative [conversion] disorders

496

1.84

6.61

2.0

2.2

3.27

4.36

iu/l

0.49

237

L04AA Selective immunosuppressants

384

2913

1.33

6.58

2.4

2.0

4.88

8.21

iu/l

0.53

166

1235

Lesion of ulnar nerve

218

1507

1.46

6.57

1.6

2.0

79.26

7.57

iu/l

0.46

646

Operations for atrial fibrillation

3.02

6.53

1.5

1.8

7.14

4.81

iu/l

—

Hypermobility syndrome

128

792

1.65

6.52

1.6

2.2

69.12

3.95

iu/l

0.48

372

Unspecified kidney failure

134

835

1.62

6.52

1.6

1.9

3.62

11.39

iu/l

0.52

311

Maternal care for known or suspected fetal abnormality and damage

371

2371

1.34

6.51

2.3

2.2

3.14

9.55

iu/l

1.01

138

1143

Other noninflammatory disorders of uterus, except cervix

418

2128

1.32

6.51

1.9

4.04

7.85

iu/l

0.50

146

866

COPD, hospital admissions 3, with asthma pneumonia sepsis

323

2041

1.36

6.50

1.8

1.7

35.62

8.38

iu/l

0.46

109

711

Other sleep disorders

179

1193

1.52

6.49

1.7

2.1

2.37

4.16

iu/l

5.22

503

Pre-eclampsia or eclampsia

485

3807

1.29

6.48

2.1

2.2

48.71

13.58

iu/l

0.53

206

1700

Female infertility, cervical, vaginal, other or unspecified origin

610

3124

1.26

6.44

2.4

2.1

79.59

6.25

iu/l

0.47

263

1417

Periapical abscess

785

6492

1.22

6.42

2.1

2.0

4.48

11.04

iu/l

1.16

326

2699

Other necrotizing vasculopathies

115

694

1.68

6.40

1.7

2.0

4.47

12.37

iu/l

0.44

272

Disorders of tooth development and eruption

288

1701

1.39

6.40

2.3

2.1

3.02

19.87

iu/l

1.15

146

745

Third [oculomotor] nerve palsy

149

2.57

6.37

1.5

1.8

4.87

46.42

iu/l

0.48

Benign neoplasm: Cerebral meninges

164

1079

1.54

6.37

1.9

3.62

9.39

iu/l

0.54

431

Oter anti-inflammatory and antirheumatic agents, non-steroids

288

1136

1.40

6.35

2.2

1.9

29.39

6.04

iu/l

0.49

468

Neuromuscular dysfunction of bladder

147

944

1.58

6.34

2.1

2.0

2.96

9.68

iu/l

0.59

392

Diabetic retinopathy, strict definition

270

1729

1.40

6.34

2.1

1.9

11.92

12.25

iu/l

0.01

119

705

COPD, hospital admission 2, with asthma infections

398

2616

1.32

6.33

1.9

1.8

28.31

7.35

iu/l

0.46

142

944

Vitreous haemorrhage

151

976

1.57

6.32

2.0

17.17

10.15

iu/l

0.20

377

Autism spe, excluding more controls

250

2.17

6.32

1.8

2.3

2.25

4.40

iu/l

2.68

127

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

164

1081

1.54

6.31

2.0

6.27

9.20

iu/l

0.22

455

Other symptoms and signs involving the urinary system

151

977

1.56

6.29

1.8

1.9

3.43

10.05

iu/l

0.54

376

Other and unspecified mood [affective] disorders

148

955

1.57

6.28

1.9

2.3

50.52

3.77

iu/l

0.48

458

Papulosquamous disorders

654

5324

1.24

6.28

1.8

2.0

3.37

11.48

iu/l

1.25

248

2176

Other skin changes

319

2375

1.35

6.23

1.9

3.35

6.26

iu/l

0.62

120

959

Other and unspecified myopathies

123

760

1.64

6.23

1.8

1.9

5.37

11.51

iu/l

0.36

298

Follow-up examination after treatment for malignant neoplasms

155

1011

1.55

6.23

1.7

1.9

6.06

4.04

iu/l

0.47

392

Later onset COPD

323

1924

1.36

6.22

1.8

1.7

3.82

9.10

iu/l

0.72

108

623

Horner syndrome

116

2.79

6.21

2.2

1.8

7.97

5.42

iu/l

0.33

Abnormal findings on diagnostic imaging of central nervous system

573

1.74

6.18

2.1

3.63

14.17

iu/l

0.54

233

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1672

9266

1.14

6.18

1.8

2.0

7.46

11.74

iu/l

0.44

652

3820

Astigmatism

117

716

1.66

6.16

2.3

2.1

2.93

11.30

iu/l

0.56

303

Otitis media, unspecified

211

1350

1.46

6.16

2.3

2.2

4.88

7.36

iu/l

0.27

618

Giant cell arteritis with polymyalgia rheumatica

321

2.01

6.15

1.9

1.8

4.07

23.22

iu/l

0.50

122

Cerebrovascular diseases

1110

6559

1.18

6.14

1.8

1.9

11.91

12.87

iu/l

0.04

385

2579

619

0.35

6.13

1.4

1.8

2.31

3.88

iu/l

—

229

Diseases of liver

537

4290

1.26

6.13

2.0

1.9

3.45

7.10

iu/l

0.98

199

1747

Convergent concomitant strabismus

114

696

1.67

6.12

3.6

2.1

6.64

3.67

iu/l

1.80

302

Symptoms and signs involving emotional state

343

1.97

6.11

1.9

2.2

3.27

4.27

iu/l

0.53

151

Hyperprolactinaemia

466

1.83

6.07

1.7

2.3

1.93

4.36

iu/l

6.60

212

Malignant neoplasm of skin

770

4305

1.22

6.05

1.7

2.0

4.90

13.53

iu/l

0.99

225

1758

Other disorders of binocular vision

160

2.48

6.03

2.4

2.1

1.71

4.10

iu/l

2.27

Emotional disorders and disorders of social functioning with onset specific to childhood

111

662

1.67

5.99

2.1

2.3

2.87

3.54

iu/l

0.69

311

Glaucoma

852

6060

1.20

5.97

1.9

6.79

13.49

iu/l

0.64

305

2326

Unspecified haematuria

563

3683

1.25

5.93

1.7

1.9

37.51

6.14

iu/l

0.49

188

1416

Implicit fungal Sepsis

389

1.89

5.92

1.7

2.0

33.42

19.75

iu/l

0.16

150

Mental and behavioural disorders due to psychoactive substance use

928

7182

1.19

5.92

1.9

2.0

22.69

11.61

iu/l

0.27

339

2972

Acute laryngitis and tracheitis

221

1539

1.43

5.92

2.2

2.72

7.04

iu/l

0.71

105

701

Fungal Sepsis

411

1.86

5.90

1.7

2.0

33.42

18.21

iu/l

0.18

165

Other specified/unspecified soft tissue disorders

507

1.77

5.85

2.0

2.49

4.45

iu/l

2.22

229

Disorders of magnesium metabolism

3.77

5.85

1.8

1.7

5.81

3.74

iu/l

—

Myopia

252

1829

1.39

5.85

2.0

2.1

3.55

6.65

iu/l

0.55

103

830

Pleural effusion

194

1343

1.46

5.84

1.7

1.8

3.36

8.60

iu/l

0.56

485

Anti-inflammatory and antirheumatic products, non-steroids

432

1679

1.30

5.81

2.0

16.40

5.13

iu/l

0.43

184

716

Substance abuse

893

7005

1.19

5.77

1.9

2.0

23.49

11.83

iu/l

0.27

325

2898

Other diseases of blood and blood-forming organs, wide

347

2647

1.32

5.77

1.8

2.0

3.71

6.06

iu/l

0.55

137

1074

Corticotropin deficiency

3.03

5.76

2.3

2.1

184.12

4.71

iu/l

0.47

Injuries to the elbow and forearm

1318

9828

1.15

5.75

1.9

2.0

14.89

10.12

iu/l

0.16

521

4049

Viral infections characterized by skin and mucous membrane lesions

714

5918

1.21

5.71

2.0

4.21

6.06

iu/l

0.58

275

2457

Injuries to the knee and lower leg

2226

10780

1.12

5.69

2.0

3.69

17.71

iu/l

1.97

915

4424

Abnormal blood-pressure reading, without diagnosis

497

1.76

5.68

1.9

2.1

3.54

4.60

iu/l

0.63

199

Inflammatory diseases of prostate (prostatitis)

116

723

1.62

5.67

1.8

4.23

6.73

iu/l

0.31

260

Noninflammatory disorders of female genital tract

889

3747

1.20

5.66

2.2

2.1

9.73

5.93

iu/l

0.25

374

1636

Cluster headache, strict, including avohilmo

102

619

1.68

5.65

2.0

2.1

3.42

4.08

iu/l

0.44

274

Other symptoms and signs involving general sensations and perceptions

410

1.84

5.63

1.7

2.0

2.76

18.27

iu/l

0.58

167

Atopic conjunctivitis

559

1.72

5.62

2.0

2.1

3.09

4.16

iu/l

0.70

253

Paralytic ileus and intestinal obstruction

370

2855

1.30

5.60

1.7

1.9

4.37

8.86

iu/l

0.67

118

1122

Deviated nasal septum

442

3486

1.27

5.60

1.9

20.30

8.29

iu/l

0.31

176

1409

Autoimmune hepatitis

3.19

5.59

1.7

2.67

2.54

iu/l

—

Maternal care for known or suspected malpresentation of fetus

430

2405

1.29

5.59

2.1

2.2

106.67

6.80

iu/l

0.48

194

1155

Pregnancy with abortive outcome

1464

6672

1.15

5.57

2.1

3.71

14.78

iu/l

1.93

633

2873

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

279

2013

1.36

5.56

2.1

2.0

2.86

6.44

iu/l

0.74

110

868

Other symptoms and signs involving the digestive system and abdomen

313

2370

1.33

5.52

1.9

2.0

3.71

4.05

iu/l

0.34

121

996

Fracture of lumbar spine and pelvis

333

2535

1.32

5.52

1.8

1.9

2.91

6.34

iu/l

0.81

112

968

Sixth [abducent] nerve palsy

292

2.00

5.52

1.6

1.8

3.26

24.65

iu/l

0.51

111

Cluster headache, strict

406

1.84

5.51

1.9

2.1

2.61

4.72

iu/l

2.98

178

Pre-eclampsia

444

3523

1.27

5.51

2.1

2.2

53.22

9.42

iu/l

0.64

187

1575

Sarcoidosis

205

1454

1.42

5.47

1.9

2.0

3.96

7.81

iu/l

0.49

606

Postprocedural disorders of digestive system, not elsewhere classified

300

1.98

5.46

1.6

2.0

2.22

23.80

iu/l

0.58

121

Other abnormal immunological findings in serum

233

2.13

5.43

1.8

2.1

3.09

4.86

iu/l

1.13

103

Congenital malformations of cardiac septa

118

725

1.60

5.43

2.4

2.1

3.73

11.42

iu/l

0.51

310

283

1972

1.35

5.41

1.6

1.8

4.62

16.39

iu/l

0.67

678

Other and unspecified drugs and medicaments

150

1006

1.51

5.39

2.0

2.1

6.92

9.57

iu/l

0.18

421

Neuralgia and neuritis, unspecified

596

1.67

5.39

1.6

2.1

2.84

4.18

iu/l

1.82

257

Familial hypercholesterolemia

176

1216

1.46

5.39

1.7

1.6

5.29

3.33

iu/l

1.09

423

Polyp of the female genital tract

611

2826

1.23

5.35

2.2

2.0

34.57

6.91

iu/l

0.43

249

1196

Monoamine oxidase A inhibitors

185

1294

1.44

5.34

1.8

2.0

3.58

8.45

iu/l

0.58

540

Angina pectoris

789

4388

1.20

5.34

1.8

1.9

23.05

10.99

iu/l

0.39

320

1627

Hypoglycaemia, other or unspecified

108

674

1.62

5.34

2.1

5.12

12.43

iu/l

0.40

278

Vasomotor and allergic rhinitis

713

5819

1.20

5.33

1.9

2.1

15.51

18.99

iu/l

0.09

282

2540

Anankastic personality disorder

500

1.74

5.33

1.9

2.3

2.76

4.26

iu/l

1.75

226

Acute pancreatitis

267

1985

1.35

5.33

1.8

2.0

3.62

3.90

iu/l

0.17

812

Striking against or struck by other objects

536

4349

1.24

5.31

1.9

2.1

3.25

6.62

iu/l

0.95

221

1852

Glaucoma suspect

553

4508

1.23

5.30

2.0

1.9

8.65

10.38

iu/l

0.11

206

1781

Pregnancy, childbirth and the puerperium

558

2356

1.25

5.29

2.0

1.9

13.67

7.27

iu/l

0.26

230

941

Other disorders of binocular movement

291

1.98

5.27

2.4

2.2

1.98

4.00

iu/l

3.07

119

Infections with a predominantly sexual mode of transmission, including avohilmo

823

6372

1.19

5.27

2.1

2.2

3.70

16.71

iu/l

1.08

324

2870

Lagophthalmos

2.97

5.26

3.7

1.7

4.10

85.76

iu/l

—

Cushing syndrome

115

2.63

5.24

1.8

2.1

2.64

4.47

iu/l

0.79

Benign neoplasm of other and ill-defined parts of digestive system

280

2104

1.34

5.24

2.0

1.9

48.05

6.73

iu/l

0.45

122

827

Personal history of other diseases and conditions

231

1678

1.39

5.23

2.2

4.13

6.86

iu/l

0.41

758

Rash and other nonspecific skin eruption

165

1135

1.47

5.23

1.9

2.0

4.19

8.54

iu/l

0.43

486

Otitis externa

388

3047

1.28

5.22

2.0

3.87

7.94

iu/l

0.74

140

1286

Other bacterial intestinal infections

270

2018

1.35

5.22

1.7

2.0

4.18

6.58

iu/l

0.36

809

Pericarditis

277

1.98

5.21

1.8

1.9

4.25

4.20

iu/l

0.01

114

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

436

1.78

5.21

2.4

2.1

4.34

4.42

iu/l

0.02

188

Psoriasis

452

3615

1.26

5.21

1.8

2.0

2.99

7.48

iu/l

1.08

168

1509

Other disorders of bone

329

2531

1.31

5.20

2.0

2.1

4.54

5.87

iu/l

0.23

124

1111

Oral lichen planus and hypothyroidism or thyroxine medication

224

2.13

5.20

2.2

2.0

2.62

4.04

iu/l

1.32

Benign neoplasm of eye and adnexa

170

1178

1.46

5.19

1.8

2.0

3.30

8.67

iu/l

0.58

485

Atypical facial pain

102

634

1.64

5.18

1.8

2.0

78.91

13.04

iu/l

0.43

260

Benign neoplasm: Sigmoid colon

267

1995

1.35

5.18

1.7

1.9

5.24

6.90

iu/l

0.22

756

Recurrent dislocation of patella

115

736

1.59

5.17

2.2

5.77

3.99

iu/l

0.32

349

Poor fetal growth

298

2268

1.33

5.17

2.5

2.3

39.40

3.78

iu/l

0.49

150

1073

Cluster headache, wide,, including avohilmo

103

643

1.63

5.14

2.0

2.2

3.42

4.04

iu/l

0.40

283

Hallux valgus (acquired)

585

3429

1.23

5.12

1.9

3.94

10.88

iu/l

1.14

225

1428

Other menopausal disorders

545

2464

1.24

5.11

2.0

3.48

7.24

iu/l

0.66

211

1047

Malignant neoplasm of bladder, including Hilmo

116

733

1.57

5.10

1.5

1.7

2.03

16.55

iu/l

0.84

251

Car occupant injured in other and unspecified transport accidents

332

2565

1.30

5.10

2.0

2.1

6.52

5.90

iu/l

0.07

136

1142

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

422

3360

1.27

5.10

2.2

3.95

5.23

iu/l

0.39

167

1571

External causes of morbidity and mortality

1251

5457

1.15

5.09

2.1

3.86

19.98

iu/l

1.08

580

2317

Secondary parkinsonism, excluding more controls

172

2.25

5.08

1.9

1.8

2.48

4.16

iu/l

1.86

Episcleritis

104

653

1.62

5.07

2.3

2.2

4.13

12.58

iu/l

0.48

271

Fall on same level involving ice and snow

1017

8783

1.16

5.06

2.0

3.42

9.58

iu/l

1.61

432

3576

385

2597

1.28

5.06

1.7

12.37

13.13

iu/l

0.03

117

905

Arthropathies in other diseases classified elsewhere

352

1.85

5.04

2.0

1.9

7.30

4.49

iu/l

0.28

151

Ulcer of lower limb, not elsewhere classified

190

1350

1.42

5.03

1.5

1.9

4.50

8.42

iu/l

0.39

507

Drug-induced osteoporosis with pathological fracture

148

2.37

5.03

1.9

1.7

3.13

43.76

iu/l

0.52

Autonomic disorders

254

2.02

5.01

1.9

2.0

6.00

4.13

iu/l

0.40

101

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

119

773

1.56

4.99

1.8

2.1

3.66

3.62

iu/l

0.01

338

Sequelae of injuries, of poisoning and of other consequences of external causes

368

2889

1.28

4.98

1.9

2.0

51.82

8.14

iu/l

0.44

160

1221

Secondary right heart disease

310

1.90

4.97

1.7

1.8

5.88

24.13

iu/l

0.44

117

Corneal ulcer

299

2286

1.32

4.97

2.2

2.1

4.15

6.16

iu/l

0.39

132

982

Degeneration of macula and posterior pole

668

4299

1.20

4.94

1.8

9.36

13.24

iu/l

0.25

214

1545

Anomalies of pupillary function

242

2.04

4.94

2.3

2.2

5.12

4.19

iu/l

0.18

103

Single delivery by forceps and vacuum extractor

324

1482

1.32

4.94

2.6

2.2

3.74

13.26

iu/l

0.86

157

681

Erosion of teeth , including avohilmo

498

4053

1.24

4.93

1.9

2.1

120.19

5.02

iu/l

0.49

171

1807

Fibroblastic disorders

328

2541

1.30

4.92

1.6

1.9

3.86

15.94

iu/l

0.83

120

999

Female genital prolapse

565

2570

1.23

4.89

2.1

2.0

27.63

7.22

iu/l

0.61

229

1068

Vitamin D deficiency

202

2.14

4.89

2.2

2.0

8.52

4.41

iu/l

0.33

Injuries to the ankle and foot

1362

10264

1.14

4.89

2.0

3.71

15.65

iu/l

1.58

547

4333

Delivery, wide proxy

640

2812

1.22

4.87

2.1

2.0

34.04

6.56

iu/l

0.61

273

1136

Cardiac arrest

386

1.73

4.87

1.8

5.72

3.95

iu/l

0.22

157

Specific development disorders of scholastic skills

502

1.69

4.86

1.7

2.2

3.62

3.67

iu/l

0.01

230

Fracture of foot, except ankle

439

3531

1.25

4.85

2.0

2.1

4.19

7.21

iu/l

0.61

181

1550

Retinal detachments and breaks

504

4115

1.23

4.82

1.8

1.9

19.07

7.30

iu/l

0.35

204

1578

Aortic aneurysm

238

1731

1.36

4.82

1.6

1.7

3.84

9.03

iu/l

0.65

594

Polycystic ovarian syndrome

148

1017

1.48

4.82

2.3

2.4

3.08

3.79

iu/l

0.88

487

Spondyloarthritis

258

1940

1.34

4.81

1.9

2.1

4.34

6.75

iu/l

0.37

101

822

Other diseases of pleura

582

4181

1.21

4.80

1.7

1.9

40.82

7.39

iu/l

0.55

196

1557

Collagenous colitis

159

1106

1.46

4.80

2.1

2.0

5.87

9.05

iu/l

0.25

459

Emotional disorders starting during childhood or adolescence

104

656

1.60

4.79

2.2

2.3

2.98

3.48

iu/l

0.44

297

Labour and delivery complicated by fetal stress [distress]

565

3024

1.22

4.78

2.6

2.2

90.80

9.87

iu/l

0.54

265

1435

Thoracic aortic aneurysm

163

1138

1.44

4.78

1.7

1.8

4.32

9.20

iu/l

0.41

416

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

255

1858

1.34

4.78

2.1

2.0

2.87

6.68

iu/l

0.73

804

Septal defects

110

695

1.57

4.77

2.5

2.1

3.06

11.74

iu/l

0.58

301

Oligomenorrhoea

486

1.70

4.77

2.1

3.74

4.00

iu/l

0.08

231

Uterine polyps

562

2697

1.23

4.75

2.1

2.0

64.12

7.05

iu/l

0.73

227

1134

Follicular cysts of skin and subcutaneous tissue

283

2162

1.32

4.75

2.0

4.93

6.23

iu/l

0.19

911

Vitamin A deficiency

3.73

4.73

2.1

15.20

5.01

iu/l

—

Sicca syndrome [Sjögren]

158

1102

1.45

4.73

2.1

2.0

3.36

8.94

iu/l

0.57

462

Cluster headache, wide

434

1.74

4.72

1.9

2.1

2.61

4.61

iu/l

2.99

192

Diabetic retinopathy, excluding more controls

419

1864

1.27

4.72

2.0

1.9

4.48

11.92

iu/l

0.64

169

727

Acute pancreatitis (for exclusion)

267

2025

1.33

4.71

1.8

1.9

3.62

6.62

iu/l

0.51

813

Other postsurgical states

102

649

1.59

4.70

1.6

2.0

2.90

13.37

iu/l

0.61

258

Eating disorder

207

1513

1.38

4.68

1.9

2.3

6.63

3.82

iu/l

0.27

700

Cramp and spasm

511

1.67

4.67

1.8

2.1

2.38

4.17

iu/l

2.57

215

Congenital malformations of heart and great arteries

199

1402

1.39

4.67

2.2

2.1

3.20

7.66

iu/l

0.60

603

Appendectomy

1190

9952

1.14

4.66

2.0

20.21

14.98

iu/l

0.16

506

4161

Urolithiasis

409

3281

1.25

4.62

1.9

3.46

8.66

iu/l

1.02

149

1288

Other disorders starting during childhood or adolecense, excluding more controls

473

1.68

4.61

1.7

2.3

3.00

4.16

iu/l

0.73

238

Intestinal stricture

434

3506

1.24

4.61

1.7

1.9

4.19

7.82

iu/l

0.66

149

1369

Other viral diseases

500

4087

1.23

4.60

2.1

3.98

5.02

iu/l

0.35

213

1806

Secondary polycythaemia

181

2.15

4.53

1.7

2.0

2.67

4.37

iu/l

1.11

Heart failure and hypertrophic cardiomyopathy

117

2.45

4.53

1.7

1.8

1.52

4.18

iu/l

—

Other and unspecified injuries of head

120

799

1.52

4.53

1.6

2.0

4.45

10.66

iu/l

0.43

336

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

211

1556

1.37

4.52

1.6

1.9

3.83

9.02

iu/l

0.68

613

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

152

1061

1.45

4.52

1.9

2.0

3.16

9.25

iu/l

0.57

426

Other disorders of the musculoskeletal system and connective tissue

228

1703

1.35

4.51

2.1

2.0

4.00

7.14

iu/l

0.45

705

Other and unspecified disorders of binocular movement

3.18

4.51

1.4

2.3

1.98

3.77

iu/l

—

Respiratory insufficiency

606

1.59

4.51

1.7

1.9

196.35

4.37

iu/l

0.53

227

Superficial injury of wrist and hand

376

3000

1.26

4.51

2.2

2.1

3.41

5.44

iu/l

0.60

139

1338

Dysplasia of cervi uteri

527

3052

1.22

4.50

2.3

2.1

26.43

6.33

iu/l

0.43

240

1382

Other coagulation defects

136

931

1.48

4.50

1.7

2.1

2.60

9.50

iu/l

0.65

409

Malignant neoplasm of digestive organs

345

3331

0.79

4.49

1.7

1.9

4.64

11.00

iu/l

0.98

124

1305

Other abnormal uterine and vaginal bleeding

456

2660

1.24

4.48

2.0

17.88

7.00

iu/l

0.34

161

1122

Gout

312

2083

1.29

4.47

1.7

1.8

4.39

7.98

iu/l

0.41

101

758

Diseases of external ear

561

4669

1.21

4.46

2.0

4.38

7.10

iu/l

0.67

204

1910

Other diseases of oesophagus

130

882

1.49

4.46

1.7

1.9

84.77

10.80

iu/l

0.43

332

Other pulmonary heart/vessel disease

351

1.79

4.46

1.7

1.8

5.67

21.69

iu/l

0.44

132

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

422

3418

1.25

4.46

2.3

2.2

2.98

7.33

iu/l

1.08

163

1547

Pyoderma gangrenosum

2.78

4.43

2.5

2.0

2.63

5.92

iu/l

1.27

Acute and transient psychotic disorders

187

1359

1.39

4.42

1.6

2.1

4.74

7.87

iu/l

0.34

595

Outcome of delivery

347

1675

1.28

4.41

2.2

2.1

3.90

12.04

iu/l

0.84

131

805

Lactose intolerance, other/unspecified

266

1.92

4.41

2.3

1.8

4.01

4.72

iu/l

0.25

Superficial injury of lower leg

474

3889

1.23

4.39

2.0

3.50

7.27

iu/l

0.94

190

1638

Short Achilles tendon (acquired)

332

1.82

4.39

2.5

2.2

3.23

4.25

iu/l

0.51

162

Intestinal malabsorption

505

1.65

4.38

2.2

2.1

4.23

14.97

iu/l

0.48

210

Prurigo nodularis

218

2.02

4.37

2.0

1.9

2.45

30.01

iu/l

0.55

Dermatitis due to substances taken internally

607

1.59

4.35

2.2

2.0

5.60

13.04

iu/l

0.38

256

Candidiasis

254

1940

1.32

4.33

1.7

2.1

3.49

6.49

iu/l

0.54

105

832

Other enthesopathies

509

4210

1.22

4.33

1.9

2.0

2.89

12.25

iu/l

1.20

213

1775

Postpartum hemorraghe, all women as controls

598

4902

1.20

4.33

2.3

2.2

3.81

20.16

iu/l

1.07

266

2276

L04AX Other immunosuppressants

975

8501

1.15

4.33

2.2

2.0

4.94

10.87

iu/l

1.14

382

3546

Covid-19 suspected case

391

3150

1.25

4.32

1.6

2.2

3.69

7.49

iu/l

0.77

120

1426

COPD, hospital admissions 1, only main diagnosis

411

2852

1.24

4.32

1.9

1.8

27.33

7.17

iu/l

0.45

145

1022

Carcinoma in situ of breast

3.69

4.31

1.6

2.1

4.75

5.57

iu/l

—

Antepartum haemorrhage, not elsewhere classified

187

1368

1.39

4.30

2.4

2.3

3.47

4.04

iu/l

0.44

665

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

200

1468

1.37

4.30

2.0

2.1

3.33

7.17

iu/l

0.53

641

Second line medication for Crohn's disease

1006

8791

1.15

4.29

2.2

2.0

4.90

10.59

iu/l

1.13

390

3684

Eating disorders

229

1725

1.34

4.29

1.8

2.3

6.25

6.79

iu/l

0.04

783

Melanocytic naevi

555

4636

1.20

4.28

1.9

2.1

7.32

8.27

iu/l

0.07

208

1994

Other disorders of nervous system

642

1.56

4.25

1.6

2.0

2.23

4.18

iu/l

4.18

252

Cardiomyopathy, Hypertrophic obstructive

127

2.34

4.25

1.6

1.7

2.53

4.27

iu/l

—

Calculus of kidney and ureter

380

3057

1.25

4.24

1.9

3.38

5.71

iu/l

0.62

137

1200

Presbycusis

162

1142

1.41

4.23

1.6

1.7

42.36

3.71

iu/l

0.49

375

Hyperosmolality and hypernatraemia

2.80

4.23

1.6

1.7

2.25

4.43

iu/l

—

Endometriosis of ovary

345

2587

1.27

4.22

2.1

4.28

7.02

iu/l

0.47

144

1133

Benign neoplasm: salivary glands, exclude unknown (D119)

129

886

1.47

4.21

1.6

2.0

135.12

10.53

iu/l

0.46

353

Other diseases of the respiratory system

251

1920

1.32

4.21

1.7

1.9

82.06

7.10

iu/l

0.59

728

Other respiratory disorders and diseases

251

1920

1.32

4.21

1.7

1.9

82.06

7.10

iu/l

0.59

728

Wide developmental disorders

402

1.72

4.19

1.9

2.1

2.27

3.75

iu/l

2.15

182

Unspecified fall

829

7033

1.16

4.18

1.9

2.0

13.90

10.67

iu/l

0.11

288

2838

Speech disturbances, not elsewhere classified

125

854

1.48

4.18

1.9

3.21

10.90

iu/l

0.55

327

Secondary parkinsonism+Parkinsonism in other disease

187

2.07

4.18

1.9

1.8

2.48

36.38

iu/l

0.54

Salpingitis and oophoritis

345

2756

1.26

4.16

1.9

2.0

3.86

15.06

iu/l

0.90

137

1183

Hypogonadotropic hypogonadism

215

1.99

4.15

1.3

2.1

1.85

3.63

iu/l

2.35

Injury, poisoning and certain other consequences of external causes

1024

4478

1.15

4.14

2.1

3.82

21.89

iu/l

0.96

463

1893

Vitamin B12 deficiency anaemia

140

979

1.44

4.14

2.2

1.9

4.35

10.34

iu/l

0.46

370

Diseases of tongue

630

1.56

4.14

2.0

2.1

3.23

4.33

iu/l

0.60

272

Toxic liver disease

155

2.19

4.14

2.5

2.2

3.56

4.61

iu/l

0.30

Abnormalities of gait and mobility

160

1147

1.41

4.12

1.8

1.9

4.07

9.67

iu/l

0.51

421

Benign neoplasm: Parotid gland

117

793

1.49

4.10

1.6

2.0

153.43

11.56

iu/l

0.45

311

Other mental disorders due to brain damage and dysfunction and to physical disease

157

1124

1.41

4.08

1.6

1.9

2.99

3.81

iu/l

1.15

398

Injuries to the head

2042

11023

1.10

4.07

1.9

2.0

8.36

16.43

iu/l

0.65

798

4571

Other blood glucose lowering drugs, excl. Insulins

212

1593

1.34

4.06

1.7

1.8

3.29

8.02

iu/l

0.62

581

Ischaemic Stroke, excluding all haemorrhages

754

4760

1.17

4.06

1.7

1.9

16.89

10.89

iu/l

0.23

240

1787

Iridocyclitis

353

2833

1.25

4.06

1.9

2.0

3.36

5.71

iu/l

0.62

144

1177

Dislocation, sprain and strain of joints and ligaments of thorax

370

1.73

4.05

1.8

2.0

2.99

4.34

iu/l

1.00

149

Nasal polyp

250

1923

1.31

4.05

2.0

1.9

3.55

6.65

iu/l

0.51

767

L04AD Calcineurin inhibitors

163

1177

1.40

4.05

1.9

2.1

3.17

8.79

iu/l

0.64

501

Chondrocostal junction syndrome [Tietze]

439

1.67

4.04

1.9

2.1

2.15

16.82

iu/l

0.60

182

Alcohol abuse, main dg, excluding more controls

195

1448

1.36

4.04

1.8

2.1

7.38

4.04

iu/l

0.33

643

Assault by bodily force

133

927

1.45

4.04

1.7

2.2

2.36

3.91

iu/l

3.90

426

Fall on and from stairs and steps

426

3491

1.23

4.03

1.9

2.0

24.97

5.42

iu/l

0.44

145

1452

Otitis externa, unspecified

196

1459

1.36

4.03

2.1

3.57

7.49

iu/l

0.55

640

Endometriosis ASRM stages 1,2

372

3010

1.25

4.02

2.1

2.98

7.85

iu/l

1.06

161

1366

Epilepsy

439

3596

1.22

4.02

1.8

2.0

3.44

6.31

iu/l

0.74

168

1476

Sleep disorders, other/unspecified

455

1.66

4.02

2.1

2.3

2.38

4.42

iu/l

3.46

213

Speech and linguistic disorders

148

1008

1.42

4.01

2.0

2.2

3.50

8.53

iu/l

0.47

449

Other viral diseases, not elsewhere classified

288

2253

1.28

4.00

2.0

2.1

4.48

6.10

iu/l

0.29

120

988

Parkinson's disease, excluding more controls

157

1035

1.40

4.00

1.5

1.8

3.35

4.78

iu/l

1.66

384

Flat foot [pes planus] (acquired)

173

1265

1.38

4.00

2.0

3.39

10.11

iu/l

0.59

525

Benign neoplasm of mouth and pharynx

162

1172

1.40

3.98

1.9

2.0

3.05

8.87

iu/l

0.64

480

Mental and behavioural disorders due to opioids

387

1.71

3.98

2.1

2.2

274.67

3.87

iu/l

0.48

169

Parkinson's disease, strict definition, excluding more controls

144

950

1.42

3.96

1.5

1.8

3.45

4.72

iu/l

1.29

349

Assault

210

1583

1.34

3.96

1.8

2.1

2.98

3.73

iu/l

0.76

719

Leiomyoma of uterus

1287

6423

1.13

3.96

2.1

2.0

4.02

15.45

iu/l

1.86

549

2730

Erectile dysfunction

417

1.67

3.95

1.8

1.7

4.81

3.76

iu/l

0.22

137

DVT of lower extremities

263

2045

1.29

3.94

1.8

2.0

3.84

4.05

iu/l

0.12

102

807

Other specified/unspecified systemic involvement of connective tissue

104

695

1.52

3.94

1.8

2.1

88.35

11.98

iu/l

0.43

291

Benign neoplasm of major salivary glands

140

990

1.43

3.93

1.6

2.0

120.57

10.07

iu/l

0.45

390

Rheumatoid arthritis

502

3704

1.21

3.93

1.9

4.02

10.15

iu/l

1.05

183

1527

Other viral diseases, including avohilmo

692

5878

1.17

3.92

2.1

3.77

7.16

iu/l

1.05

303

2568

Secondary parkinsonism

192

2.01

3.91

1.9

1.8

2.48

34.57

iu/l

0.54

Diseases of appendix

1302

10402

1.12

3.91

2.0

24.10

14.05

iu/l

0.34

555

4325

Contact with and exposure to communicable diseases

592

4995

1.19

3.91

2.1

2.2

3.42

10.03

iu/l

1.34

330

2236

Ventral hernia

355

2865

1.25

3.90

1.8

2.0

20.44

6.59

iu/l

0.38

138

1137

Biguanides

1666

9084

1.11

3.90

1.9

2.0

8.67

10.74

iu/l

0.15

669

3773

Other and unspecified abdominal hernia

382

1.70

3.89

1.8

2.0

2.66

4.36

iu/l

1.35

150

Acute and subacute iridocyclitis

290

2288

1.28

3.89

1.8

2.0

3.58

6.09

iu/l

0.52

111

974

Mixed and other personality disorders

142

1010

1.42

3.88

2.1

2.2

2.54

3.81

iu/l

2.82

453

Chronic periodontitis, complicated

868

7381

1.15

3.87

2.0

1.9

13.37

10.81

iu/l

0.10

327

2947

Anterior Iridocyclitis

307

2441

1.27

3.86

1.9

2.0

3.44

5.98

iu/l

0.58

119

1038

Myositis

243

1.89

3.84

1.6

2.1

3.29

4.45

iu/l

0.47

110

Degenerative macular diseases

157

1137

1.39

3.84

2.0

1.8

4.41

9.59

iu/l

0.43

404

Primary coxarthrosis, bilateral

392

3203

1.23

3.84

1.8

78.13

5.85

iu/l

0.69

145

1194

Myasthenia gravis

160

2.12

3.83

2.1

1.9

4.21

3.77

iu/l

—

Dermatophytosis, including avohilmo

1116

9704

1.13

3.83

2.1

2.0

24.41

11.92

iu/l

0.38

444

4001

Zoster [herpes zoster]

281

2213

1.28

3.83

2.0

1.9

4.69

6.65

iu/l

0.32

111

870

Adhesive capsulitis of shoulder

261

2037

1.29

3.83

1.9

2.0

3.53

8.14

iu/l

0.66

835

Selective deficiency of immunoglobulin G [IgG] subclasses

2.77

3.82

2.6

1.8

2.01

4.20

iu/l

—

Lactose intolerance

309

1.78

3.82

2.3

1.9

3.92

4.57

iu/l

0.25

117

Mixed disorders of conduct and emotions, excluding more controls

258

1.86

3.82

2.1

2.4

3.10

4.12

iu/l

0.46

132

Other disorders of kidney and ureter

176

1300

1.37

3.81

2.0

1.9

4.34

8.63

iu/l

0.43

499

Peripheral arterial reconstruction

171

1256

1.37

3.81

1.8

1.7

3.58

9.13

iu/l

0.51

428

Herpesviral [herpes simplex] infections, including avohilmo

490

4097

1.20

3.81

2.0

2.1

4.30

6.84

iu/l

0.59

182

1821

Coxarthrosis, primary, with hip surgery

642

5086

1.17

3.80

1.9

1.8

53.20

12.09

iu/l

0.55

219

1901

Other noninflammatory disorders of vulva and perineum

202

1527

1.34

3.79

2.1

2.80

4.26

iu/l

4.18

668

Bacterial intestinal infections, IBD co-morbidities

264

2066

1.29

3.78

1.7

2.0

4.18

6.55

iu/l

0.36

833

Scoliosis

155

1125

1.39

3.77

1.8

2.1

2.93

8.87

iu/l

0.67

486

Examination and encounter for administrative purposes

106

717

1.49

3.77

2.0

1.8

2.35

4.17

iu/l

3.88

280

Explicit Sepsis, including avohilmo

663

5150

1.17

3.76

1.7

1.9

20.73

5.10

iu/l

0.60

239

2046

Poisoning by narcotics and psychodysleptics [hallucinogens]

175

2.06

3.76

1.3

2.3

2.32

3.97

iu/l

—

Dissocial personality disorder

128

2.24

3.76

2.2

2.96

4.17

iu/l

0.62

Budesonide

235

1815

1.30

3.75

2.0

2.1

3.22

6.71

iu/l

0.63

796

Fissure and fistula of anal and rectal regions

365

2969

1.24

3.74

1.8

2.0

2.92

8.26

iu/l

1.06

143

1252

Other or ill-defined heart diseases

455

1.62

3.74

2.1

2.0

2.73

4.04

iu/l

1.59

201

Nephropathy related operations

153

1109

1.39

3.73

2.1

2.0

5.12

9.29

iu/l

0.33

434

Melanocytic naevi of trunk

203

1539

1.33

3.72

2.0

2.1

3.52

7.35

iu/l

0.56

671

Artificial joint operation, meniscal resection

1425

8193

1.11

3.70

1.8

1.9

22.37

10.98

iu/l

0.34

537

3247

Redundant prepuce, phimosis and paraphimosis

184

1351

1.35

3.70

1.8

4.38

5.22

iu/l

0.17

506

Artrosis, including avohilmo

1366

6700

1.12

3.69

1.9

2.0

8.14

7.10

iu/l

0.08

551

2832

Hypertrophic cardiomyopathy

327

1.74

3.69

1.6

1.9

2.11

21.88

iu/l

0.59

133

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

233

1.90

3.68

2.0

2.3

3.25

4.55

iu/l

0.68

102

Coagulation defects, purpura and other haemorrhagic conditions

295

2349

1.26

3.68

1.9

2.0

6.92

6.15

iu/l

0.07

113

996

221

1701

1.31

3.68

2.3

3.17

3.83

iu/l

0.73

842

Appendicitis, broad definition

1288

10362

1.12

3.67

2.0

24.18

14.08

iu/l

0.34

553

4315

Other diseases of blood and blood-forming organs

100

673

1.50

3.67

1.5

2.0

2.47

12.51

iu/l

0.61

269

Other disorders of white blood cells

529

1.57

3.66

1.7

2.1

5.00

14.87

iu/l

0.44

217

Unspecified/other endometriosis

202

1504

1.33

3.65

2.2

2.71

4.11

iu/l

3.48

709

Torsion of ovary, ovarian pedicle and fallopian tube

322

1.75

3.65

1.6

2.2

4.87

3.86

iu/l

0.33

161

Diseases of arteries, arterioles and capillaries

931

5998

1.14

3.64

1.8

1.9

3.84

11.97

iu/l

1.56

338

2303

Acidosis

123

2.23

3.64

1.7

1.6

3.43

3.64

iu/l

0.05

Pustulosis palmaris et plantaris

507

1.58

3.64

2.2

2.1

4.03

15.66

iu/l

0.51

204

Disorders of myoneural junction and muscle in diseases classified elsewhere

2.61

3.63

2.5

1.8

9.13

5.55

iu/l

—

Haemorrhage in early pregnancy

580

4805

1.18

3.60

2.3

2.1

12.78

14.59

iu/l

0.06

251

2123

Explicit Sepsis

644

5036

1.17

3.59

1.7

1.9

21.05

5.13

iu/l

0.60

235

2003

Postviral fatigue syndrome

125

2.26

3.58

1.6

2.4

2.41

4.69

iu/l

—

Polyhydramnios

100

678

1.50

3.58

2.4

2.3

5.15

3.90

iu/l

0.47

326

Varicose veins

967

6443

1.14

3.58

1.9

2.0

9.09

11.13

iu/l

0.12

415

2587

Other disorders of penis

578

1.53

3.58

1.8

3.84

3.14

iu/l

0.38

218

Other disorders of breast

283

2255

1.27

3.57

2.0

2.1

3.89

9.22

iu/l

0.75

112

990

Other disorders of the genitourinary system

210

1611

1.32

3.56

2.0

1.9

3.47

7.79

iu/l

0.62

633

Hernia

1591

9582

1.11

3.56

1.8

2.0

8.21

12.07

iu/l

0.35

591

3967

Superficial injury of abdomen, lower back and pelvis

253

1987

1.28

3.56

1.9

2.1

37.97

6.51

iu/l

0.44

864

Intrahepatic Cholestasis of Pregnancy (ICP)

159

1173

1.37

3.56

2.0

2.3

2.92

3.69

iu/l

1.62

540

Maltreatment syndromes

654

1.50

3.56

2.1

2.2

3.09

3.69

iu/l

0.61

304

Gout, FINNGEN

312

2492

1.25

3.56

1.7

4.39

7.52

iu/l

0.54

101

875

Zoster [herpes zoster], including avohilmo

849

7186

1.14

3.55

1.9

2.0

4.57

12.98

iu/l

1.45

326

2885

Acute appendicitis, no complications

958

8420

1.13

3.55

2.1

2.0

30.54

9.48

iu/l

0.69

423

3578

Speech therapy

396

3269

1.22

3.55

1.7

2.0

83.36

6.36

iu/l

0.68

105

1332

Other abnormal findings of blood chemistry

494

1.58

3.54

2.1

2.79

15.57

iu/l

0.58

204

Other predominantly sexually transmitted diseases, not elsewhere classified

334

2712

1.24

3.54

2.1

2.2

3.90

5.75

iu/l

0.48

132

1269

Background retinopathy and retinal vascular changes

165

2.04

3.54

2.0

1.8

6.30

5.04

iu/l

0.15

Use of pramipexole

326

2639

1.24

3.53

1.7

1.9

7.45

6.26

iu/l

0.11

114

1024

Enterocolitis due to Clostridium difficile

146

1061

1.39

3.53

1.7

2.0

4.64

9.56

iu/l

0.39

414

Postprocedural disorders of nervous system

141

1021

1.40

3.53

1.9

2.2

2.48

3.72

iu/l

4.53

465

Other specified and unspecified disorders of conjunctiva

2.55

3.52

3.6

1.7

3.59

4.54

iu/l

—

Encephalitis

295

1.76

3.51

2.0

6.15

4.66

iu/l

0.43

117

Gastric ulcer

217

1673

1.30

3.51

1.8

1.9

88.25

7.86

iu/l

0.74

620

Other specified/unspecified dorsopathies

363

1.68

3.51

2.2

2.0

3.74

20.86

iu/l

0.53

142

Other and unspecified coagulation defects

632

1.51

3.51

1.7

2.2

2.70

12.61

iu/l

0.60

270

Congenital hypothyroidism without goiter

2.82

3.50

2.1

1.80

5.89

iu/l

—

Impotence

310

1.73

3.47

2.1

1.8

2.64

3.60

iu/l

0.86

120

Other misadventures during surgical and medical care

230

1.86

3.47

2.1

3.39

4.65

iu/l

0.54

Hordeolum and other deep inflammation of eyelid

666

1.49

3.46

1.9

2.0

4.54

12.21

iu/l

0.44

277

Hernia of abdominal wall

659

5694

1.16

3.46

1.8

2.0

13.44

10.53

iu/l

0.11

236

2261

Secondary hypertension

100

672

1.48

3.43

2.0

2.1

3.29

4.12

iu/l

0.44

295

Complications of labour and delivery

1312

6555

1.12

3.40

2.2

2.0

9.18

11.88

iu/l

0.17

597

2786

Scar conditions and fibrosis of skin

532

1.55

3.39

2.5

2.1

5.94

14.38

iu/l

0.38

230

Malignant neoplasm of bladder

365

1.65

3.39

1.5

1.8

2.53

20.64

iu/l

0.54

136

Transplanted organ and tissue status

128

917

1.41

3.39

2.0

3.58

10.22

iu/l

0.54

372

Supervision of normal pregnancy

444

2110

1.21

3.39

2.4

2.1

42.44

10.54

iu/l

0.38

197

987

Carcinoma in situ of breast, lobular

2.58

3.38

2.4

1.6

4.03

4.18

iu/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1181

8225

1.12

3.37

2.1

14.32

15.17

iu/l

0.02

515

3528

Benign neoplasm: Rectum

238

1869

1.28

3.37

1.8

1.9

4.40

7.19

iu/l

0.39

702

Congenital malformations of eye, ear, face and neck

113

794

1.44

3.37

1.9

2.1

3.33

3.82

iu/l

0.44

349

Other diseases of stomach and duodenum

621

1.50

3.36

2.1

2.0

5.82

14.30

iu/l

0.39

238

Chronic pancreatitis

149

1097

1.37

3.34

2.0

1.9

54.26

4.22

iu/l

0.48

424

Valvular operations

137

996

1.38

3.31

1.9

1.7

3.98

3.85

iu/l

0.04

358

Acute appendicitis

1201

10025

1.11

3.30

2.0

25.52

13.64

iu/l

0.39

521

4190

Total colectomy

424

1.60

3.30

2.1

4.90

4.18

iu/l

0.23

178

Total colectomy operation

424

1.60

3.30

2.1

4.90

4.18

iu/l

0.23

178

Vascular disorders of the intestines

542

1.53

3.30

1.5

1.9

3.12

15.82

iu/l

0.56

201

Myocardial infarction, without ST-elevation

457

3471

1.19

3.27

1.7

1.8

48.46

5.74

iu/l

0.90

163

1204

Major coronary heart disease event excluding revascularizations

794

4587

1.15

3.27

1.7

1.9

26.01

10.66

iu/l

0.47

287

1706

Radiculopathy

223

1745

1.29

3.26

2.1

2.0

37.30

7.70

iu/l

0.43

695

Postmenopausal bleeding

467

2050

1.20

3.26

2.0

1.9

3.30

8.13

iu/l

0.66

175

819

Gout, idiopatic and unspecified

259

2063

1.26

3.26

1.7

4.51

8.28

iu/l

0.54

719

Antenatal screening

463

2175

1.20

3.25

2.3

2.1

41.83

10.35

iu/l

0.38

202

1014

Autism

325

1.69

3.25

1.8

2.2

2.25

3.88

iu/l

1.97

150

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

180

1373

1.33

3.25

1.9

2.2

3.00

3.86

iu/l

1.65

621

Benign lipomatous neoplasm

442

3721

1.19

3.24

1.7

2.0

22.01

7.42

iu/l

0.36

172

1513

Smoking dependency

135

985

1.38

3.24

2.2

2.1

12.58

4.22

iu/l

0.63

414

Benign neoplasm of thyroid gland

364

1.65

3.24

1.9

2.0

2.21

19.56

iu/l

0.58

151

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

371

1.64

3.23

1.8

4.38

20.09

iu/l

0.46

140

Other diseases of arteries and capillaries

128

926

1.39

3.23

1.7

2.0

3.40

9.93

iu/l

0.53

373

Benign neoplasm of urinary organs

442

1.58

3.22

1.6

2.0

3.89

17.51

iu/l

0.50

172

Spermatocele

394

1.61

3.22

1.5

1.7

3.07

3.49

iu/l

0.24

149

Benign neoplasm: Stomach

140

1029

1.37

3.21

2.2

1.9

90.12

9.56

iu/l

0.45

404

Plantar fascial fibromatosis

170

1287

1.33

3.21

1.8

2.2

3.30

9.54

iu/l

0.60

573

Trigeminal neuralgia

101

702

1.46

3.21

1.8

2.0

5.92

12.33

iu/l

0.34

281

Amenorrhoea

150

1116

1.36

3.21

2.1

2.2

124.64

3.97

iu/l

0.75

534

Other and unspecified disorders of white blood cells

388

1.62

3.20

1.6

2.0

3.81

18.93

iu/l

0.52

160

Septicaemia

589

4626

1.16

3.19

1.7

1.9

23.41

6.80

iu/l

0.55

211

1815

Psoriasis vulgaris

265

2124

1.26

3.19

1.8

2.0

2.52

6.49

iu/l

0.90

108

896

Viral pneumonia (known virus, not influenza)

244

1.79

3.19

1.9

1.8

24.49

29.87

iu/l

0.06

Psoriatic and enteropathic arthropathies

180

1375

1.32

3.18

1.6

2.1

2.76

3.74

iu/l

2.30

604

Idiopathic urticaria

282

1.74

3.18

2.2

2.1

2.47

4.00

iu/l

1.41

122

Glaucoma secondary to eye inflammation

2.55

3.18

2.2

1.9

2.19

4.64

iu/l

—

Other congenital malformations

150

1116

1.36

3.18

2.4

2.1

3.47

8.44

iu/l

0.52

485

Blepharospasm

2.54

3.18

1.5

1.7

2.82

5.69

iu/l

—

Mental and behavioural disorders due to tobacco

135

989

1.38

3.17

2.2

2.1

12.58

4.17

iu/l

0.64

416

Sequelae of injuries of upper limb

147

1092

1.36

3.16

2.0

2.1

4.40

8.92

iu/l

0.43

467

Acute generalized exanthematous pustulosis

493

1.54

3.15

1.9

2.1

4.08

15.59

iu/l

0.50

203

Hypermetropia

118

846

1.41

3.14

2.3

2.0

3.52

10.27

iu/l

0.51

350

Peritonsillar abscess

339

2795

1.22

3.13

2.2

2.1

3.86

5.51

iu/l

0.43

153

1281

Mixed hyperlipidaemia

275

1.73

3.12

1.9

1.8

4.80

4.01

iu/l

0.17

103

Twin gestation

184

1416

1.31

3.12

2.1

2.2

2.91

4.14

iu/l

1.48

693

Chondropathies

237

1881

1.27

3.12

2.2

2.1

4.80

6.69

iu/l

0.25

835

Barrett oesophagus

414

1.59

3.12

1.9

2.0

19.41

19.13

iu/l

0.00

153

Herpesviral [herpes simplex] infections

191

1476

1.30

3.12

2.1

4.47

7.44

iu/l

0.35

641

Dermatographic urticaria

127

925

1.39

3.11

2.1

3.35

9.44

iu/l

0.54

405

Pustular psoriasis

551

1.51

3.11

2.2

2.1

4.10

14.44

iu/l

0.50

227

Stroke, excluding SAH

798

5068

1.14

3.11

1.7

1.9

15.88

11.90

iu/l

0.15

259

1942

Chalazion

164

1241

1.33

3.11

2.0

1.9

4.22

8.22

iu/l

0.44

533

Injuries to the hip and thigh

713

5596

1.15

3.10

1.7

1.9

7.12

9.14

iu/l

0.17

260

2184

Premature separation of placenta [abruptio placentae]

323

1.68

3.09

2.1

2.2

2.27

3.82

iu/l

3.15

154

Ulcer of oesophagus

527

1.51

3.08

1.7

1.8

4.56

17.11

iu/l

0.47

178

Multiple gestation

189

1463

1.31

3.08

2.1

2.2

2.86

4.10

iu/l

1.60

713

Other or unspecified ileus, impaction or obstruction

235

1865

1.27

3.07

1.5

1.9

4.23

7.24

iu/l

0.39

709

Other or unspecified paralytic strabismus

2.98

3.07

2.0

1.9

1.41

4.31

iu/l

—

Dialysis, with operation codes

152

1140

1.34

3.06

2.1

2.0

5.26

9.44

iu/l

0.34

446

Hypersomnia

147

2.03

3.06

1.7

2.2

1.57

5.13

iu/l

3.42

Failed induction of labour

138

1023

1.37

3.05

2.5

2.3

3.27

3.91

iu/l

0.59

488

Glaucoma-related operations

488

1.53

3.05

2.0

1.8

3.98

16.66

iu/l

0.48

180

Gestational [pregnancy-induced] hypertension

552

4752

1.17

3.05

2.2

3.20

21.41

iu/l

1.14

258

2128

Misadventures to patients during surgical and medical care

218

1718

1.28

3.05

2.1

2.0

3.23

7.03

iu/l

0.61

718

Pulmonary oedema

106

2.21

3.05

1.8

1.7

2.00

5.00

iu/l

—

Other viral diseases, not elsewhere classified, including avohilmo

459

3875

1.18

3.05

2.0

2.1

3.99

6.89

iu/l

0.69

201

1734

Emphysema

536

1.50

3.05

1.8

3.74

4.08

iu/l

0.15

185

Generalized skin eruption due to drugs and medicaments

441

1.57

3.05

1.9

2.1

4.35

17.03

iu/l

0.49

181

Deficiency of other B group vitamins

182

1.90

3.04

2.5

1.9

3.52

4.22

iu/l

0.33

Gout, unspecified

207

1620

1.28

3.04

1.7

4.82

9.37

iu/l

0.51

573

Ehlers-Danlos syndrome, including avohilmo

183

1.92

3.04

2.1

2.4

3.68

4.76

iu/l

0.38

Autism spe

324

1.67

3.04

1.8

2.2

2.25

3.89

iu/l

2.00

151

Immunodeficiencies

522

1.52

3.03

2.0

2.1

2.25

14.70

iu/l

0.61

217

Allergic rhinitis

573

4894

1.16

3.02

1.9

2.2

18.30

7.63

iu/l

0.34

226

2204

Other specified and unspecified retinal disorders

324

1.66

3.02

1.8

1.9

5.41

21.16

iu/l

0.44

134

Metatarsalgia

169

1291

1.32

3.02

1.8

2.1

2.81

9.57

iu/l

0.68

578

Other noninflammatory disorders of vagina

154

1162

1.34

3.02

2.0

4.12

4.32

iu/l

0.10

490

Mental and behavioural disorders due to alcohol

706

5897

1.14

3.02

1.8

2.0

5.01

8.92

iu/l

0.76

254

2417

Perineal laceration during delivery

384

2593

1.20

3.01

2.3

2.2

3.22

10.78

iu/l

0.87

166

1229

Late syphilis

107

2.20

3.01

1.8

1.9

2.11

4.71

iu/l

—

Gastroduodenal ulcer

305

2490

1.23

3.00

1.7

1.8

62.81

7.69

iu/l

0.72

104

918

Use of glatiramer acetate

220

1.82

3.00

2.9

2.2

10.94

4.66

iu/l

1.24

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

132

973

1.37

3.00

1.8

2.0

2.98

10.09

iu/l

0.63

388

Explicit bacterial Sepsis, including avohilmo

139

1032

1.36

3.00

1.9

2.0

3.37

9.67

iu/l

0.56

405

Acne, including avohilmo

457

3140

1.18

3.00

2.0

2.3

3.10

19.40

iu/l

0.59

193

1408

Benign neoplasm: Kidney

333

1.65

2.98

1.6

2.0

2.68

21.92

iu/l

0.57

133

Pruritus

197

1539

1.29

2.98

2.0

2.1

4.06

7.39

iu/l

0.46

666

Motor disorders, excluding more controls

2.24

2.98

2.2

2.1

2.23

5.29

iu/l

—

Congenital malformations of genital organs

183

1408

1.30

2.97

1.8

2.2

2.82

3.95

iu/l

2.50

650

Radial styloid tenosynovitis [de Quervain]

110

789

1.41

2.97

2.2

3.53

4.16

iu/l

0.41

377

Preterm labour and delivery

500

4290

1.17

2.97

2.1

3.70

12.51

iu/l

1.04

216

1860

Syphilis, including avohilmo

220

1.80

2.97

1.7

2.1

3.73

4.03

iu/l

—

Syphilis

220

1.80

2.97

1.7

2.1

3.73

4.03

iu/l

—

Gout, strict definition

178

1371

1.30

2.97

1.7

4.12

8.45

iu/l

0.42

482

Benign neoplasm: Ascending colon

183

1416

1.30

2.97

2.0

1.8

4.28

8.35

iu/l

0.45

534

Fall involving bed

242

1.76

2.97

1.5

1.7

2.24

29.34

iu/l

0.55

Divergent concomitant strabismus

125

916

1.38

2.96

2.1

3.17

9.43

iu/l

0.54

396

Conductive and sensorineural hearing loss

1219

7316

1.11

2.96

1.9

3.55

14.19

iu/l

2.01

465

2923

Disorders of oesophagus in diseases classified elsewhere

170

1.92

2.94

1.6

1.9

6.69

42.29

iu/l

—

Melanocytic naevi of other and unspecified parts of face

103

732

1.42

2.94

2.1

2.2

27.08

11.25

iu/l

0.27

319

Sequelae of cerebrovascular disease

450

3265

1.18

2.93

1.6

1.8

25.87

8.99

iu/l

0.46

144

1205

Diabetic retinopathy

494

2616

1.18

2.93

1.9

1.8

9.04

15.90

iu/l

0.36

192

1007

Other and specified injuries of hip and thigh

199

1.84

2.93

1.5

1.9

2.43

4.18

iu/l

—

Other septicaemia, including avohilmo

529

4278

1.16

2.92

1.7

1.9

25.43

7.13

iu/l

0.54

189

1649

Enthesopathies of lower limb, excluding foot

372

3118

1.20

2.92

1.9

2.0

23.96

6.02

iu/l

0.41

151

1336

Infections with a predominantly sexual mode of transmission

589

5112

1.15

2.91

2.1

2.2

3.67

11.14

iu/l

1.51

226

2319

Unknown and unspecified causes of morbidity

101

716

1.42

2.90

2.0

2.1

11.41

3.78

iu/l

0.48

294

Osteonecrosis

625

1.46

2.90

1.9

2.0

104.65

13.25

iu/l

0.43

251

Other diseases of gallbladder

422

1.56

2.90

1.8

2.0

5.02

4.22

iu/l

0.18

163

Visual field defects

113

817

1.40

2.90

1.8

2.0

5.10

11.42

iu/l

0.40

316

Benign neoplasm: Conjunctiva

336

1.63

2.90

1.7

2.0

2.58

4.25

iu/l

1.67

133

Transport accidents

834

6166

1.13

2.89

2.1

4.80

21.91

iu/l

1.30

341

2661

Benign neoplasm: Rectum, anus and anal canal

262

2123

1.24

2.89

1.8

1.9

4.32

6.77

iu/l

0.38

793

Delivery

744

3446

1.14

2.89

2.1

2.0

30.14

8.73

iu/l

0.52

312

1395

Other disorders of skin and subcutaneous tissue, not elsewhere classified

203

1598

1.28

2.89

2.0

4.07

7.30

iu/l

0.44

661

Malignant neoplasm of tonsil and base of tongue, including Hilmo

164

1.92

2.88

1.7

2.1

5.82

33.90

iu/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

223

1776

1.26

2.88

2.0

1.9

4.13

7.33

iu/l

0.45

685

Other diseases of peritoneum

496

1.51

2.87

1.6

2.1

2.83

15.48

iu/l

0.58

205

Ganglion

373

3133

1.20

2.87

2.0

2.1

3.67

12.01

iu/l

0.78

149

1385

Placenta praevia

661

1.44

2.87

2.3

3.46

3.94

iu/l

0.30

321

Torsion of testis

109

2.14

2.87

1.7

2.1

1.87

3.06

iu/l

—

Use of disulfiram, acamprosate or naltrexone

113

819

1.39

2.86

1.5

2.1

14.00

4.11

iu/l

0.42

354

Faecal incontinence

154

1172

1.33

2.85

1.9

4.69

4.09

iu/l

0.23

475

Pilonidal cyst

127

939

1.36

2.85

1.9

2.1

3.40

3.79

iu/l

0.39

416

Memory loss

115

837

1.39

2.84

1.6

1.9

3.17

3.79

iu/l

0.34

305

Osteopathy in diseases classified elsewhere

2.73

2.84

1.7

1.8

2.50

4.98

iu/l

—

Other surgical follow-up care

393

1.58

2.84

1.6

2.1

2.74

4.23

iu/l

1.80

163

Mental and behavioural disorders due to alcohol, excluding acute intoxication

580

5002

1.15

2.83

1.8

2.0

5.56

9.87

iu/l

0.67

205

2028

Other septicaemia

516

4196

1.16

2.83

1.7

1.9

25.94

7.17

iu/l

0.54

185

1613

Drug-induced osteoporosis

117

2.10

2.82

2.2

1.9

1.62

4.42

iu/l

2.62

Other hearing loss

370

3010

1.20

2.82

1.7

1.8

21.26

9.94

iu/l

0.27

132

1124

Hyperaldosteronism

254

1.72

2.81

1.6

2.0

3.84

4.34

iu/l

0.09

Sensorineural hearing loss

1136

6843

1.11

2.81

1.9

3.70

14.93

iu/l

1.96

428

2726

Other/unspecified rheumatoid arthritis

179

1393

1.29

2.81

1.8

2.0

3.89

8.19

iu/l

0.50

548

Open wound of forearm

136

1019

1.34

2.80

1.5

2.1

3.35

9.14

iu/l

0.57

446

Chronic Coagulation defects

301

1.66

2.79

2.0

2.2

2.69

4.31

iu/l

2.07

130

Hypertrophic scar

706

1.42

2.79

1.9

2.1

4.14

11.42

iu/l

0.48

314

Suppurative and unspecified otitis media

648

5034

1.14

2.79

2.0

2.2

76.08

8.49

iu/l

0.46

277

2241

Hypertrophic disorders of skin

106

765

1.40

2.79

2.0

2.1

4.05

10.62

iu/l

0.47

344

Spondylopathies (FG)

213

1696

1.26

2.78

1.8

2.1

3.23

3.72

iu/l

0.44

763

Other neurotic disorders

435

1.53

2.77

1.8

1.9

3.55

17.54

iu/l

0.53

173

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

104

2.15

2.77

1.6

1.8

4.10

56.28

iu/l

—

Fracture of forearm

978

7903

1.11

2.76

1.9

2.0

18.44

9.85

iu/l

0.24

396

3272

Retinal haemorrhage

203

1.80

2.76

2.1

1.8

2.29

32.50

iu/l

0.53

Vitiligo

125

2.06

2.76

2.6

2.0

2.31

4.79

iu/l

1.18

FESS (DNB20)

189

1485

1.28

2.76

2.3

2.1

3.63

7.35

iu/l

0.53

657

Small fibre neuropathy

248

1.72

2.75

1.5

1.9

2.83

28.05

iu/l

0.54

Lichen simplex chronicus

325

1.62

2.75

1.9

2.0

2.46

21.36

iu/l

0.56

134

Drug-induced hypoglycaemia without coma

132

2.01

2.74

3.0

1.9

14.17

5.46

iu/l

0.49

Other disorders of veins

693

6023

1.14

2.73

1.8

2.0

30.79

11.16

iu/l

0.34

230

2458

Dacryoadenitis

2.36

2.73

1.4

1.8

4.13

3.01

iu/l

—

Other acquired deformities of musculoskeletal system and connective tissue

461

1.52

2.73

1.9

2.0

4.60

16.42

iu/l

0.46

186

Other disorders of optic [2nd] nerve and visual pathways

692

1.42

2.73

2.1

3.54

12.38

iu/l

0.54

281

Myocardial infarction

609

3715

1.15

2.72

1.8

1.9

37.61

12.41

iu/l

0.61

215

1357

Other keratitis

178

1391

1.29

2.72

2.1

5.21

7.48

iu/l

0.25

610

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

398

1.56

2.72

2.0

2.1

3.66

iu/l

0.00

193

Seborrhoeic dermatitis

134

1007

1.34

2.72

1.8

2.0

4.17

9.59

iu/l

0.46

410

Diseases of middle ear and mastoid

1035

7630

1.11

2.71

2.0

2.1

50.35

9.03

iu/l

0.43

436

3265

Explicit bacterial Sepsis

134

1007

1.34

2.71

1.9

2.0

3.42

9.78

iu/l

0.55

396

Cerebral cysts

643

1.43

2.70

1.7

2.2

5.70

3.99

iu/l

0.20

280

Erythema intertrigo

212

1.77

2.70

2.0

6.49

30.18

iu/l

0.44

Other disorders of iris and ciliary body

235

1.73

2.68

2.2

2.0

3.95

27.85

iu/l

0.52

100

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

133

985

1.34

2.66

2.1

2.2

4.08

3.52

iu/l

0.31

453

Reimbursement for rheumatic diseases

952

8525

1.11

2.66

1.9

2.0

4.82

11.05

iu/l

1.17

358

3554

Acute nasopharyngitis (common cold)

146

1105

1.32

2.66

2.0

2.1

4.10

9.15

iu/l

0.49

464

Intestinal adhesions without obstruction

115

848

1.37

2.65

1.5

2.0

5.40

11.31

iu/l

0.40

340

Other and unspecified psoriasis

679

1.41

2.65

1.8

2.1

1.97

12.33

iu/l

0.67

279

Beningn neoplasm: Meninges, unspecified

141

1.96

2.64

1.9

1.8

3.23

4.36

iu/l

0.61

Spinal osteochondrosis

2.30

2.64

2.0

1.44

4.74

iu/l

—

Convergence insufficiency and excess

185

1.83

2.63

2.3

2.4

1.85

4.04

iu/l

2.24

Otalgia

140

1065

1.33

2.63

2.1

2.0

2.59

3.99

iu/l

2.25

449

Abnormality of white blood cells, not elsewhere classified

2.25

2.62

1.4

1.9

2.20

5.76

iu/l

—

Qualitative platelet defects

2.89

2.62

2.3

1.9

1.92

5.20

iu/l

—

ILD-related respiratory insufficiency

229

1.72

2.62

1.9

1.8

21.33

30.52

iu/l

0.11

Acromegaly and pituitary gigantism

2.44

2.61

1.5

1.8

1.32

3.96

iu/l

—

Alcohol use disorder, ICD-based

534

4652

1.15

2.61

1.8

2.0

5.76

8.65

iu/l

0.41

190

1903

Chronic conjunctivitis

338

1.59

2.61

2.5

1.9

2.93

4.22

iu/l

0.60

139

Diabetic nephropathy, excluding more controls

207

1345

1.26

2.61

1.8

1.9

15.95

9.07

iu/l

0.25

535

Primary open-angle glaucoma, strict

332

2779

1.20

2.60

1.7

1.8

3.98

6.45

iu/l

0.53

109

1007

Nail disorders

131

989

1.34

2.60

1.9

2.1

3.60

9.69

iu/l

0.57

422

Disorders of breast

1041

8302

1.11

2.60

2.0

2.1

18.50

10.99

iu/l

0.21

408

3582

Lung diseases due to external agents

147

1127

1.31

2.59

1.6

1.9

5.67

9.32

iu/l

0.26

421

Melanoma in situ

402

1.54

2.59

1.5

1.9

3.31

17.93

iu/l

0.51

163

Premenstrual syndrome

231

1.73

2.58

2.1

2.2

3.01

3.67

iu/l

0.45

113

Dermatophytosis

182

1436

1.28

2.58

2.3

2.0

77.56

7.61

iu/l

0.47

598

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

713

6254

1.13

2.58

2.1

3.82

11.69

iu/l

1.35

296

2738

Seropositive rheumatoid arthritis

376

3176

1.18

2.58

1.8

2.0

4.09

8.82

iu/l

0.76

133

1294

Postpartum hemorraghe, parous women as controls

598

4394

1.14

2.58

2.3

2.2

3.81

24.45

iu/l

1.18

266

2020

Primary biliary cholangitis, wide definition

193

1.79

2.57

2.2

1.6

6.87

2.69

iu/l

0.71

Fracture of femur

338

2560

1.19

2.57

1.7

1.8

10.75

13.11

iu/l

0.09

127

921

Other prurigo

101

2.13

2.57

1.9

1.8

1.88

5.72

iu/l

1.75

Injury of muscle and tendon at forearm level

157

1.88

2.55

1.5

1.9

4.54

4.34

iu/l

0.05

Other congenital malformations of face and neck

332

1.59

2.55

1.9

2.2

4.74

4.05

iu/l

0.28

141

Visual impairment including blindness (binocular or monocular)

676

1.40

2.54

2.4

1.9

3.90

12.70

iu/l

0.52

273

Diabetic maculopathy

175

1300

1.28

2.54

2.1

1.9

5.12

3.26

iu/l

0.60

546

Disorders of iron metabolism

122

2.00

2.53

1.5

1.7

4.16

4.30

iu/l

—

Carcinoma in situ of other and unspecified digestive organs

364

1.56

2.53

1.8

1.9

4.62

20.35

iu/l

0.47

142

Other peripheral vertigo

136

1037

1.32

2.53

1.7

2.0

2.60

9.70

iu/l

0.69

416

Rosacea

218

1763

1.25

2.52

2.3

2.1

2.42

6.81

iu/l

0.84

774

Use of antiglaucoma preparations and miotics

669

1.40

2.51

2.0

1.9

2.70

12.83

iu/l

0.57

255

Intentional self-harm by sharp object

318

1.60

2.50

1.5

2.1

2.52

4.03

iu/l

0.88

148

Glaucoma secondary to other eye disorders

357

1.56

2.50

2.7

1.9

2.95

20.66

iu/l

0.53

138

Bulimia nervosa (incl. atypical)

554

1.45

2.50

1.9

2.4

15.16

3.81

iu/l

0.41

271

Ventricular septal defect, a heart condition

217

1.73

2.49

3.2

2.2

2.90

4.46

iu/l

0.86

ILD, hospital admission 2, with pulmonary infections

108

797

1.36

2.49

1.8

1.9

13.25

11.88

iu/l

0.04

294

Melanoma in situ of trunk

116

2.02

2.49

1.5

1.8

3.93

4.85

iu/l

—

Other enthesopathy of foot (+metatarsalgia)

180

1427

1.27

2.49

1.8

2.1

2.80

9.17

iu/l

0.73

645

Unspecified visual impairment (binocular)

123

1.99

2.48

1.7

1.8

6.47

5.62

iu/l

—

Malignant neoplasm of tonsil and base of tongue

137

1.93

2.48

1.8

2.2

7.17

40.30

iu/l

—

Cyst of kidney

646

1.41

2.47

1.9

2.70

13.33

iu/l

0.58

245

Retinal breaks without detachment

231

1884

1.23

2.47

1.9

35.84

6.94

iu/l

0.44

748

Other benign neoplasm of uterus: Other parts/unspecified

391

1.53

2.46

1.6

1.7

3.59

18.43

iu/l

0.48

154

Disorders of optic nerve and visual pathways

150

1164

1.30

2.46

2.2

2.1

4.31

8.46

iu/l

0.41

493

Ectropion of eyelid

218

1.71

2.46

1.9

1.5

3.83

34.63

iu/l

0.49

Ethmoidectomy

191

1527

1.26

2.45

2.3

2.1

3.60

7.24

iu/l

0.53

676

Glucosamine medication

648

4577

1.13

2.45

1.8

16.12

11.73

iu/l

0.14

207

1689

Failure and rejection of transplanted organs and tissues

103

2.08

2.45

1.5

1.8

7.05

4.42

iu/l

—

Allergic urticaria

140

1078

1.31

2.44

2.1

3.14

8.72

iu/l

0.57

461

Other abnormal findings in urine

124

1.97

2.43

2.0

1.8

2.83

6.04

iu/l

—

Arterial embolism and thrombosis

432

1.49

2.42

1.6

1.8

2.76

18.41

iu/l

0.55

161

Diabetic nephropathy

208

1660

1.24

2.42

1.8

1.9

15.95

7.85

iu/l

0.32

664

Hereditary deficiency of other clotting factors

111

2.05

2.41

2.0

3.02

4.07

iu/l

—

Benign neoplasm: Skin of other and unspecified parts of face

147

1141

1.30

2.41

1.9

2.0

4.13

9.02

iu/l

0.47

459

Vascular diseases of the intestine

281

1.62

2.41

1.4

1.7

3.69

24.82

iu/l

0.50

110

Postprocedural disorders of eye and adnexa, not elsewhere classified

3.81

2.41

1.9

—

2.67

—

Other female pelvic inflammatory diseases

298

2502

1.20

2.39

2.0

2.1

3.31

8.98

iu/l

0.93

124

1077

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

240

1972

1.22

2.39

1.6

1.9

2.89

8.08

iu/l

0.96

774

Superficial injury of hip and thigh

209

1692

1.24

2.39

1.8

1.9

4.49

7.19

iu/l

0.34

675

Benign neoplasm: Other parts of oropharynx

2.21

2.39

2.1

2.0

4.50

5.70

iu/l

—

Superficial injury of forearm

163

1284

1.28

2.39

1.8

2.1

2.96

7.88

iu/l

0.62

557

Causalgia

191

1.77

2.38

1.7

2.1

3.31

4.49

iu/l

0.63

Somnolence, stupor and coma

394

1.51

2.38

1.5

2.1

1.90

18.66

iu/l

0.62

163

Panhypopituitarism

154

1.85

2.37

1.7

2.0

223.38

4.58

iu/l

0.47

Other degenerative diseases of the nervous system

393

2453

1.17

2.37

1.9

2.0

19.77

4.14

iu/l

0.54

157

963

Neovascular glaucoma

354

1.54

2.37

2.5

1.9

2.95

21.29

iu/l

0.53

133

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

568

1.42

2.37

1.9

2.2

3.05

4.27

iu/l

1.52

258

Stroke, including SAH

845

5456

1.11

2.37

1.8

1.9

14.91

11.38

iu/l

0.15

281

2092

Palmar fascial fibromatosis [Dupuytren]

155

1214

1.28

2.36

1.5

1.8

4.71

4.24

iu/l

0.14

449

Biomechanical lesions, not elsewhere classified

535

1.44

2.35

2.6

2.0

3.47

14.97

iu/l

0.53

212

Late syphilis, including avohilmo

140

1.89

2.35

1.8

2.0

2.07

4.44

iu/l

—

Other bursopathies

183

1464

1.26

2.35

1.8

2.0

46.99

4.02

iu/l

0.48

610

Colonic or urogenital fistula

391

3361

1.17

2.35

1.8

2.0

2.90

7.65

iu/l

1.05

155

1395

Benign neoplasm: Tongue

245

1.66

2.34

1.4

1.9

2.40

4.19

iu/l

2.16

Paranoid personality disorder

192

1.75

2.34

2.4

2.1

2.48

4.63

iu/l

1.70

Other benign neoplasms of skin

565

4986

1.14

2.33

1.9

2.0

3.91

6.74

iu/l

0.83

219

2013

Abnormal findings on examination of urine, without diagnosis

404

1.50

2.33

2.5

2.0

2.31

18.15

iu/l

0.59

166

Malignant neoplasm of digestive organs, including Hilmo

424

3599

0.86

2.31

1.7

1.9

4.49

10.33

iu/l

0.99

146

1432

Other specified disorders of muscle

285

1.60

2.31

1.5

2.0

4.65

4.58

iu/l

0.01

128

Cerebral palsy and other paralytic syndromes

155

1219

1.28

2.31

1.7

2.0

2.92

8.44

iu/l

0.63

504

Other juvenile arthritis

488

1.45

2.30

2.0

2.2

3.42

4.44

iu/l

0.67

230

Raynaud syndrome

150

1177

1.29

2.29

1.7

2.1

3.50

8.26

iu/l

0.53

513

Habitual aborter

318

1.57

2.29

2.6

2.2

3.24

3.87

iu/l

0.37

152

Acute gastritis

698

1.37

2.29

1.8

2.0

3.09

12.43

iu/l

0.56

270

Protozoal diseases

270

1.62

2.29

1.5

1.9

78.16

3.93

iu/l

0.46

103

Dermatopolymyositis

120

1.96

2.29

1.3

1.8

4.41

4.64

iu/l

—

Open wound of lower leg

224

1839

1.22

2.28

1.8

1.9

4.86

6.75

iu/l

0.25

764

Disturbances of smell and taste

457

1.46

2.25

1.8

2.1

2.42

16.56

iu/l

0.60

188

Other/unspecified enthesopathies of lower limb, excluding foot

115

873

1.33

2.25

2.1

3.18

10.36

iu/l

0.61

378

Single spontaneous delivery

727

3432

1.12

2.25

2.1

2.0

31.19

8.75

iu/l

0.52

300

1390

Other epidermal thickening

457

1.46

2.25

2.8

2.0

2.44

16.38

iu/l

0.59

190

Congenital malformations of ovaries, fallopian tubes and broad ligaments

114

866

1.33

2.24

1.7

2.3

3.07

3.76

iu/l

0.82

392

Umbilical hernia

353

3023

1.17

2.24

1.7

2.0

3.41

4.61

iu/l

0.69

113

1244

Injuries to unspecified part of trunk, limb or body region

145

1136

1.29

2.24

1.7

2.1

2.27

8.73

iu/l

0.74

479

Demyelinating diseases of the central nervous system

149

1173

1.28

2.23

2.4

2.2

6.80

8.12

iu/l

0.11

523

Immunodeficiency with predominantly antibody defects

296

1.58

2.23

2.0

2.1

2.48

4.03

iu/l

1.57

124

Other and unspecified rosacea

149

1173

1.28

2.23

2.3

2.1

2.33

8.46

iu/l

0.75

512

Inflammatory disorders of breast

140

1095

1.29

2.22

1.9

2.2

2.75

8.72

iu/l

0.67

488

Psoriatic arthropathies

146

1146

1.28

2.22

1.6

2.1

2.96

10.06

iu/l

0.59

495

Other congenital malformations, including avohilmo

215

1763

1.23

2.22

2.1

34.59

6.73

iu/l

0.43

103

785

Other/unspecified disorders of vestibular function

409

1.48

2.22

2.0

3.89

17.82

iu/l

0.50

167

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

655

1.37

2.21

1.7

2.2

3.29

3.78

iu/l

0.24

307

Morphin

143

1.84

2.20

1.5

1.8

2.67

42.28

iu/l

—

Blindness, monocular

2.29

2.20

3.0

1.8

7.88

3.42

iu/l

—

Other encephalitis

273

1.60

2.20

1.9

2.0

6.85

4.51

iu/l

0.61

109

Exposure to other specified factors

1416

11256

1.08

2.19

1.9

2.0

5.23

15.42

iu/l

1.28

553

4705

Wet age-related macular degeneration

197

1544

1.24

2.19

1.7

18.76

19.53

iu/l

0.01

525

Benign neoplasm: Bronchus and lung

2.06

2.19

1.9

2.44

3.69

iu/l

—

Childhood asthma (age<16), excluding more controls

234

1510

1.22

2.18

2.3

208.51

3.46

iu/l

0.50

726

Testicular dysfunction

258

1.60

2.16

1.4

2.1

2.11

4.18

iu/l

2.66

117

Carcinoma in situ of colon

235

1.64

2.16

1.5

1.9

3.71

28.81

iu/l

0.51

Female infertility, associated with anovulation

174

1402

1.25

2.15

2.5

2.3

2.91

3.80

iu/l

1.90

677

Endocarditis

235

1.63

2.15

1.7

1.8

3.36

4.21

iu/l

0.46

Retinal vascular occlusion

137

1072

1.29

2.14

1.7

1.8

2.85

9.78

iu/l

0.59

380

Malignant neoplasm of other connective and soft tissue, including Hilmo

363

1.50

2.14

1.7

2.1

4.27

19.38

iu/l

0.48

150

Phlebitis and thrombophlebitis (not including DVT)

331

2833

1.17

2.14

1.7

2.0

4.51

6.71

iu/l

0.38

117

1174

Benign neoplasm: Descending colon

647

1.37

2.14

2.3

1.9

72.76

3.76

iu/l

0.50

247

Bullous disorders

537

1.41

2.14

1.7

2.0

2.68

14.91

iu/l

0.59

215

Inflammatory bowel disease

487

4286

1.14

2.14

1.9

2.1

3.23

6.79

iu/l

1.02

184

1835

Family history of malignant neoplasm

202

1656

1.23

2.12

1.9

2.2

3.43

6.92

iu/l

0.57

740

Xanthelasma of eyelid

2.19

2.12

1.3

1.6

3.08

3.81

iu/l

—

Carrier of infectious disease

284

1.57

2.12

3.0

2.2

2.91

4.16

iu/l

1.04

123

Folate deficiency anaemia

2.18

2.11

1.1

1.9

6.79

4.54

iu/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

159

1273

1.26

2.11

2.0

2.3

2.92

4.01

iu/l

2.31

591

Congenital malformations and deformations of the musculoskeletal system

146

1149

1.27

2.10

1.9

2.1

2.94

3.71

iu/l

1.11

507

Nonalcoholic steatohepatitis

2.13

2.10

2.7

1.9

1.94

4.52

iu/l

1.73

Alcoholic liver disease

834

0.69

2.10

1.7

1.9

2.48

11.05

iu/l

0.64

326

Atrial septal defect

395

1.48

2.10

2.2

1.9

4.39

4.36

iu/l

0.01

161

Malignant neoplasm of head and neck, including Hilmo

105

795

1.33

2.09

1.6

1.8

3.98

11.40

iu/l

0.48

304

Injury of unspecified body region

110

840

1.32

2.09

1.8

2.0

2.25

10.75

iu/l

0.67

340

Allergic colitis

253

1.60

2.08

1.8

2.1

7.54

3.77

iu/l

0.56

117

Meralgia paraesthetica

366

1.49

2.08

1.7

2.0

3.02

4.62

iu/l

1.10

149

Childhood asthma (age<16)

234

1519

1.21

2.07

2.3

208.51

3.47

iu/l

0.50

725

Sequelae of intentional self-harm, assault and events of undetermined intent

2.18

2.07

3.1

2.2

2.30

4.53

iu/l

—

Fasciculation

125

1.88

2.06

2.8

2.2

3.71

5.20

iu/l

0.58

Other and unspecified glaucoma

600

1.38

2.06

1.7

1.8

2.03

13.64

iu/l

0.61

234

Other diseases of biliary tract

112

859

1.31

2.06

1.9

2.87

4.59

iu/l

2.68

324

Osteonecrosis due to drugs

125

1.88

2.05

2.1

1.8

5.59

4.10

iu/l

—

Liquid cancers, including Hilmo

462

3578

1.14

2.05

1.6

1.9

4.74

8.07

iu/l

0.62

140

1445

Presence of other devices

307

2579

1.18

2.05

1.9

3.71

12.41

iu/l

0.72

120

964

Superficial injury of ankle and foot

210

1736

1.22

2.04

1.9

2.1

2.98

6.79

iu/l

0.68

771

Any death

741

5731

0.90

2.04

1.5

1.9

5.57

9.22

iu/l

0.58

212

2219

Mixed disorders of conduct and emotions

311

1.54

2.04

2.1

2.3

3.10

3.59

iu/l

0.19

158

Injuries to the wrist and hand

1805

11199

1.07

2.04

2.0

12.30

14.44

iu/l

0.10

719

4638

Other inflammatory liver diseases

705

1.34

2.03

2.1

4.07

12.32

iu/l

0.50

285

Disorders of globe

208

1.66

2.03

2.2

1.9

5.23

31.76

iu/l

0.48

Corneal scars and opacities

263

1.58

2.03

1.7

2.0

2.52

27.12

iu/l

0.55

102

Other superficial mycoses, including avohilmo

176

1430

1.24

2.03

1.7

2.2

3.74

7.33

iu/l

0.48

640

Other disorders of prostate

162

1.74

2.03

1.6

2.0

3.35

3.71

iu/l

—

Special screening examination for neoplasms

602

1.37

2.02

1.6

2.0

2.77

4.08

iu/l

1.60

252

Primary biliary cholangitis (PBC)

193

1.68

2.02

2.3

1.6

10.16

2.63

iu/l

1.05

Exclusion endpoint for clefts

216

1.65

2.02

2.2

3.27

4.20

iu/l

0.27

Dystonia

646

1.36

2.02

1.7

2.1

92.01

13.31

iu/l

0.42

267

Inflammatory diseases of the central nervous system

116

897

1.30

2.02

1.8

2.1

4.08

10.00

iu/l

0.47

379

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

344

1.50

2.01

1.6

2.0

2.49

21.68

iu/l

0.57

134

Malnutrition

178

1.71

2.01

1.8

2.74

39.16

iu/l

—

Other drug-induced secondary parkinsonism

2.19

2.01

1.7

1.8

2.12

4.54

iu/l

—

Endometriosis ASRM stages 3,4

439

3860

1.14

2.00

2.1

3.94

7.18

iu/l

0.78

179

1684

Superficial injury of thorax

205

1694

1.22

2.00

2.1

2.0

2.79

7.15

iu/l

0.72

699

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

180

1471

1.23

1.99

1.9

2.2

3.00

7.48

iu/l

0.69

662

Melanocytic naevi of lower limb, including hip

537

1.39

1.99

1.6

2.2

2.62

4.28

iu/l

2.90

232

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

179

1.71

1.99

2.5

2.2

4.61

4.93

iu/l

0.07

Spontaneous abortion

955

5851

1.10

1.98

2.1

11.47

13.71

iu/l

0.09

394

2584

Fourth [trochlear] nerve palsy

202

1.66

1.98

2.1

4.75

4.38

iu/l

—

Glomerular diseases

217

1805

1.21

1.98

1.9

2.0

49.73

7.15

iu/l

0.62

724

Other and unspecified haemorrhagic conditions

149

1.78

1.97

2.7

2.0

4.86

5.07

iu/l

—

Macular pucker

197

1624

1.22

1.97

1.7

1.8

20.34

8.14

iu/l

0.36

572

Arterial embolism and thrombosis of lower extremity artery

233

1.60

1.97

1.7

2.83

29.93

iu/l

0.53

Other erythematous conditions

379

1.47

1.96

1.6

1.9

1.77

19.87

iu/l

0.61

150

Benign leiomyoma with endometriosis

265

2248

1.19

1.96

1.9

2.0

4.69

6.58

iu/l

0.32

911

Granulomatous disorders of skin and subcutaneous tissue

314

1.52

1.96

3.0

2.2

2.97

21.21

iu/l

0.54

136

Chronic hepatitis, not elsewhere classified

371

1.47

1.96

1.9

2.1

2.89

4.02

iu/l

0.65

152

Retinal vascular disorders

137

1086

1.27

1.96

1.7

1.8

2.85

9.71

iu/l

0.59

385

Inguinal or femoral hernia, bilateral

726

1.33

1.95

1.6

1.8

3.31

3.63

iu/l

0.21

264

Vertigo of central origin

142

1.79

1.95

1.2

1.8

1.57

49.69

iu/l

—

Diabetic neuropathy

134

1055

1.27

1.95

1.9

1.8

123.74

3.42

iu/l

0.51

405

MS-disease / Multiple Sclerosis

127

1000

1.28

1.95

2.3

2.1

7.50

8.97

iu/l

0.10

437

Streptococcal septicaemia, including avohilmo

112

867

1.30

1.94

1.7

2.0

4.22

10.73

iu/l

0.45

337

Ingrowing nail

582

1.37

1.93

1.7

2.1

3.44

13.64

iu/l

0.55

246

Diabetes insipidus

2.01

1.93

2.9

1.9

346.62

5.13

iu/l

—

Fall on and from ladder

590

1.37

1.93

1.5

1.9

3.47

13.78

iu/l

0.51

231

Pneumocystosis, including avohilmo

150

1.76

1.93

1.3

1.9

115.44

4.35

iu/l

—

Pneumocystosis

150

1.76

1.93

1.3

1.9

115.44

4.35

iu/l

—

796

6465

1.10

1.93

1.8

2.0

15.69

10.23

iu/l

0.20

284

2651

Glomerular disorders in diseases classified elsewhere

136

1080

1.27

1.93

1.6

2.1

22.61

9.33

iu/l

0.36

421

Sequelae of injuries of lower limb

133

1054

1.27

1.92

2.0

2.1

136.51

8.82

iu/l

0.47

452

Other and unspecified iridocyclitis

524

1.39

1.91

1.7

2.2

2.81

4.27

iu/l

1.99

219

Dementia due to Parkinsons disease, excluding more controls

128

1.82

1.91

1.4

1.7

2.37

4.57

iu/l

—

300

1.52

1.91

2.2

2.1

3.93

4.16

iu/l

0.05

126

Non-allergic asthma

117

913

1.29

1.91

2.0

2.78

9.61

iu/l

0.60

392

Ménière disease

130

1029

1.27

1.91

2.1

2.0

3.23

9.83

iu/l

0.61

408

Congenital malformations of the musculoskeletal system, not elsewhere classified

197

1.66

1.90

1.9

2.1

3.18

4.49

iu/l

0.58

260

1.57

1.90

2.9

2.1

2.35

4.05

iu/l

1.40

129

Unstable angina pectoris

412

2836

1.14

1.90

1.7

1.8

23.63

12.48

iu/l

0.22

159

1001

Other pleural conditions

106

817

1.30

1.90

1.8

4.15

11.57

iu/l

0.46

297

Traumatic subdural haemorrhage

135

1002

1.26

1.90

1.6

1.7

3.91

4.44

iu/l

0.27

355

Polypectomy (DHB20)

584

1.36

1.89

1.8

1.9

2.72

4.10

iu/l

1.27

235

Early lumbar disc prolapse, operated

153

1235

1.25

1.89

2.2

4.41

4.24

iu/l

0.08

581

Allergic contact dermatitis

230

1934

1.20

1.89

2.0

2.1

3.17

10.14

iu/l

0.93

875

Other lesions of median nerve

252

1.57

1.89

1.8

2.06

28.25

iu/l

0.56

Benign neoplasm: Transverse colon

130

1030

1.27

1.89

2.1

1.9

5.21

9.83

iu/l

0.35

386

Other disorders of optic disc

129

1.82

1.88

1.7

2.0

4.36

3.91

iu/l

—

Postmenopausal atrophic vaginitis

447

2142

1.14

1.88

2.0

1.9

21.59

7.92

iu/l

0.35

184

872

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

152

1.75

1.87

2.2

4.25

4.95

iu/l

—

Malignant neoplasm of head and neck

636

1.34

1.87

1.5

1.8

4.26

13.74

iu/l

0.47

236

Other and unspecified postprocedural disorders of eye and adnexa

3.70

1.87

2.2

1.9

—

2.78

—

Dermatopolymyositis (FG)

122

1.84

1.87

1.4

2.0

3.80

4.26

iu/l

—

Other otitis externa (chronic)

100

768

1.31

1.86

1.9

2.1

3.25

11.21

iu/l

0.56

318

Benign neoplasm: Liver/bile ducts

318

1.50

1.86

1.6

2.1

2.38

4.28

iu/l

2.12

134

Overexertion and strenuous or repetitive movements

138

1104

1.26

1.86

2.0

2.1

3.18

8.62

iu/l

0.56

473

Fracture of skull and facial bones

295

2536

1.17

1.85

1.9

2.0

4.50

5.90

iu/l

0.26

116

1056

Vascular dementia

589

1.35

1.85

1.5

1.6

2.86

3.53

iu/l

0.67

195

Right bundle-branch block

261

1.55

1.85

1.5

1.7

2.26

4.39

iu/l

2.24

Atrial septal defect, secundum type

301

1.51

1.85

2.3

2.0

2.48

3.61

iu/l

1.11

126

Benign lipomatous neoplasm of other sites/unspecified

108

839

1.30

1.84

1.8

2.0

3.44

11.00

iu/l

0.54

328

Alopecia areata

360

1.47

1.84

2.5

2.2

4.44

18.60

iu/l

0.48

160

Asthma mixed form (mode), excluding more controls

502

1.38

1.83

2.0

2.2

2.16

4.07

iu/l

2.83

226

475

1.39

1.83

2.0

224.01

15.88

iu/l

0.45

197

Streptococcal septicaemia

108

840

1.29

1.83

1.7

2.0

4.30

10.94

iu/l

0.45

328

Cerebral aneurysm, nonruptured

124

982

1.27

1.83

2.0

3.13

4.12

iu/l

0.93

411

Trigger finger

229

1932

1.19

1.82

2.1

2.87

7.84

iu/l

0.74

834

Alcohol use disorder, Swedish definition

727

6005

1.10

1.82

1.8

2.0

17.41

10.77

iu/l

0.22

252

2460

Lateral epicondylitis

203

1695

1.20

1.81

1.7

2.1

2.19

8.33

iu/l

0.84

742

Protozoal diseases, including avohilmo

287

1.52

1.81

1.5

2.0

78.16

3.87

iu/l

0.46

110

Unspecified misadventure during surgical and medical care

589

1.35

1.81

2.2

2.1

2.32

13.66

iu/l

0.64

246

Other specified congenital malformation syndromes affecting multiple systems

184

1.66

1.81

2.2

3.25

4.37

iu/l

0.29

Other and unspecified diseases of blood and blood-forming organs

239

1.57

1.81

1.5

2.0

2.48

27.70

iu/l

—

Hyphaema and other vascular disorders of iris and ciliary body

161

1.70

1.80

2.6

2.0

4.35

39.22

iu/l

0.51

Oral lichen planus

296

1.51

1.80

2.1

2.0

2.53

23.32

iu/l

0.57

123

Other disorders starting during childhood or adolescence

609

1.34

1.80

1.7

2.2

3.00

3.73

iu/l

0.40

283

Benign neoplasm: Connective and other soft tissue of head, face and neck

146

1.74

1.80

1.6

1.9

2.24

3.75

iu/l

—

Viral pneumonia (unknown virus, not influenza)

711

1.32

1.80

2.0

2.1

3.74

11.71

iu/l

0.52

303

Other disorders of cornea

139

1118

1.25

1.80

2.0

4.02

9.08

iu/l

0.49

459

Schizophrenia

210

1761

1.20

1.79

1.6

2.0

2.19

7.00

iu/l

0.93

760

Foreign body in respiratory tract

565

1.36

1.78

1.7

2.0

5.52

3.99

iu/l

0.35

234

Other and unspecified paralytic syndromes

139

1.76

1.78

1.7

2.1

3.01

4.46

iu/l

—

Disorders of eyelid in diseases classified elsewhere

321

1.48

1.78

2.3

1.9

2.49

21.70

iu/l

0.55

131

Parkinson's disease

157

1280

1.23

1.78

1.5

1.8

3.35

9.04

iu/l

0.56

447

Other embolism and thrombosis

170

1399

1.22

1.77

1.9

2.0

2.84

4.01

iu/l

1.92

579

Tic and related disorders

124

1.80

1.77

2.1

2.2

2.79

5.45

iu/l

—

Nonsuppurative otitis media, including avohilmo

570

4432

1.12

1.77

2.0

2.2

3.43

6.39

iu/l

0.86

225

1965

Arthropathic psoriasis

156

1273

1.23

1.77

1.6

2.1

2.97

8.34

iu/l

0.68

546

Benign neoplasm of breast

209

1756

1.20

1.77

1.9

2.0

137.50

7.03

iu/l

0.72

738

Stenosis and insufficiency of lacrimal passages

128

1022

1.26

1.77

2.3

1.8

4.73

9.47

iu/l

0.41

427

Other infectious diseases

713

1.31

1.76

2.3

2.0

3.34

12.08

iu/l

0.54

283

Bitten or struck by other mammals

195

1628

1.21

1.76

1.9

2.2

4.47

6.84

iu/l

0.31

740

Other noninfective disorders of lymphatic vessels and lymph nodes

405

1.42

1.76

1.6

2.2

2.26

3.99

iu/l

2.83

179

Other puerperal infections

169

1393

1.22

1.76

2.7

2.3

3.23

4.03

iu/l

1.13

650

Chromosomal abnormalities, not elsewhere classified

257

1.54

1.75

2.1

2.2

2.25

4.55

iu/l

1.81

109

Pneumonia due to Streptococcus pneumoniae

372

1.44

1.74

1.8

2.0

2.65

3.84

iu/l

1.29

150

Left ventricular outflow tract obstruction (LVOTO), broad definition

123

980

1.26

1.73

2.2

2.0

3.96

4.04

iu/l

0.03

419

Parkinson's disease, including avohilmo

162

1330

1.22

1.73

1.5

1.8

3.92

8.91

iu/l

0.49

464

Viral infections of the central nervous system, including avohilmo

114

901

1.27

1.73

2.0

3.29

9.84

iu/l

0.55

384

Juvenile arthritis (FINNGEN)

586

1.34

1.72

2.0

2.2

3.54

4.22

iu/l

0.49

278

Chronic ulcer of skin, not elsewhere classified

629

1.33

1.72

1.8

1.9

3.19

13.36

iu/l

0.55

246

Use of amantadine

156

1.69

1.71

2.0

1.9

7.01

4.10

iu/l

—

Ehlers-Danlos syndrome

149

1.72

1.71

2.0

2.3

3.60

4.63

iu/l

0.31

L02BA Anti-estrogens

212

2503

0.84

1.71

1.8

2.0

5.47

9.22

iu/l

0.48

1039

Open wound of head

767

6589

1.09

1.70

1.9

2.0

5.17

13.77

iu/l

1.23

274

2627

Atrophic disorders of skin

269

2317

1.17

1.69

2.0

4.68

9.40

iu/l

0.61

117

980

Orchitis and epididymitis

509

1.36

1.69

1.7

1.8

3.41

3.22

iu/l

0.05

197

Female infertility, tubal origin

719

1.31

1.69

2.3

2.1

3.93

3.80

iu/l

0.05

327

Simple and mucopurulent chronic bronchitis

308

1.47

1.69

1.8

9.51

4.14

iu/l

0.98

106

Benign neoplasm: Spinal meninges

1.90

1.69

1.8

3.63

4.84

iu/l

—

Respiratory conditions due to other external agents

180

1.63

1.68

1.3

1.8

1.53

40.22

iu/l

—

Behavioural disorders, excluding more controls

203

1.59

1.68

3.3

2.2

3.13

4.38

iu/l

0.72

106

Arnold-Chiari syndrome

127

1.78

1.68

1.8

2.4

8.48

4.31

iu/l

—

Excessive earwax

947

7926

1.08

1.67

1.8

1.9

11.42

12.38

iu/l

0.04

386

3113

Superficial injury of shoulder and upper arm

173

1436

1.21

1.67

1.9

2.0

58.72

7.57

iu/l

0.44

609

Other specified and unspecified disorders of eye and adnexa

376

1.42

1.66

2.4

2.0

2.32

19.02

iu/l

0.59

158

Renal cell carcinoma of kidney

212

1.57

1.66

1.6

1.9

3.22

30.30

iu/l

0.51

Polyarthritis, unspecified

385

1.42

1.65

2.0

2.1

2.87

4.32

iu/l

1.20

167

Pervasive developmental disorders excl. Autism + Asperger

133

1.74

1.65

1.9

2.2

2.19

4.12

iu/l

—

Brain meningioma

547

1.35

1.65

1.6

2.0

2.39

14.47

iu/l

0.61

224

Suggestive for eosinophilic asthma

120

960

1.26

1.65

1.9

2.1

4.59

4.04

iu/l

0.24

396

Acne

194

1622

1.20

1.65

2.0

2.2

2.31

3.47

iu/l

4.57

746

Lesion of sciatic nerve

310

1.46

1.64

1.8

4.98

22.90

iu/l

0.47

125

Lichen planus

186

1558

1.20

1.64

2.0

4.30

7.71

iu/l

0.43

631

842

6737

1.09

1.64

1.8

2.0

15.13

11.09

iu/l

0.15

298

2772

Congenital malformations of cardiac chambers and connections

2.21

1.64

2.4

1.9

1.14

4.56

iu/l

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

319

1.46

1.64

1.6

2.2

4.78

3.76

iu/l

0.25

139

Benign neoplasm: Rectosigmoid junction

327

1.45

1.64

2.0

1.9

2.66

22.98

iu/l

0.55

124

Colectomy operation

204

1723

1.19

1.63

1.9

4.99

7.37

iu/l

0.29

658

Long labour

498

3791

1.12

1.63

2.3

2.1

3.91

14.60

iu/l

1.17

237

1737

Atlantoaxial subluxation

2.12

1.63

2.1

1.8

6.23

5.95

iu/l

—

Gastrointestinal stromal tumor and sarcoma

1.90

1.62

2.0

1.9

7.26

3.71

iu/l

—

Congenital malformations of uterus and cervix

312

1.47

1.62

1.9

2.4

2.42

3.99

iu/l

1.90

148

Benign neoplasm: Choroid

688

1.30

1.62

2.0

3.74

12.55

iu/l

0.52

272

In situ neoplasms

637

5800

1.10

1.62

1.9

2.0

25.00

6.57

iu/l

0.42

259

2345

Secondary uncertain malignant neoplasm

151

1241

1.22

1.62

1.6

1.9

4.17

8.78

iu/l

0.45

473

Complications associated with artificial fertilization

271

1.50

1.62

1.7

2.2

1.67

4.14

iu/l

—

133

Sequelae of other external causes

601

1.32

1.62

1.9

2.1

2.25

13.37

iu/l

0.64

251

Endometriosis diagnosis and infertility diagnosis occurring together

207

1755

1.19

1.61

2.0

2.2

3.65

6.95

iu/l

0.57

795

Retinal detachment with retinal break

150

1233

1.22

1.61

1.8

1.9

4.85

8.85

iu/l

0.37

470

Benign neoplasm: Caecum

131

1062

1.24

1.61

1.8

1.9

2.75

9.64

iu/l

0.64

404

Endocrine disorders, other/unspecified

223

1.55

1.59

2.1

2.0

2.21

28.15

iu/l

0.55

Anorexia (incl.atypical)

107

849

1.27

1.59

1.7

2.3

2.23

9.39

iu/l

0.66

399

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1077

7372

1.08

1.59

2.2

2.1

15.20

16.18

iu/l

0.03

476

3247

Other benign neoplasms of uterus

586

1.33

1.58

1.6

1.9

3.49

13.88

iu/l

0.49

223

Thiazolidinediones

126

1019

1.24

1.58

1.9

4.29

10.12

iu/l

0.46

378

Hemiplegia

499

1.35

1.58

1.8

2.0

2.25

3.85

iu/l

2.63

201

Disorders resulting from impaired renal tubular function

313

1.45

1.58

1.9

5.19

23.40

iu/l

0.46

122

Disorders of parathyroid gland, other and/or unspecified

2.16

1.57

1.3

1.8

2.32

4.97

iu/l

—

Complications following infusion, transfusion and therapeutic injection

137

1.71

1.57

1.7

1.8

7.48

5.74

iu/l

—

Guillain-Barre syndrome

137

1.70

1.57

2.0

1.9

6.40

5.35

iu/l

—

ILD, hospital admissions 3, with pneumonia sepsis

691

1.29

1.57

1.7

1.9

16.62

12.44

iu/l

0.10

254

Infections of genitourinary tract in pregnancy

174

1457

1.20

1.57

1.9

2.2

3.65

3.82

iu/l

0.10

635

Ankylosing spondylitis, strict definition

482

0.66

1.57

1.4

2.1

5.16

3.97

iu/l

—

209

Liveborn infants according to place of birth

1.98

1.57

1.5

1.9

2.30

3.96

iu/l

—

Other congenital malformations of intestine

1.97

1.57

1.4

2.0

4.70

3.69

iu/l

—

Bronchitis, not specified as acute or chronic

104

824

1.27

1.56

1.6

2.1

574.41

3.81

iu/l

0.49

332

Bronchiectasis

727

1.29

1.56

2.2

2.0

15.95

3.94

iu/l

0.50

272

Open wound of shoulder and upper arm

184

1.60

1.56

2.0

4.72

3.83

iu/l

0.28

Volvulus

232

1.52

1.56

1.6

2.0

3.40

27.17

iu/l

0.51

100

Other and unspecified intracranial injuries

273

1.48

1.55

1.6

2.0

3.89

25.17

iu/l

0.49

109

Benign neoplasm: Liver

290

1.47

1.55

1.6

2.1

2.45

4.47

iu/l

2.01

123

Alzheimer’s disease (Atypical or mixed), excluding more controls

475

1.31

1.55

1.7

1.6

2.37

4.44

iu/l

2.56

157

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

478

4302

1.11

1.54

2.1

3.72

6.61

iu/l

0.76

198

1885

Parkinson's disease, strict definition

144

1185

1.22

1.54

1.5

1.8

3.45

9.21

iu/l

0.51

410

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

119

949

1.25

1.54

1.8

1.7

3.30

10.78

iu/l

0.53

326

Persistent delusional disorders

100

791

1.27

1.54

1.6

2.0

3.23

11.45

iu/l

0.58

316

Brain meningioma, including Hilmo

563

1.33

1.53

1.6

2.0

2.39

14.26

iu/l

0.62

229

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

365

1.41

1.53

2.1

2.3

3.00

4.32

iu/l

0.70

159

Whooping cough

1.96

1.53

3.5

2.1

3.27

4.94

iu/l

—

Carcinoma in situ of skin of other and unspecified parts of face

703

1.29

1.52

1.4

1.7

5.87

12.90

iu/l

0.32

253

Tongue abnormality

660

1.30

1.52

1.8

2.1

3.43

12.89

iu/l

0.53

259

Abdominal aortic aneurysm (AAA)

481

1.34

1.51

1.6

1.7

3.52

17.22

iu/l

0.48

166

Erysipelas

762

6044

1.09

1.51

1.7

1.9

54.17

6.12

iu/l

0.75

275

2377

Carcinoma in situ of skin of scalp and neck

154

1.64

1.51

1.3

1.6

2.70

48.33

iu/l

—

Acne vulgaris

149

1233

1.21

1.50

1.9

2.2

2.13

3.52

iu/l

6.56

573

Infectious mononucleosis, including avohilmo

145

1199

1.22

1.50

2.0

2.2

3.14

3.77

iu/l

0.61

546

Infectious mononucleosis

145

1199

1.22

1.50

2.0

2.2

3.14

3.77

iu/l

0.61

546

Disorders of synovium and tendon in diseases classified elsewhere

202

1.55

1.50

1.8

2.1

184.83

4.11

iu/l

0.47

Retinoschisis and retinal cysts

186

1.58

1.50

2.0

1.8

5.22

3.80

iu/l

0.29

SLE (Finngen)

317

1.43

1.49

2.0

1.7

7.80

2.73

iu/l

1.00

114

Vascular dementia (subcortical)

210

1.54

1.49

1.6

3.34

3.63

iu/l

—

Other disorders of male genital organs

218

1.52

1.49

1.9

2.2

2.05

3.42

iu/l

1.74

Mental retardation, excluding more controls

330

1.42

1.49

2.1

2.2

2.13

4.67

iu/l

3.59

146

Other congenital malformations of peripheral vascular system

171

1.61

1.49

2.5

1.9

1.81

3.93

iu/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

307

2595

1.14

1.49

1.8

1.7

2.89

7.61

iu/l

0.99

878

Operations 2 for CAVS

307

2595

1.14

1.49

1.8

1.7

2.89

7.61

iu/l

0.99

878

Postpartum haemorrhage due to anatomy

248

2151

1.16

1.48

2.4

4.11

3.78

iu/l

0.27

103

1021

Helminthiases, including avohilmo

523

1.33

1.48

1.9

2.2

3.90

3.65

iu/l

0.07

224

Calcific aortic valvular stenosis, operated

308

2605

1.14

1.48

1.8

1.7

2.87

7.59

iu/l

1.00

100

883

Calcific aortic valvular stenosis

308

2605

1.14

1.48

1.8

1.7

2.87

7.59

iu/l

1.00

100

883

Diseases of spleen

187

1.57

1.48

1.7

1.9

2.40

36.56

iu/l

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

437

1.36

1.48

2.0

2.2

1.77

4.13

iu/l

4.00

193

Certain conditions originating in the perinatal period

134

976

1.23

1.47

2.3

2.2

3.40

3.63

iu/l

0.14

442

Other and unspecified disorders of skin and subcutaneous tissue

672

1.29

1.47

2.0

3.84

12.74

iu/l

0.51

265

Galactorrhea

164

1.63

1.47

1.8

2.2

3.89

4.63

iu/l

—

Event of undetermined intent

690

1.28

1.47

1.8

2.1

2.46

11.59

iu/l

0.64

305

Other disorders of choroid

117

1.74

1.47

1.8

2.0

1.55

55.84

iu/l

—

Malignant neoplasm, without specification of site, including Hilmo

343

1.41

1.46

1.4

1.8

3.53

20.83

iu/l

0.51

137

Pneumothorax

567

1.31

1.46

1.9

356.60

14.22

iu/l

0.46

220

Primary open-angle glaucoma

385

3304

1.12

1.46

1.7

1.8

3.86

11.03

iu/l

0.73

121

1194

Status epilepticus

327

1.42

1.46

1.8

2.0

132.05

4.55

iu/l

0.47

133

Nontraumatic intracranial haemmorrhage

167

1981

0.84

1.46

1.8

41.21

4.03

iu/l

0.48

750

Alcohol abuse, main dg

195

1661

1.18

1.45

1.8

2.0

7.38

7.01

iu/l

0.02

723

Nonhereditary hypogammaglobulinemia

110

1.76

1.45

1.5

2.0

2.29

4.11

iu/l

—

Other degenerative diseases of the basal ganglia

125

1.70

1.45

1.3

1.6

4.60

5.19

iu/l

—

Alcohol-induced chronic pancreatitis

481

1.34

1.45

2.0

114.03

4.25

iu/l

0.48

198

Fracture of lower leg, including ankle

881

8027

1.08

1.44

1.9

2.0

3.47

13.05

iu/l

2.07

357

3272

Hyperkinetic disorders (excl. ADHD)

217

1.52

1.44

2.5

2.3

3.21

4.58

iu/l

0.59

Atopic dermatitis, strict definition with reimbursement

549

4799

1.10

1.44

2.1

2.2

4.06

19.36

iu/l

0.93

242

2180

Herpesviral keratitis and keratoconjunctivitis

430

1.36

1.44

2.1

2.21

17.17

iu/l

0.60

179

Acute alcohol intoxication, ICD10

252

2191

1.15

1.44

1.8

2.0

6.98

6.13

iu/l

0.07

104

933

Other congenital malformations, not elsewhere classified

1.86

1.44

1.6

1.9

6.78

5.83

iu/l

—

Achalasia of cardia

133

1.68

1.44

1.9

346.67

5.44

iu/l

—

Asthma mixed form (mode)

525

1.32

1.44

2.0

2.2

2.16

4.01

iu/l

2.72

228

Monoplegia

141

1.66

1.43

1.7

2.0

2.75

4.46

iu/l

—

Idiopathic thrombocytopenic purpura

295

1.44

1.43

2.4

2.0

3.52

4.34

iu/l

0.44

120

Dependent personality disorder

221

1.52

1.43

1.4

2.0

2.92

4.35

iu/l

0.86

Kyphosis

118

1.72

1.43

1.4

1.7

3.46

52.15

iu/l

—

Other chondrocalcinosis

1.85

1.43

1.3

1.7

1.91

4.90

iu/l

—

Acquired absence of organs, not elsewhere classified

1.85

1.43

1.6

1.9

2.07

3.87

iu/l

—

Mixed specific developmental disorders

196

1.53

1.43

2.2

2.92

3.99

iu/l

0.54

Chronic iridocyclitis

526

1.32

1.43

2.6

2.1

4.20

14.76

iu/l

0.48

216

Calcific aortic valvular stenosis, including rheumatic fever

307

2601

1.14

1.42

1.8

1.7

2.89

7.60

iu/l

0.99

880

Testicular hypofunction

229

1.50

1.42

1.3

2.1

1.89

4.17

iu/l

—

101

Seronegative rheumatoid arthritis

167

1408

1.19

1.42

1.8

2.0

3.38

4.03

iu/l

0.43

570

Separation of retinal layers (serosa)

380

1.38

1.42

1.8

1.9

2.41

4.16

iu/l

2.30

147

Embedded and impacted teeth

499

3669

1.11

1.41

2.3

2.2

3.05

17.24

iu/l

0.60

232

1638

Hereditary corneal dystrophies

355

1.39

1.41

1.7

2.0

3.89

21.01

iu/l

0.51

138

Benign neoplasm: Tonsil

111

1.74

1.41

1.9

1.62

3.98

iu/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

112

909

1.24

1.41

1.8

2.0

3.11

10.90

iu/l

0.62

353

Lesion of femoral nerve

1.98

1.40

2.3

1.8

3.37

4.02

iu/l

—

Algoneurodystrophy

407

1.37

1.40

1.8

2.1

3.86

3.97

iu/l

0.04

176

Open bite

731

1.27

1.40

2.0

2.2

87.98

3.57

iu/l

0.49

333

Perichondritis of external ear

142

1.64

1.40

2.0

1.7

5.57

46.63

iu/l

—

Colorectal adenocarcinoma

161

1883

0.84

1.40

1.7

1.9

6.06

8.43

iu/l

0.27

706

Unspecified chronic bronchitis

263

1.46

1.39

1.3

1.9

28.86

4.32

iu/l

0.45

Mixed connective tissue disease

174

1.57

1.39

1.8

1.9

3.17

37.80

iu/l

—

Hydrocele

615

1.29

1.39

1.7

3.15

7.27

iu/l

0.50

223

Other and unspecified vascular occlusions

103

829

1.25

1.39

1.7

1.8

2.88

11.63

iu/l

0.56

290

Acute alcohol intoxication

297

2619

1.14

1.39

1.8

2.0

6.40

5.82

iu/l

0.05

117

1082

Benign neoplasm: Skin of ear and external auricular canal

322

1.41

1.39

1.7

1.9

2.83

23.15

iu/l

0.57

126

Other obstructed labour

137

1138

1.21

1.39

2.3

2.1

4.54

4.01

iu/l

0.30

508

Diseases of peritoneum

126

1037

1.22

1.38

1.7

2.0

3.16

9.91

iu/l

0.63

411

Other peripheral vascular diseases

117

956

1.23

1.38

1.8

2.1

2.79

9.74

iu/l

0.63

400

Family history of certain disabilities and chronic diseases leading to disablement

688

1.27

1.38

2.2

2.90

3.82

iu/l

0.84

317

Alcohol dependence

294

2592

1.14

1.38

1.8

1.9

7.32

6.03

iu/l

0.12

114

1035

Pedal cyclist injured in other and unspecified transport accidents

108

1326

0.81

1.38

2.1

2.38

7.85

iu/l

0.74

567

Mental and behavioural disorders associated with the puerperium

167

1.59

1.37

2.2

2.4

4.25

5.27

iu/l

—

Impacted teeth

374

2870

1.12

1.37

2.3

3.27

3.63

iu/l

0.39

166

1294

Lichen planus, including avohilmo

281

2473

1.14

1.37

1.9

2.0

4.08

9.46

iu/l

0.78

107

1007

Crushed, pushed or stepped on by crowd or human stampede

109

886

1.24

1.36

1.9

2.1

3.36

3.66

iu/l

0.20

389

Unspecified nephritic syndrome

183

1.55

1.36

2.5

1.9

3.33

5.06

iu/l

0.67

Other rupture of muscle

1.96

1.36

3.0

2.2

4.04

5.38

iu/l

—

Other and unspecified immunodeficiencies with predominantly antibody defects

128

1.67

1.35

2.1

3.21

3.60

iu/l

—

Sequelae of other and unspecified effects of external causes

2.09

1.35

2.3

2.0

1.55

4.98

iu/l

—

Seropositive rheumatoid arthritis, strict definition

164

1932

0.85

1.35

1.9

2.0

4.13

6.84

iu/l

0.43

798

Alzheimer disease, excluding more controls

195

1077

1.17

1.35

1.6

1.8

35.00

4.30

iu/l

0.47

381

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

136

1.64

1.34

1.5

2.1

2.06

4.47

iu/l

—

Paralytic ileus

282

1.43

1.34

1.2

1.9

3.61

23.95

iu/l

—

118

Colorectal cancer

206

2287

0.86

1.34

1.7

1.9

5.38

7.45

iu/l

0.30

887

Infection of intervertebral disc (pyogenic)

1.80

1.34

2.1

1.7

5.26

76.16

iu/l

—

Vasomotor rhinitis (mode)

105

852

1.24

1.34

2.0

2.1

4.44

10.55

iu/l

0.43

348

Crystal arthropathies, rheuma endpoint

136

1.64

1.34

1.3

1.7

2.18

4.44

iu/l

—

Intussusception

233

1.48

1.33

3.3

2.1

2.98

27.33

iu/l

0.54

101

Other specified/unspecified hearing loss

109

888

1.23

1.33

1.6

1.9

2.99

4.18

iu/l

1.00

341

Cellulitis

298

2638

1.13

1.33

1.8

2.0

58.19

5.87

iu/l

0.47

110

1096

Artificial opening status

471

1.33

2.1

2.0

2.60

17.03

iu/l

0.59

182

Other congenital malformations of nervous system

137

1.64

1.32

1.8

2.4

8.48

4.18

iu/l

—

Haemangioma, any site

121

998

1.22

1.32

2.2

2.0

2.76

10.03

iu/l

0.69

407

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

187

1604

1.17

1.31

1.7

2.1

45.58

7.19

iu/l

0.44

680

Use of dimethyl fumarate

114

1.71

1.31

2.3

2.1

5.77

5.34

iu/l

—

Benign neoplasm: Spinal cord

137

1.63

1.31

2.3

1.8

3.73

4.72

iu/l

—

Crohn disease

188

1614

1.17

1.31

1.6

2.1

3.45

7.07

iu/l

0.56

713

Adenocarcinoma and ductal carcinoma of pancreas

282

0.60

1.31

2.3

2.0

3.18

23.60

iu/l

—

118

Anorexia

169

1.56

1.31

1.6

2.1

3.51

4.45

iu/l

0.21

Contusion of ankle

499

1.31

2.1

4.28

4.26

iu/l

0.01

217

Corneal degeneration

169

1.56

1.30

1.8

1.9

5.80

39.63

iu/l

0.48

Xerosis cutis

145

1.61

1.30

3.8

1.9

2.51

4.39

iu/l

1.00

Alzheimer’s disease (Early onset)

331

0.63

1.30

1.5

1.8

1.75

4.34

iu/l

—

131

Ankylosing spondylitis

113

927

1.23

1.30

1.8

2.1

3.43

9.86

iu/l

0.57

400

Viral hepatitis, including avohilmo

105

855

1.24

1.30

1.9

2.1

2.72

3.89

iu/l

1.76

371

Progressive vascular leukoencephalopathy

284

1.42

1.30

1.6

5.12

4.27

iu/l

0.20

115

Pure hyperglyceridaemia

153

1.58

1.30

1.6

1.8

2.50

4.23

iu/l

—

Problems related to social environment

293

1.41

1.29

2.4

1.9

3.57

23.45

iu/l

0.52

121

Nonpyogenic thrombosis of intracranial venous system

1.75

1.29

1.8

2.0

2.59

5.27

iu/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

730

1.25

1.29

1.9

2.0

4.08

12.32

iu/l

0.51

288

Other and unspecified injuries of forearm

1.82

1.29

2.2

1.9

3.55

5.37

iu/l

—

Dermatitis due to ingested food

378

1.35

1.29

2.0

4.48

3.70

iu/l

0.16

169

Lichen ruber planus, wide definition including periferal and oral lichen planus

338

3023

1.12

1.29

1.9

2.0

3.81

8.40

iu/l

0.83

130

1237

Periodontal disease, other/unspecified

302

1.41

1.29

2.5

2.0

3.05

23.17

iu/l

0.53

121

Malignant neoplasm of oropharynx

122

1.66

1.28

2.1

2.3

7.11

4.33

iu/l

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.03

1.28

1.9

1.7

4.90

3.98

iu/l

—

Effects of foreign body entering through natural orifice

298

2645

1.13

1.28

1.6

2.0

3.82

5.66

iu/l

0.39

112

1106

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

379

1.36

1.28

1.6

2.0

2.68

19.33

iu/l

0.56

152

Other infectious diseases, including avohilmo

111

911

1.22

1.28

2.1

2.0

3.01

10.36

iu/l

0.60

364

Other and unspecified injuries of abdomen, lower back and pelvis

162

1.57

1.27

3.1

2.1

2.89

4.88

iu/l

—

Other crystal arthropathies

138

1.61

1.27

1.3

1.7

2.18

4.88

iu/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

109

1324

0.82

1.27

1.6

1.9

2.93

8.50

iu/l

0.64

508

Unspecified maternal hypertension

187

1.53

1.27

2.2

2.6

2.08

4.84

iu/l

2.99

Viral infections of the central nervous system

101

822

1.24

1.27

2.0

2.1

3.31

10.50

iu/l

0.55

351

Anaemia in chronic diseases classified elsewhere

162

1.56

1.27

1.6

1.7

6.92

4.47

iu/l

—

Ulcerative colitis

355

3187

1.12

1.26

2.0

3.21

7.63

iu/l

0.92

143

1368

Bruxism

253

1.44

1.26

2.3

2.2

1.84

4.16

iu/l

2.64

116

Other and unspecified erythematous conditions

346

1.37

1.26

1.6

1.9

1.78

21.41

iu/l

0.60

136

Chronic suppurative otitis media

652

1.26

1.7

2.1

3.80

12.06

iu/l

0.51

288

Von Willebrand disease

171

1.55

1.26

2.0

2.1

2.06

4.62

iu/l

2.21

Carcinoma in situ, bladder

211

1.48

1.26

1.3

1.8

1.51

4.76

iu/l

—

Other superficial mycoses

253

1.44

1.26

1.8

2.0

5.21

4.37

iu/l

0.23

100

Benign neoplasm of middle ear and respiratory system

724

1.25

2.0

3.10

12.29

iu/l

0.57

279

Other follicular disorders

113

932

1.22

1.25

2.1

2.2

3.62

3.92

iu/l

0.12

422

Viral warts, including avohilmo

339

3039

1.12

1.25

2.0

2.1

3.76

5.44

iu/l

0.46

132

1345

Hypotension due to drugs

100

1.72

1.24

2.1

1.9

2.06

4.95

iu/l

—

Carcinoma in situ of other and unspecified sites

228

1.46

1.24

1.3

1.8

1.35

4.70

iu/l

—

Other maltreatment syndromes

321

1.38

1.24

1.9

2.1

2.71

3.72

iu/l

0.97

138

Disorders of optic nerve, not elsewhere classified

171

1.54

1.24

2.3

1.8

6.96

3.78

iu/l

—

Failed attempted abortion

188

1.52

1.24

2.0

2.6

4.17

4.13

iu/l

0.01

Dementia in other diseases classified elsewhere

364

1.36

1.23

2.3

1.9

4.27

4.10

iu/l

0.05

133

Malignant neoplasm, without specification of site

212

1.47

1.23

1.3

1.8

2.78

28.05

iu/l

—

Melanocytic naevi of upper limb, including shoulder

271

1.42

1.23

1.5

2.0

2.70

4.24

iu/l

1.20

112

Oral leukoplakia, including avohilmo

254

1.43

1.23

1.8

2.63

28.68

iu/l

0.54

Chronic myeloid leukaemia

2.21

1.23

1.5

2.1

—

5.29

—

Other specified/unspecified spondylopathies

196

1.49

1.23

1.5

1.7

458.79

34.69

iu/l

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

188

1.51

1.23

1.9

1.8

2.77

4.74

iu/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

417

1.33

1.22

2.5

2.2

3.64

4.08

iu/l

0.17

183

Malignant neoplasm of vulva, including Hilmo

148

1.58

1.22

1.3

1.9

3.97

42.09

iu/l

—

Mandibular retrognathia

104

851

1.23

1.22

2.0

2.1

2.48

3.93

iu/l

3.65

376

Primary ovarian failure

289

1.40

1.22

1.9

2.2

4.70

4.03

iu/l

0.18

130

Amblyopia ex anopsia

461

1.31

1.22

2.3

2.0

2.88

15.43

iu/l

0.56

202

Dermatitis herpetiformis

156

1.56

1.21

1.8

3.82

4.58

iu/l

—

Use of rivastigmine

154

1306

1.18

1.21

1.7

3.29

9.04

iu/l

0.53

426

Oesophagitis

496

1.30

1.21

1.5

2.0

5.97

16.75

iu/l

0.39

185

Aortic valve malfunction, age under 60 years

111

917

1.22

1.21

2.3

2.1

4.07

3.99

iu/l

0.03

392

Other endocrine disorders

551

1.28

1.21

2.1

2.2

2.06

13.59

iu/l

0.62

238

Dementia

433

3257

0.91

1.21

1.7

1.8

18.59

10.20

iu/l

0.22

152

1119

Epiphora

205

1.48

1.21

2.3

1.7

3.17

30.08

iu/l

0.49

Mental and behavioural disorders of puerperium, not classified elsewhere

173

1.53

1.21

2.2

4.25

4.42

iu/l

—

Dementia due to Parkinson's disease

148

1.57

1.21

1.4

1.5

2.37

3.50

iu/l

—

Other localized connective tissue disorders

222

1.46

1.21

2.2

2.0

2.35

4.16

iu/l

1.54

Other abortion

141

1.60

1.20

2.0

2.4

3.45

3.78

iu/l

0.13

Other protozoal intestinal diseases, including avohilmo

264

1.42

1.20

1.4

2.1

2.21

4.37

iu/l

—

111

Other bullous disorders

264

1.42

1.20

1.9

2.0

3.34

4.14

iu/l

0.25

108

Myocardial infarction, with ST-elevation

151

1284

1.18

1.20

1.7

1.8

3.98

8.72

iu/l

0.45

454

Patent foramen ovale

214

1.47

1.19

2.0

3.47

4.70

iu/l

—

Seborrhoeic keratosis

347

3124

1.11

1.19

2.0

1.9

3.90

8.38

iu/l

0.77

142

1224

Unspecified lump in breast

280

2492

1.13

1.19

1.8

2.0

2.99

8.99

iu/l

0.98

114

1054

Other psoriatic arthropathies

137

1157

1.19

1.6

2.1

3.03

8.82

iu/l

0.66

494

Haemorrhage, not elsewhere classified

315

1.37

1.19

2.1

1.9

4.66

4.27

iu/l

0.09

126

Hydronephrosis

138

1166

1.19

1.6

2.1

3.77

8.92

iu/l

0.51

474

Viral hepatitis

811

1.23

1.18

1.9

2.1

2.77

3.71

iu/l

1.30

352

Abscess of lung

102

1.69

1.17

2.1

1.8

1.79

5.34

iu/l

—

Cleft lip

0.00

1.17

0.0

2.0

—

3.87

—

Amputation

748

1.23

1.17

1.8

6.45

12.15

iu/l

0.27

276

Symptoms and signs involving appearance and behaviour

1.76

1.17

1.7

2.0

2.82

5.31

iu/l

—

Polycystic ovarian syndrome, broad definition

236

2082

1.14

1.17

2.4

2.3

3.03

3.70

iu/l

1.37

112

993

Squamous cell neoplasms and carcinomas of the skin

721

1.24

1.17

2.0

1.7

3.52

12.97

iu/l

0.51

249

Other and unspecified disorders of psychological development

114

1.64

1.17

1.8

2.0

2.70

3.87

iu/l

—

Other and unspecified mononeuropathies of upper limb

308

1.38

1.17

1.6

2.0

3.64

22.03

iu/l

0.53

133

Malignant neoplasm of breast, HER2-negative

678

4709

0.93

1.16

1.8

2.1

16.59

12.09

iu/l

0.14

261

2045

Airway disease due to specific organic dust

2.58

1.16

1.0

2.3

—

2.17

—

Liposarcoma, including Hilmo

1.83

1.16

2.2

1.8

7.06

3.78

iu/l

—

Other local infections of skin and subcutaneous tissue

137

1160

1.19

1.16

1.8

2.1

3.15

8.79

iu/l

0.62

488

Tic disorders

134

1.59

1.16

2.1

2.3

2.79

5.06

iu/l

—

Ulcerative colitis, NAS

191

1661

1.15

1.16

2.0

2.1

3.01

7.07

iu/l

0.69

727

Toxic effects of substances chiefly nonmedicinal as to source

153

1309

1.17

1.15

1.9

2.1

4.79

7.80

iu/l

0.32

568

Toxic effect of ethanol

413

1.32

1.14

1.6

2.1

5.93

4.28

iu/l

0.33

177

Burns classified according to extent of body surface involved

1.78

1.14

1.6

2.2

3.48

4.18

iu/l

—

Hirsutism in women

310

1.37

1.14

1.7

2.3

2.54

4.28

iu/l

1.71

149

Benign neoplasm: Other and unspecified parts of mouth

318

1.36

1.14

1.8

2.0

3.20

4.04

iu/l

0.28

126

Hidradenitis suppurativa

493

1.29

1.14

2.4

2.2

2.28

4.00

iu/l

2.43

222

Placental disorders

127

1.61

1.14

2.6

2.3

4.69

3.69

iu/l

0.21

Other respiratory diseases principally affecting the interstitium

189

1645

1.15

1.13

1.9

1.8

8.75

7.71

iu/l

0.06

596

Other factor of the environment

127

1.60

1.13

1.8

2.0

2.11

4.34

iu/l

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

135

1.58

1.13

1.8

2.3

2.12

4.96

iu/l

—

Inguinal hernia, bilateral

707

1.23

1.13

1.6

1.8

3.39

3.65

iu/l

0.15

256

Other secondary coxarthrosis

336

1.35

1.13

2.2

1.9

2.85

21.27

iu/l

0.56

138

Eosinophilic disease (BM)

127

1.59

1.12

1.8

1.9

8.28

3.90

iu/l

—

Intentional self-harm by unspecified means

176

1.50

1.12

2.3

2.1

2.20

4.25

iu/l

—

Other disorders of bone density and structure

302

1.37

1.12

2.8

2.0

5.31

23.26

iu/l

0.46

123

Acute suppurative otitis media

445

3793

1.10

1.12

1.9

2.2

110.43

8.20

iu/l

0.47

187

1717

Hydatidiform mole

207

0.57

1.12

1.4

2.4

1.73

4.83

iu/l

—

Psoriatic arthropathies, ICD10

140

1193

1.18

1.11

1.6

2.1

2.99

8.64

iu/l

0.66

508

Endometriosis of rectovaginal septum and vagina

132

1120

1.19

1.11

2.0

1.9

3.15

4.07

iu/l

1.26

464

Sacrococcygeal disorders, not elsewhere classified

389

1.32

1.11

2.1

2.2

3.03

17.74

iu/l

0.56

173

Hypertrichosis

346

1.35

1.11

1.7

2.2

2.47

4.16

iu/l

1.86

165

Malignant neoplasm of breast, HER2-negative, including Hilmo

695

4779

0.93

1.11

1.9

2.1

4.38

11.97

iu/l

1.05

269

2074

Congenital malformations of breast, including avohilmo

286

1.38

1.11

1.9

2.3

2.70

3.73

iu/l

0.78

132

Unspecified urinary incontinence

131

1111

1.19

1.11

1.9

2.0

6.93

9.11

iu/l

0.17

450

Other and unspecified local infections of skin and subcutaneous tissue

130

1102

1.19

1.10

1.9

2.1

3.19

9.02

iu/l

0.61

465

Presbyopia

109

910

1.20

1.10

2.1

2.0

3.54

4.13

iu/l

0.31

385

Other inflammation of vagina/vulva

603

1.26

1.10

2.8

2.3

3.91

3.99

iu/l

0.03

273

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

629

1.25

1.10

1.6

2.0

2.88

13.19

iu/l

0.59

255

Other diseases of spinal cord

286

1.38

1.10

1.7

1.9

5.65

4.50

iu/l

0.17

116

Gluteal tendinitis

558

1.26

1.10

1.8

2.1

3.07

14.60

iu/l

0.61

235

Malignant neoplasm of breast

681

4714

0.93

1.09

1.8

2.1

16.53

12.08

iu/l

0.14

262

2046

Specific developmental disorder of motor function

140

1.55

1.09

2.2

2.23

3.97

iu/l

—

Other specified/unspecified inflammatory spondylopathies

594

1.25

1.09

2.0

2.2

3.56

4.12

iu/l

0.20

268

Benign neoplasm: Skin of lower limb, including hip

295

1.37

1.09

2.1

1.9

3.90

4.15

iu/l

0.09

115

Malignant neoplasm of corpus uteri, including Hilmo

139

1187

1.18

1.09

1.8

1.9

132.19

9.08

iu/l

0.47

462

Injury of eye and orbit

185

1614

1.15

1.09

1.8

2.0

3.32

7.19

iu/l

0.58

677

Bursitis of shoulder

261

1.39

1.09

1.9

2.1

3.42

4.74

iu/l

—

118

Other appendicitis

119

1003

1.19

1.08

1.7

2.1

2.95

9.49

iu/l

0.65

431

Pemphigoid

202

1.45

1.08

1.6

1.7

1.91

33.18

iu/l

—

Other congenital malformations of intestine, including avohilmo

1.67

1.08

1.4

1.8

4.30

4.32

iu/l

—

Congenital malformations of the respiratory system, including avohilmo

169

1.49

1.08

2.7

2.0

2.93

4.17

iu/l

0.65

Other articular cartilage disorders

219

1.43

1.08

1.7

2.0

1.72

4.08

iu/l

—

Embolic stroke

312

1.35

1.08

1.5

1.7

3.33

4.28

iu/l

0.40

119

Haemolytic anaemias

330

1.34

1.08

2.1

2.0

175.63

21.48

iu/l

0.41

133

Malignant neoplasm of rectum

827

0.79

1.07

1.6

1.9

5.89

11.29

iu/l

0.31

313

Cysts of oral region, not elsewhere classified

595

1.25

1.07

2.1

2.74

13.94

iu/l

0.60

239

Dislocation of lens

1.67

1.07

2.5

1.8

2.70

4.51

iu/l

—

Seronegative juvenile rheumatoid arthritis

245

1.41

1.07

1.8

2.1

4.11

4.36

iu/l

—

104

Malignant neoplasm of breast, including Hilmo

696

4777

0.93

1.07

1.9

2.1

4.38

11.97

iu/l

1.05

269

2074

Conotruncal defects

129

1.57

1.07

2.2

2.1

2.43

4.02

iu/l

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

338

0.68

1.07

1.6

1.9

2.28

20.57

iu/l

—

137

Erysipelas, including avohilmo

1091

7642

1.06

1.07

1.8

2.0

39.44

8.69

iu/l

0.65

389

3121

Other disorders of breast and lactation associated with childbirth

271

1.39

1.07

2.5

2.4

2.51

3.47

iu/l

0.68

120

Convalescence

632

1.24

1.06

1.9

2.0

4.31

4.23

iu/l

0.02

266

Abscess of anal and rectal regions

101

840

1.21

1.06

1.6

2.1

3.78

10.27

iu/l

0.52

371

Cervical polyps

166

1441

1.16

1.06

2.0

3.33

4.10

iu/l

0.78

622

Conductive hearing loss, unspecified

111

932

1.20

1.06

2.2

2.0

2.48

4.42

iu/l

4.58

395

Ectopic pregnancy

316

2856

1.11

1.06

2.1

166.69

14.25

iu/l

0.45

122

1281

Malignant neoplasm of pancreas

556

0.75

1.05

1.9

1.8

2.51

14.37

iu/l

0.57

216

Malignant neoplasm of brain

324

0.67

1.04

1.7

2.2

4.85

19.72

iu/l

0.46

147

Other secondary gonarthrosis

535

1.26

1.04

1.5

2.0

3.65

4.00

iu/l

0.11

220

LSIL lesion of the vulva

385

1.31

1.04

2.2

2.1

2.51

17.72

iu/l

0.59

173

Sacroiliitis, not elsewhere classified

607

1.24

1.04

1.8

2.3

2.72

12.55

iu/l

0.62

278

Other orthopaedic follow-up care

616

1.24

1.04

2.0

1.9

5.02

4.12

iu/l

0.34

240

Malignant neoplasm of penis, including Hilmo

2.30

1.04

1.0

2.0

—

4.46

—

Other conjunctival vascular disorders and cysts

221

1.42

1.04

2.5

1.8

2.29

4.59

iu/l

2.17

Bell's palsy

158

1369

1.16

1.04

2.0

4.65

7.90

iu/l

0.38

589

Haemangioma and lymphangioma, any site

127

1082

1.18

1.03

2.2

2.0

2.75

9.44

iu/l

0.70

447

Bicipital tendinitis

491

1.27

1.03

1.9

2.2

4.06

4.18

iu/l

0.03

220

Other and unspecified injuries of lower leg

121

1027

1.18

1.03

2.1

2.54

9.02

iu/l

0.66

442

Other specified/unspecified bacterial intestinal infections

698

1.22

1.03

1.8

2.0

3.67

12.23

iu/l

0.51

279

Spinal instabilities

307

1.35

1.03

2.2

2.1

4.06

23.52

iu/l

0.52

124

Other and unspecified injuries of wrist and hand

456

1.28

1.03

1.7

2.1

2.22

3.92

iu/l

2.77

202

Combinations of oral blood glucose lowering drugs

322

2916

1.11

1.03

1.8

1.9

27.52

9.75

iu/l

0.33

128

1090

Migraine without aura, drug-induced

147

1.52

1.02

1.7

2.0

1.68

4.40

iu/l

—

Sudden idiopathic hearing loss

123

1046

1.18

1.02

1.7

1.9

3.78

4.05

iu/l

0.09

416

Other aneurysm

394

1.30

1.02

1.9

4.30

4.22

iu/l

0.02

153

Dementia, including avohilmo

471

3486

0.92

1.02

1.7

1.8

17.64

9.68

iu/l

0.22

162

1224

Oral lichen planus, including avohilmo , including avohilmo

103

863

1.20

1.02

1.8

2.0

2.49

11.06

iu/l

0.68

342

Granuloma annulare

180

1.46

1.02

2.8

2.0

2.76

4.00

iu/l

0.78

Tic and related disorders

147

1.52

1.02

2.1

2.3

2.79

4.59

iu/l

—

Bullous pemphigoid

155

1.50

1.02

1.7

1.95

40.50

iu/l

—

Other diseases of pancreas

799

1.21

1.02

1.7

2.0

2.58

4.47

iu/l

2.51

309

Actinic keratosis

460

3852

1.09

1.02

1.7

1.8

3.31

10.76

iu/l

0.93

143

1364

Basal cell carcinoma, including Hilmo

609

3833

1.08

1.01

1.7

1.9

5.59

13.00

iu/l

0.71

178

1529

Pulmonary eosinophilia, not elsewhere classified

1.67

1.01

2.9

1.8

3.38

4.69

iu/l

—

Benign neoplasm: Short bones of lower limb

1.64

1.01

1.4

2.0

3.50

4.86

iu/l

—

Purpura and other haemorrhagic conditions

171

1493

1.15

1.01

2.1

2.0

9.57

7.69

iu/l

0.11

607

Colon adenocarcinoma, helper endpoint

1148

0.83

1.01

1.7

1.8

6.53

9.40

iu/l

0.20

418

Subarachnoid haemorrhage

1006

0.82

1.01

2.0

1.9

3.64

4.38

iu/l

0.42

395

Migraine, unspecified, drug-induced

1.75

1.01

1.3

1.9

1.97

4.68

iu/l

—

Inflammation of lacrimal passages (chronic)

115

1.58

1.00

1.9

1.7

3.86

63.17

iu/l

—

Myocardial infarction, strict

525

3437

1.08

1.00

1.7

1.9

42.86

10.69

iu/l

0.71

186

1249

Personal history of certain other diseases

257

1.38

1.00

2.2

2.4

3.35

3.98

iu/l

0.33

119

Benign neoplasm: Small intestine

352

1.32

1.00

1.9

1.8

3.29

20.45

iu/l

0.52

141

Complications of internal orthopaedic prosthetic devices, implants and grafts

285

2570

1.11

1.00

1.8

3.19

6.47

iu/l

0.75

963

Viral warts

142

1225

1.16

1.00

1.9

2.2

2.97

8.23

iu/l

0.64

533

Familial hypercholesterolemia, with ischemic heart disease

664

1.22

1.00

1.6

1.7

5.49

13.80

iu/l

0.38

232

Nummular dermatitis

810

1.20

1.00

2.2

2.0

3.71

11.56

iu/l

0.54

316

Left hemicolectomy

156

1.49

0.99

1.7

1.8

8.97

4.77

iu/l

—

Deep endometriosis

162

1413

1.15

0.99

2.0

2.1

3.05

7.68

iu/l

0.65

612

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

409

3755

1.09

0.99

2.0

3.16

5.22

iu/l

0.76

159

1564

Enteropathic arthropathies

266

1.37

0.99

1.9

2.1

2.21

4.58

iu/l

3.22

121

Use of biperiden

521

1.26

0.99

1.5

2.1

2.25

3.90

iu/l

3.69

221

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.99

0.0

2.1

—

5.87

—

Nightmares

2.01

0.99

1.7

2.0

—

3.56

—

Motor disorders

147

1.50

0.99

2.2

2.3

2.23

3.87

iu/l

—

Discharge from other and unspecified firearms

0.00

0.99

0.0

1.8

—

4.07

—

Pedal cyclist injured in transport accident

265

2943

0.90

0.98

2.2

2.1

3.24

8.03

iu/l

0.92

104

1270

Combined immunodeficiencies

1.65

0.98

2.2

1.9

2.28

5.23

iu/l

—

Artificial joint re-operation

675

1.22

0.98

1.6

1.9

3.63

12.86

iu/l

0.51

256

Medicines for HER+ breast cancer

560

5601

0.93

0.98

1.9

2.0

18.36

13.67

iu/l

0.12

229

2289

Optic atrophy

165

1.47

0.98

3.1

1.9

2.72

4.45

iu/l

—

Wegener granulomatosis

124

1.55

0.98

1.5

1.9

4.49

5.41

iu/l

—

Isolated proteinuria

258

1.37

0.98

2.7

2.1

1.96

4.32

iu/l

2.90

Asthma and opportunity respiratory infection

433

1.28

0.97

2.1

2.0

4.52

3.89

iu/l

0.14

169

Cytomegalovirus infection, IBD co-morbidity

207

1.41

0.97

2.0

1.9

3.71

4.27

iu/l

0.11

Malignant neoplasm of small intestine, including Hilmo

241

1.38

0.97

1.8

2.0

4.66

25.92

iu/l

0.47

105

Embolic stroke with flimmer

132

1.52

0.97

1.6

4.01

5.37

iu/l

—

Peripheral artery disease

477

3480

1.08

0.97

1.8

3.74

11.50

iu/l

0.84

177

1223

Right hemicolectomy

460

1.27

0.97

1.7

1.9

3.55

17.58

iu/l

0.54

175

N06DA Anticholinesterases

317

2690

0.91

0.96

1.6

1.7

25.25

11.76

iu/l

0.25

106

889

Use of anticholinesterases

317

2690

0.91

0.96

1.6

1.7

25.25

11.76

iu/l

0.25

106

889

Lumbosacral plexus disorders

0.00

0.96

0.0

2.1

—

4.05

—

Malignant neoplasm of oropharynx, including Hilmo

149

1.49

0.96

2.0

2.3

7.11

36.10

iu/l

—

Drowning and submersion while in natural water

0.00

0.96

0.0

2.4

—

5.77

—

Invasive ventilation

686

1.22

0.96

1.8

2.1

7.08

12.38

iu/l

0.24

272

Suppurative and necrotic conditions of lower respiratory tract

425

1.28

0.96

1.9

2.86

18.32

iu/l

0.56

165

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

576

1.24

0.96

1.7

1.9

2.26

4.15

iu/l

3.67

233

Hodgkin lymphoma, hilmo

259

1.36

0.96

1.9

1.51

4.51

iu/l

—

Cystic disease of liver

1.81

0.95

1.4

1.7

5.20

4.48

iu/l

—

Paraplegia, diplegia of upper limbs

191

1.43

0.95

1.9

3.88

5.05

iu/l

0.22

Unspecific neurodegenerative disorder

407

3031

0.92

0.95

1.6

1.7

19.61

10.78

iu/l

0.21

142

1014

Habit and impulse disorders

183

1.44

0.95

1.5

2.3

2.23

4.78

iu/l

2.01

Erosion and ectropion of cervix uteri

338

1.31

0.95

2.0

1.8

3.96

4.09

iu/l

0.07

140

Other papulosquamous disorders

101

1.61

0.95

1.7

1.8

3.79

4.02

iu/l

—

Basal cell carcinoma

581

3689

1.08

0.94

1.7

1.9

5.59

13.43

iu/l

0.71

164

1452

Schizoid personality disorder

150

1.48

0.94

1.4

1.8

1.68

3.79

iu/l

2.38

Necrobiosis lipoidica, not elsewhere classified

1.71

0.93

4.5

2.2

3.78

4.73

iu/l

—

Alzheimer’s disease (Atypical or mixed)

760

1.20

0.93

1.7

2.34

3.89

iu/l

2.83

238

Ulcer of vagina/vulva

419

1.28

0.93

1.8

2.3

3.52

16.38

iu/l

0.52

186

Acute lymphadenitis

689

1.21

0.93

1.9

2.2

3.34

11.80

iu/l

0.56

299

Pneumonitis due to solids and liquids

643

1.22

0.93

1.6

1.9

7.72

13.42

iu/l

0.23

242

Malignant neoplasm of oral cavity, including Hilmo

374

1.29

0.93

1.4

1.9

3.19

19.74

iu/l

0.51

144

Peripheral artery operations in Hilmo

112

954

1.18

0.93

2.1

1.8

5.93

10.22

iu/l

0.26

345

1.66

0.92

1.4

1.9

1.98

4.88

iu/l

—

Viral encephalitis, not elsewhere classified/unspecified

184

1.43

0.92

1.9

1.8

2.77

4.62

iu/l

—

Other renal tubulo-interstitial diseases

261

1.35

0.92

1.9

2.1

2.74

4.67

iu/l

1.11

111

Skin changes due to chronic exposure to nonionizing radiation

476

3993

1.08

0.92

1.7

1.8

3.27

10.46

iu/l

0.94

147

1427

Kela reimbursement Agammaglobulinemia (D80-84)

1.62

0.92

2.3

2.2

2.54

3.03

iu/l

—

Abnormal findings on diagnostic imaging of breast

176

1.44

0.92

2.0

1.8

2.72

4.49

iu/l

1.23

Arthropathy in Crohn disease

110

1.57

0.92

1.8

2.1

1.80

4.87

iu/l

—

Generalized epilepsy

500

1.25

0.92

1.9

2.2

2.54

3.96

iu/l

2.80

219

Benign neoplasm: Parathyroid gland

1.62

0.92

1.5

1.7

7.07

68.13

iu/l

—

Secondary malignant neoplasm of respiratory and digestive organs

110

1.56

0.91

2.0

1.9

2.47

50.14

iu/l

—

Diffuse brain injury

305

1.32

0.91

2.2

2.1

3.57

4.65

iu/l

0.48

132

Other arterial embolism and thrombosis

193

1.41

0.91

1.5

1.6

2.63

36.65

iu/l

—

Malignant neoplasm of breast, HER-positive

507

4056

0.93

0.90

1.9

2.0

20.24

13.31

iu/l

0.17

203

1734

Corneal pigmentations and deposits

2.11

0.90

1.0

2.3

—

3.68

—

Synovial cyst of popliteal space [Baker]

829

1.19

0.90

1.6

2.0

3.68

4.15

iu/l

0.23

348

Other (seronegative) rheumatoid arthritis, wide

266

2408

1.11

0.90

1.8

2.0

3.62

6.34

iu/l

0.56

959

Dislocation, sprain and strain of joints and ligaments of elbow

811

1.19

0.90

1.8

2.1

4.61

10.32

iu/l

0.40

358

Social disorders starting during childhood or adolecense, excluding more controls

1.72

0.90

1.4

2.5

1.34

6.91

iu/l

—

Other and unspecified corneal deformities and disorders

341

1.30

0.90

2.1

2.0

5.02

21.01

iu/l

0.47

139

LSIL lesion of the cervix uteri, vagina or vulva

271

2457

1.11

0.90

2.2

3.09

6.06

iu/l

0.81

123

1125

Osteochondrosis of ankle, juvenile

1.68

0.90

3.5

2.3

4.70

6.32

iu/l

—

Drug-induced cataract

228

1.37

0.89

2.6

1.9

2.93

3.87

iu/l

0.73

Biological medicines for asthma

254

1.35

0.89

2.4

2.0

3.22

4.11

iu/l

0.31

105

Pemphigus

1.82

0.89

1.5

2.0

1.97

4.21

iu/l

—

Hepatomegaly and splenomegaly, not elsewhere classified

1.63

0.89

2.4

2.2

1.93

6.06

iu/l

—

Eustachian salpingitis and obstruction

119

1025

1.17

0.88

2.1

2.2

4.27

4.00

iu/l

0.11

436

Pigmented purpuric dermatosis

1.63

0.88

2.4

1.8

535.76

5.70

iu/l

—

Benign neoplasm: Oesophagus

103

1.57

0.88

1.7

5.47

4.36

iu/l

—

Flatulence and related conditions

1.60

0.88

2.4

2.0

1.78

5.15

iu/l

—

Personal history of medical treatment

1.60

0.88

2.5

1.9

2.73

5.85

iu/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

509

4061

0.93

0.88

1.9

2.0

20.09

13.31

iu/l

0.17

205

1735

Focal epilepsy

266

2410

1.11

0.88

1.9

2.0

2.93

6.21

iu/l

0.78

101

995

Occupational exposure to risk-factors

272

1.33

0.88

1.4

2.1

2.28

4.80

iu/l

3.04

110

Atopic dermatitis, strict definition

521

4752

1.07

0.87

2.1

2.2

4.17

10.30

iu/l

1.12

231

2149

Left ventricular outflow tract obstruction, narrow definition

467

1.25

0.87

2.1

2.0

2.53

4.24

iu/l

2.21

198

Cytomegaloviral disease, including avohilmo

229

1.37

0.87

1.9

2.0

3.62

4.24

iu/l

0.13

510

4273

1.07

0.87

1.7

1.8

3.25

11.99

iu/l

1.21

163

1543

Normotensive glaucoma

832

1.18

0.87

1.6

1.8

3.89

11.16

iu/l

0.48

312

Congenital ovarian cysts

686

1.20

0.87

1.8

2.2

3.01

3.82

iu/l

0.88

318

Fracture at wrist and hand level

493

4577

1.08

0.87

2.0

3.83

4.95

iu/l

0.43

200

1927

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

128

1.50

0.86

3.9

1.7

3.42

53.16

iu/l

—

Otosclerosis

802

0.82

0.86

1.8

2.0

2.50

11.53

iu/l

0.66

317

Other facial nerve disorders

317

1.30

0.86

1.8

2.0

4.13

4.93

iu/l

0.18

116

Renal tubulo-interstitial disorders in diseases classified elsewhere

1.69

0.86

1.5

2.3

3.47

7.04

iu/l

—

Loose body in joint

204

1.38

0.86

2.3

1.9

3.67

4.90

iu/l

—

Papilloedema, unspecified

256

1.34

0.86

2.0

2.1

2.30

5.04

iu/l

2.47

106

Burn and corrosion of trunk

282

1.32

0.86

2.2

2.0

2.81

4.21

iu/l

0.83

111

Congenital malformations of aortic and mitral valves

379

1.27

0.86

2.3

2.0

2.55

4.08

iu/l

1.76

157

Impacted maxillary molar

113

973

1.17

0.86

2.5

2.3

3.63

3.64

iu/l

0.00

455

Urethral stricture

352

1.28

0.86

1.9

1.8

139.08

4.14

iu/l

0.49

119

Impacted cerumen

135

1178

1.15

0.85

2.0

1.9

3.33

8.94

iu/l

0.56

454

Aggressive periodontitis

222

1.36

0.84

1.6

1.9

2.32

4.50

iu/l

2.27

Foreign body or object entering through skin

642

1.21

0.84

1.6

2.2

3.82

4.19

iu/l

0.12

286

Mental retardation, wide definition

421

1.26

0.84

2.0

2.1

2.13

4.11

iu/l

2.83

180

Superficial injuries involving multiple body regions

283

1.32

0.84

2.2

2.0

3.17

4.09

iu/l

0.39

111

Complications of other internal prosthetic devices, implants and grafts

407

1.26

0.84

1.9

2.0

5.23

18.87

iu/l

0.46

161

Malignant neoplasm of corpus uteri

123

1068

1.16

0.84

1.8

1.9

144.12

9.88

iu/l

0.47

398

Varicella [chickenpox]

443

1.25

0.84

2.2

2.0

3.07

4.19

iu/l

0.79

191

Agranulocytosis

149

1311

1.14

0.84

2.2

2.0

3.54

8.28

iu/l

0.55

531

Open wound of wrist and hand

643

5845

1.06

0.84

2.0

15.54

7.58

iu/l

0.29

261

2462

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

479

0.77

0.83

1.5

1.8

2.30

16.19

iu/l

—

185

Whooping cough, including avohilmo

214

1.37

0.83

3.0

2.2

6.20

4.38

iu/l

0.25

Vascular dementia (undefined)

220

1.36

0.83

1.3

1.5

2.16

3.74

iu/l

—

Injury of muscle and tendon at hip and thigh level

133

1162

1.15

0.83

1.8

2.1

2.88

8.67

iu/l

0.68

505

Drug-induced obesity

105

1.55

0.83

1.5

2.2

1.84

5.34

iu/l

—

Other and unspecified injuries of thorax

180

1.40

0.83

1.2

2.0

3.69

4.08

iu/l

—

Malignant neoplasm of eye and adnexa, including Hilmo

113

1.52

0.83

1.6

1.9

1.66

46.08

iu/l

—

Sexual dysfunction

180

1.40

0.83

1.5

1.9

1.86

4.86

iu/l

—

Scarlet fever

1.64

0.83

2.2

2.4

2.24

5.22

iu/l

—

Pyothorax

310

1.30

0.83

1.8

2.0

3.06

23.13

iu/l

0.53

122

Malignant neoplasm of other connective and soft tissue

197

1.38

0.83

1.8

2.0

6.93

29.79

iu/l

—

Multiple myeloma

197

1.38

0.82

2.0

1.9

2.10

31.85

iu/l

0.54

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

197

1.38

0.82

2.0

1.9

2.10

31.85

iu/l

0.54

Injuries to the shoulder and upper arm

1358

10044

1.04

0.82

1.9

2.0

9.71

11.13

iu/l

0.08

519

4083

Exposure to other and unspecified man-made environmental factors

206

1.37

0.82

1.5

2.1

4.37

4.27

iu/l

—

Anomalies of dental arch relationship, including avohilmo

322

2673

1.09

0.82

2.0

2.2

193.63

8.30

iu/l

0.58

122

1202

Abrasion of teeth

588

5525

1.07

0.82

2.2

2.0

85.25

10.97

iu/l

0.44

244

2329

Optic atrophy, wide definition

172

1.41

0.82

3.1

1.9

2.72

4.60

iu/l

—

Venous complications and haemorrhoids in the puerperium

147

1.45

0.82

2.0

1.8

5.48

3.53

iu/l

0.24

Congenital malformations of the respiratory system

155

1.43

0.81

2.7

2.0

2.57

4.22

iu/l

0.95

Dislocation, sprain and strain of joints and ligaments of knee

1047

9030

1.05

0.81

2.0

3.28

17.32

iu/l

1.66

439

3804

Varicella [chickenpox], including avohilmo

535

1.22

0.81

2.0

2.1

2.94

3.96

iu/l

0.81

235

Benign neoplasm: Skin of eyelid, including canthus

202

1815

1.12

0.81

1.8

2.0

3.75

7.05

iu/l

0.50

723

Contusion of other and unspecified parts of foot

682

1.19

0.81

1.7

2.1

2.43

3.89

iu/l

3.56

301

Nonsuppurative otitis media

381

3057

1.08

0.81

2.0

2.2

3.59

5.25

iu/l

0.45

151

1349

Other and unspecified nonscarring hair loss

114

1.52

0.81

2.2

1.98

4.65

iu/l

—

Erythema nodosum

356

1.27

0.81

2.0

2.1

4.79

18.89

iu/l

0.46

156

Dyshidrosis [pompholyx]

181

1.40

0.81

1.8

2.1

2.76

4.25

iu/l

—

Colorectal cancer, including Hilmo

253

2591

0.91

0.81

1.7

1.9

5.06

10.04

iu/l

0.65

1001

Other abnormalities of plasma proteins

122

1.49

0.81

1.5

1.8

2.87

5.08

iu/l

—

Gonococcal infection

356

1.27

0.81

2.1

2.0

4.76

4.08

iu/l

0.23

147

Drug-induced neutropenia

793

1.18

0.81

1.9

2.0

3.83

11.70

iu/l

0.55

318

Otorrhagia

1.75

0.80

2.3

1.8

1.98

4.33

iu/l

—

Noninfective disorders of pinna

0.00

0.80

0.0

2.7

—

3.60

—

Fetus and newborn affected by other complications of labour and delivery

0.00

0.80

0.0

1.9

—

2.28

—

Pre-eclampsia superimposed on chronic hypertension

1.59

0.80

2.3

2.4

2.04

4.35

iu/l

—

Acute bronchiolitis

574

1.20

0.80

2.3

1.9

4.24

3.61

iu/l

0.22

254

Benign neoplasm: Duodenum

207

1.36

0.80

1.6

1.8

3.87

33.08

iu/l

—

Sunburn

0.00

0.80

0.0

2.5

—

3.49

—

Helminthiases

173

1.40

0.80

2.2

1.9

5.60

4.57

iu/l

0.15

Chronic myringitis

1.69

0.80

4.5

2.2

2.51

5.40

iu/l

—

Crohn disease (strict definition, all UC cases excluded)

601

1.20

0.79

1.6

2.2

4.13

iu/l

0.00

273

Malignant neoplasm of tonsil

106

1.52

0.79

2.2

2.3

8.30

4.25

iu/l

—

Malignant neoplasm of mesothelium and soft tissue

321

1.28

0.79

1.8

2.1

5.84

21.28

iu/l

0.42

134

Alcoholic cardiomyopathy

0.00

0.79

0.0

2.5

—

3.54

—

Injury of blood vessels at hip and thigh level

0.00

0.79

0.0

2.3

—

5.34

—

Disorders of speech understanding and production

429

1.24

0.79

2.2

1.9

2.30

16.69

iu/l

0.57

179

Congenital malformations of breast

269

1.32

0.79

1.9

2.3

2.75

3.85

iu/l

0.79

124

Rheumatic fever incl heart disease

223

0.67

0.79

2.8

1.8

3.81

30.31

iu/l

—

Specific development disorders of speech and language

588

1.20

0.79

2.4

2.0

3.19

12.56

iu/l

0.52

258

Cytomegaloviral disease

225

1.34

0.79

2.0

3.71

4.23

iu/l

0.10

Haemolytic-uraemic syndrome

0.00

0.79

0.0

2.7

—

3.52

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

182

1.39

0.79

1.6

2.1

3.36

4.53

iu/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

123

1.48

0.78

1.8

2.3

2.24

5.21

iu/l

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

814

1.17

0.78

1.6

2.2

4.53

3.88

iu/l

0.21

360

Mucosal proctocolitis

173

1545

1.12

0.78

2.3

2.1

3.22

7.21

iu/l

0.62

689

Other and unspecified epidermal thickening

269

1.31

0.78

2.1

2.0

1.87

4.08

iu/l

2.97

114

Other/unspecified synovitis and tenosynovitis

160

1423

1.13

0.78

1.9

2.1

3.78

9.07

iu/l

0.55

634

Malignant neoplasm of brain, including Hilmo

473

0.78

1.5

2.1

4.41

15.35

iu/l

0.47

204

Motorcycle rider injured in noncollision transport accidents

296

1.29

0.77

2.7

2.2

2.74

4.33

iu/l

1.01

136

Assault by other specified means

107

1.52

0.77

1.5

2.4

3.08

4.86

iu/l

—

Previous suicide attempt

132

1.46

0.77

1.5

2.1

1.66

4.29

iu/l

—

Sequelae of infectious and parasitic diseases, including avohilmo

741

1.18

0.77

2.0

5.41

11.40

iu/l

0.37

318

Other complications of labour and delivery, not elsewhere classified

240

1935

1.10

0.76

2.3

2.2

207.70

12.94

iu/l

0.47

931

Chronic viral hepatitis

558

1.21

0.76

1.7

2.2

2.37

3.63

iu/l

2.27

244

Vascular syndromes of brain in cerebrovascular disorders

323

1.28

0.76

1.4

1.8

3.02

4.16

iu/l

0.86

125

Benign neoplasm: Pancreas

235

1.33

0.76

1.9

1.8

3.34

29.57

iu/l

0.52

Lesion of radial nerve

341

1.27

0.76

2.0

276.50

20.71

iu/l

0.45

144

Acute alcohol intoxication ICD-9

235

1.33

0.76

1.7

1.9

2.01

3.95

iu/l

1.88

297

1.29

0.76

1.7

2.2

3.29

4.17

iu/l

0.40

134

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

124

1.47

0.76

2.4

2.0

2.13

3.80

iu/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

844

0.84

0.76

1.7

1.8

5.38

11.21

iu/l

0.35

315

Sequelae of tuberculosis, including avohilmo

1.53

0.76

1.7

1.6

3.46

68.87

iu/l

—

Maternal care for cervical incompetence

550

1.21

0.76

2.1

2.25

14.20

iu/l

0.61

225

Malignant neoplasm of stomach

377

1.25

0.75

1.7

2.0

4.95

19.06

iu/l

0.43

149

Varicose veins of other sites

577

1.20

0.75

1.5

2.0

3.00

3.84

iu/l

0.71

241

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

150

1333

1.13

0.75

2.1

3.53

7.94

iu/l

0.53

560

Other/unspecified cytomegaloviral diseases

175

1.38

0.75

2.0

3.82

4.89

iu/l

0.22

Injury of cranial nerves

1.69

0.75

1.2

2.0

—

4.54

—

Other viral hepatitis, including avohilmo

734

1.18

0.75

1.7

2.2

2.35

3.87

iu/l

3.44

322

Other viral hepatitis

688

1.18

0.75

1.7

2.2

2.38

3.66

iu/l

2.87

300

Other and unspecified follicular disorders

432

1.23

0.75

2.0

2.2

4.86

3.97

iu/l

0.22

193

Oesophageal varices

324

0.74

0.75

1.6

2.1

2.58

4.05

iu/l

—

135

Benign mammary dysplasia

229

2084

1.10

0.75

2.0

76.11

6.62

iu/l

0.48

852

Acute appendicitis, with complications

243

2217

1.10

0.74

2.0

3.85

9.63

iu/l

0.78

933

Injury of nerves and spinal cord at neck level

184

1.37

0.74

1.8

1.9

2.46

4.86

iu/l

1.73

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

133

1.44

0.74

1.6

2.0

3.93

5.14

iu/l

—

Endometriosis of fallopian tube

100

1.53

0.74

3.2

1.8

2.71

3.95

iu/l

—

Degenerative diseases of the nervous system

340

2642

0.92

0.74

1.7

22.11

11.87

iu/l

0.22

125

876

Other contact dermatitis

110

959

1.15

0.73

1.7

2.1

2.40

9.68

iu/l

0.70

410

HSIL lesion of the cervix uteri

369

3431

1.08

0.73

2.3

2.2

35.30

5.38

iu/l

0.48

175

1594

Arthropathy in ulcerative colitis

142

1.43

0.73

2.1

2.0

2.38

3.87

iu/l

1.35

Noise effects on inner ear

263

1.30

0.73

1.8

2.0

4.56

4.73

iu/l

0.02

107

Malignant neoplasm of tonsil, including Hilmo

125

1.45

0.73

2.1

2.2

8.30

42.24

iu/l

—

Seropositive rheumatoid arthritis, wide

376

3498

1.08

0.73

1.8

2.0

4.09

7.88

iu/l

0.76

133

1406

Other and unspecified degenerative diseases of nervous system

176

1.37

0.73

1.9

1.7

2.94

4.91

iu/l

1.56

Pollen allergy

314

2860

1.08

0.73

1.9

2.2

30.02

3.79

iu/l

0.49

121

1302

Aspergillosis

1.69

0.73

2.1

1.8

2.52

2.88

iu/l

—

Alzheimer’s disease (Late onset), excluding more controls

146

840

1.13

0.73

1.6

1.7

46.56

4.59

iu/l

0.48

287

Use of donepezil

167

1774

0.90

0.72

1.5

1.7

45.42

3.83

iu/l

0.50

582

Acute posthaemorrhagic anaemia

264

1.29

0.72

1.8

4.55

27.79

iu/l

0.50

101

Ankylosing spondylitis, ICD10

109

952

1.15

0.72

1.8

2.2

3.27

3.90

iu/l

0.50

410

Tularaemia

109

1.48

0.71

2.9

2.0

2.52

3.56

iu/l

—

Adrenomedullary hyperfunction

1.97

0.71

1.0

2.0

—

3.25

—

Olecranon bursitis

462

1.22

0.71

1.7

2.0

2.36

4.18

iu/l

3.06

191

Medical treatment for female infertility

435

4036

1.07

0.71

2.4

2.2

98.54

11.82

iu/l

0.44

211

1874

malignant neoplasm of male genital organs

197

1070

1.11

0.71

1.6

1.7

4.14

13.31

iu/l

0.60

404

Anisometropia and aniseikonia

327

1.26

0.71

2.1

2.0

2.37

20.62

iu/l

0.55

138

Use of fingolimod

135

1.43

0.70

3.9

2.2

14.30

4.48

iu/l

—

All dysplastic lesions of the cervix uteri

536

4976

1.06

0.70

2.3

2.2

25.88

17.98

iu/l

0.13

248

2249

Injury of nerves at shoulder and upper arm level

1.52

0.70

1.4

1.8

3.21

5.45

iu/l

—

Other infestations, including avohilmo

169

1.37

0.70

1.7

1.8

2.54

40.41

iu/l

—

Pediculosis, acariasis and other infestations

647

1.18

0.70

2.0

2.1

104.04

3.87

iu/l

0.49

286

Other vitreous opacities

409

1.23

0.70

1.9

2.1

2.41

17.24

iu/l

0.58

176

Chronic tubulo-interstitial nephritis

391

1.23

0.69

1.9

2.1

3.66

18.69

iu/l

0.53

161

Complications following abortion and ectopic and molar pregnancy

437

1.22

0.69

2.0

2.1

3.54

17.77

iu/l

0.56

180

LSIL lesion of the cervix uteri

216

1970

1.10

0.69

2.3

2.2

3.23

6.67

iu/l

0.72

895

malignant neoplasm of male genital organs, including Hilmo

201

1092

1.11

0.69

1.6

1.7

4.21

13.17

iu/l

0.59

410

Aspergillosis, including avohilmo

1.66

0.69

2.1

1.8

2.52

3.01

iu/l

—

Sulfonylureas

297

2552

0.92

0.69

1.7

1.8

3.10

7.62

iu/l

0.94

876

Alzheimer disease, including avohilmo

351

2612

0.93

0.69

1.6

1.7

22.00

12.07

iu/l

0.21

123

862

Use of cabergoline

144

1.40

0.69

1.4

2.3

1.57

4.74

iu/l

2.91

Eosinophilia

144

1.40

0.68

1.9

8.28

5.32

iu/l

—

Postzoster neuralgia

127

1.43

0.68

1.8

1.6

2.09

55.86

iu/l

—

Early lumbar disc prolapse operation

156

1400

1.12

0.68

2.2

4.38

3.69

iu/l

0.40

650

Abnormalities of forces of labour

182

1648

1.11

0.68

2.5

2.1

3.95

4.20

iu/l

0.14

741

Iridocyclitis in diseases classified elsewhere

179

1.35

0.67

1.5

2.1

2.01

5.29

iu/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

811

0.85

0.67

1.7

1.8

5.49

11.53

iu/l

0.35

301

Enterobiasis, including avohilmo

312

1.26

0.67

2.0

2.3

2.77

3.46

iu/l

0.48

137

Malignant neoplasm of stomach, including Hilmo

438

1.21

0.67

1.7

1.9

5.32

17.23

iu/l

0.41

170

Obstructed labour due to malposition and malpresentation of fetus

439

3817

1.07

0.67

2.2

3.90

13.39

iu/l

1.04

190

1761

Amputation of thigh

179

1.35

0.67

1.4

1.6

2.93

42.30

iu/l

—

Lumbosacral root disorders, not elsewhere classified

111

1.46

0.66

1.7

1.8

6.68

5.07

iu/l

—

Parapsoriasis

197

1.33

0.66

2.3

2.1

2.04

4.67

iu/l

—

Benign neoplasm of brain and other parts of central nervous system

660

1.17

0.66

1.9

2.0

3.61

12.79

iu/l

0.52

262

Benign neoplasm: Anus and anal canal

232

1.30

0.66

2.3

1.8

3.41

3.81

iu/l

0.14

Other congenital malformations of skin

476

1.20

0.66

2.9

2.1

3.38

15.92

iu/l

0.55

201

Neuroendocrine tumor and carcinoma of pancreas

1.64

0.66

2.0

1.8

2.44

5.25

iu/l

—

Contact with sharp glass

440

1.21

0.65

2.2

4.37

3.82

iu/l

0.22

195

Toxic effect of other and unspecified substances

137

1.40

0.65

1.5

2.2

4.98

4.76

iu/l

—

Additional codes for the location of defect, injury or illness

652

1.17

0.65

1.6

2.0

3.19

12.77

iu/l

0.58

271

Benign neoplasm: Skin of lip

120

1.43

0.65

1.8

1.9

9.11

5.32

iu/l

—

Inflammatory disease of cervix uteri

839

1.15

0.65

2.4

2.0

4.92

10.83

iu/l

0.40

342

Acute otitis externa, noninfective

163

1.36

0.65

1.8

2.1

2.21

38.93

iu/l

—

Amputation of ankle bones

137

1.40

0.65

1.5

1.9

2.67

4.99

iu/l

—

Other and unspecified nail disorders

251

1.28

0.65

2.0

4.77

4.52

iu/l

0.04

Diffuse large B-cell lymphoma, including Hilmo

404

1.22

0.64

1.9

2.0

5.86

17.93

iu/l

0.40

163

Diffuse large B-cell lymphoma, helper endpoint

404

1.22

0.64

1.9

2.0

5.87

17.93

iu/l

0.40

163

Diffuse large B-cell lymphoma

404

1.22

0.64

1.9

2.0

5.87

17.93

iu/l

0.40

163

All dysplastic lesions of the cervix uteri, vagina or vulva

605

5603

1.06

0.64

2.2

23.75

19.49

iu/l

0.07

273

2522

Optic neuritis

533

1.19

0.64

2.1

2.2

5.47

4.04

iu/l

0.29

233

Tubulo-interstitial nephritis, not specified as acute or chronic

718

1.16

0.64

1.6

2.0

4.48

11.94

iu/l

0.45

292

Alzheimer disease

296

2281

0.93

0.64

1.6

1.7

25.02

13.12

iu/l

0.21

106

755

Idiopathic gout

681

1.16

0.64

1.6

1.8

3.19

12.81

iu/l

0.52

250

Adhesive middle ear disease

165

0.66

0.63

2.5

2.2

1.86

3.86

iu/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

591

3802

1.06

0.63

1.7

1.9

5.37

13.11

iu/l

0.74

176

1505

Mucinous and mucinous cystic tumor, including Hilmo

1.58

0.63

2.5

2.0

3.72

5.06

iu/l

—

Other congenital malformations of circulatory system

270

1.27

0.63

1.9

2.0

2.10

4.11

iu/l

2.47

112

Macular cyst

261

1.27

0.63

2.4

1.8

3.90

26.46

iu/l

0.48

101

HSIL lesion of the cervix uteri, vagina or vulva

400

3758

1.07

0.63

2.3

2.2

33.53

8.91

iu/l

0.40

185

1716

Malignant neoplasm of oral cavity

270

1.27

0.62

1.4

1.9

2.91

24.32

iu/l

—

112

Guttate psoriasis

147

1.37

0.62

1.4

2.1

1.94

4.68

iu/l

—

Synovial hypertrophy, not elsewhere classified

1.48

0.62

1.6

2.1

3.37

5.09

iu/l

—

Other infective otitis externa

674

1.16

0.62

1.8

2.1

3.58

12.73

iu/l

0.55

274

Amputation of foot

147

1.37

0.62

1.8

2.67

5.08

iu/l

—

ILD medications: azathioprine

195

1782

1.10

0.62

1.8

2.0

3.34

6.72

iu/l

0.58

782

Need for immunization against other single infectious diseases

0.00

0.62

0.0

2.5

—

7.48

—

Conduct disorder

253

1.27

0.61

3.3

2.1

3.13

3.96

iu/l

0.45

119

Other nonscarring hair loss

165

1.35

0.61

2.0

2.1

2.14

4.07

iu/l

—

Duodenal ulcer

805

1.15

0.61

1.5

1.9

2.83

11.92

iu/l

0.58

285

Rickettsioses

0.00

0.61

0.0

2.3

—

2.16

—

Dysplastic lesion of the vulva of unknown severity

0.00

0.61

0.0

2.0

—

4.91

—

Other disorders involving the immune mechanism, not elsewhere classified

289

1.25

0.61

1.6

2.0

5.96

4.37

iu/l

0.21

115

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

357

0.78

0.61

1.4

1.9

2.12

20.20

iu/l

—

141

Androgenic alopecia

122

1.41

0.61

3.0

2.0

3.28

4.74

iu/l

—

Assault by blunt object

139

1.38

0.61

1.6

2.3

6.60

4.60

iu/l

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

0.61

0.0

1.6

—

6.38

—

Unspecified privation

131

1174

1.12

0.61

1.8

2.0

3.12

8.45

iu/l

0.59

496

Achilles tendinitis

131

1174

1.12

0.61

1.9

2.1

68.68

8.89

iu/l

0.44

502

Pedal cyclist injured in noncollision transport accidents

123

1375

0.89

0.60

2.5

2.1

3.18

7.48

iu/l

0.57

610

Other autoimmune haemolytic anaemias

105

1.44

0.60

2.6

1.9

518.97

4.45

iu/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

227

1.29

0.60

1.7

2.1

2.60

4.32

iu/l

—

Malignant neoplasm of small intestine

174

1.33

0.60

1.8

2.1

4.64

33.46

iu/l

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

183

1.32

0.60

1.2

2.1

2.15

4.76

iu/l

—

Upper arm

0.00

0.60

0.0

2.5

—

4.04

—

Rheumatoid arthritis, including avohilmo

555

5272

1.05

0.60

1.9

2.0

4.03

10.19

iu/l

0.89

200

2140

Certain zoonotic bacterial diseases, including avohilmo

290

1.25

0.60

2.1

2.0

4.33

4.13

iu/l

0.06

114

Sequelae of infectious and parasitic diseases

723

1.15

0.60

2.0

5.50

11.61

iu/l

0.37

311

Decubitus ulcer and pressure area

500

1.18

0.60

1.3

1.9

2.93

16.12

iu/l

0.56

193

Other and unspecified aplastic anaemias

1.46

0.59

2.0

1.9

3.25

5.49

iu/l

—

Fracture of shoulder and upper arm

504

4769

1.06

0.59

1.9

3.93

8.16

iu/l

0.67

188

1906

Abnormalities of ear ossicles

0.00

0.59

0.0

2.2

—

3.45

—

Foreign body entering into or through eye or natural orifice

780

1.14

0.59

1.7

2.1

2.18

4.05

iu/l

5.22

336

Crohn disease (strict definition, require KELA, min 2 HDR)

743

1.15

0.59

1.5

2.2

4.74

3.92

iu/l

0.26

332

Other/unspecified seropositive rheumatoid arthritis

369

3467

1.07

0.58

1.8

2.0

4.12

7.91

iu/l

0.75

130

1394

Lifestyle-related condition

123

1.40

0.58

1.9

2.0

2.32

4.38

iu/l

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

622

1.16

0.58

1.7

1.9

4.25

13.56

iu/l

0.48

243

Injury of muscle and tendon at wrist and hand level

157

1425

1.10

0.58

1.8

2.0

51.04

7.48

iu/l

0.43

618

Congenital malformations of the urinary system, including avohilmo

669

1.16

0.58

1.9

2.2

2.85

12.15

iu/l

0.61

289

Impetigo

548

1.17

0.58

2.4

2.2

6.19

4.29

iu/l

0.21

242

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

576

1.17

0.58

2.0

2.1

6.34

4.13

iu/l

0.44

257

Pediculosis, acariasis and other infestations, including avohilmo

260

2414

1.08

0.58

2.0

2.1

32.84

5.98

iu/l

0.44

106

1087

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

364

3421

1.07

0.58

1.8

2.0

4.12

7.96

iu/l

0.75

129

1377

Crohn's disease of small intestine

820

1.14

0.57

1.6

2.1

3.81

3.83

iu/l

0.01

361

Alzheimer’s disease (Early onset), excluding more controls

259

0.76

0.56

1.5

1.7

1.75

3.90

iu/l

—

Contusion of toe(s) with damage to nail

124

1.38

0.56

1.9

2.25

3.59

iu/l

—

Nystagmus and other irregular eye movements

150

1.35

0.56

1.6

2.1

11.73

4.96

iu/l

—

Congenital malformations of gallbladder, bile ducts and liver

1.46

0.56

1.3

1.9

4.71

3.99

iu/l

—

Crohn disease (strict definition, require KELA)

756

1.14

0.56

1.5

2.2

4.64

3.92

iu/l

0.24

338

Unspecified jaundice

393

1.20

0.56

2.3

1.9

2.53

4.29

iu/l

1.83

163

Rhinophyma

1.64

0.56

1.0

2.0

—

4.62

—

Viral conjunctivitis

248

1.26

0.56

3.0

2.2

3.10

4.50

iu/l

0.90

110

Infections specific to the perinatal period

1.46

0.56

1.8

1.7

3.63

iu/l

—

Post-traumatic wound infection, not elsewhere classified

266

1.25

0.55

1.5

2.0

2.21

4.30

iu/l

2.20

108

Nephrotic syndrome

275

1.24

0.55

2.7

2.1

6.00

4.38

iu/l

—

108

Infective dermatitis

137

1239

1.11

0.55

2.3

2.0

3.76

8.39

iu/l

0.51

515

Certain zoonotic bacterial diseases

168

1.32

0.55

2.6

1.9

3.53

4.11

iu/l

0.24

Benign neoplasm of ovary

277

2585

1.07

0.55

1.8

2.0

23.34

6.93

iu/l

0.36

112

1062

Personality and behavioural disorders due to brain disease, damage and dysfunction

107

1.41

0.55

1.8

1.9

3.37

4.69

iu/l

—

1.61

0.55

1.3

2.1

—

3.07

—

Ankle and foot

1.48

0.55

1.4

2.0

3.33

3.97

iu/l

—

180

1.30

0.55

2.1

1.9

2.35

3.58

iu/l

0.71

Secondary and unspecified malignant neoplasm of lymph nodes

776

1.14

0.55

1.7

1.9

5.48

11.71

iu/l

0.36

299

Fistulae involving female genital tract

204

1.29

0.55

1.3

1.8

3.44

3.91

iu/l

0.21

Disorders in reading

204

1.29

0.55

1.8

2.1

3.97

4.13

iu/l

—

Myelodysplastic syndrome, including Hilmo

186

1.30

0.54

1.4

1.9

3.08

32.90

iu/l

—

Injuries involving multiple body regions

413

1.19

0.54

2.0

3.43

3.87

iu/l

0.20

168

Congenital malformations of the nervous system

267

1.24

0.54

2.5

2.1

6.47

3.67

iu/l

0.37

112

Cholecystitis

149

1355

1.10

0.54

2.0

1.9

17.86

4.10

iu/l

0.47

536

Sequelae of injuries of neck and trunk

276

1.24

0.54

1.9

2.0

2.08

4.21

iu/l

2.94

115

Intracerebral haemorrhage

1036

0.89

0.53

1.6

1.8

77.35

3.93

iu/l

0.48

387

Mental and behavioural disorders due to cannabinoids

313

1.22

0.53

2.0

2.2

2.77

4.03

iu/l

0.63

140

Macular hole

553

1.16

0.53

1.8

1.9

6.74

14.69

iu/l

0.32

210

Other meningitis

178

1.30

0.53

1.3

2.1

1.93

4.35

iu/l

—

Contact with nonpowered hand tool

368

1.20

0.53

2.3

1.9

3.46

3.94

iu/l

0.22

155

Acute nephritic syndrome

181

0.71

0.53

1.8

1.9

518.34

4.94

iu/l

—

Inguinal hernia

635

4411

0.96

0.53

1.7

1.9

16.37

6.07

iu/l

0.36

234

1742

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

501

0.83

0.52

2.2

2.1

2.71

15.70

iu/l

0.58

201

Bicuspidal aortic valve syndrome

332

1.21

0.52

2.1

1.9

2.71

4.29

iu/l

1.51

136

Residual foreign body in soft tissue

544

0.84

0.52

1.9

2.2

2.75

4.58

iu/l

3.26

244

Abnormal findings in nipple discharge synovial fluid wound secretions

179

1.30

0.52

1.4

1.8

2.57

4.28

iu/l

—

Pleural plaque

517

1.16

0.52

1.6

1.7

4.95

17.26

iu/l

0.43

170

Toxic effect of alcohol

170

1.30

0.52

1.5

2.2

2.47

4.10

iu/l

—

Vestibular neuronitis

107

960

1.12

0.52

1.6

2.0

3.17

9.86

iu/l

0.60

399

Femoral hernia

397

1.19

0.51

1.9

2.0

320.97

4.31

iu/l

0.77

159

Colon adenocarcinoma

1075

0.89

0.51

1.7

1.8

6.53

9.79

iu/l

0.22

390

malignant neoplasm of female genital organs, including Hilmo

274

2443

1.07

0.51

1.8

2.0

64.09

9.19

iu/l

0.44

100

1010

Phakomatoses, not elsewhere classified

109

1.39

0.51

2.1

1.9

2.08

4.48

iu/l

—

Dislocation, sprain and strain of joints and ligaments of head

518

1.16

0.51

2.4

2.1

120.90

3.67

iu/l

0.48

223

Other specified/unspecified disorders of bone/cartilage

251

1.24

0.51

1.4

1.9

3.64

27.30

iu/l

—

Sequelae of other and unspecified infectious and parasitic diseases

574

1.15

0.51

2.0

2.1

6.34

4.13

iu/l

0.44

257

Malignant neoplasm of eye, brain and central nervous system

402

0.82

0.51

1.7

2.1

3.82

17.37

iu/l

0.50

172

Injury of muscle and tendon at lower leg level

147

1609

0.91

0.51

1.9

4.92

7.17

iu/l

0.27

670

Mental retardation

403

1.19

0.51

2.1

2.13

3.98

iu/l

2.52

170

Malignant neoplasm of pancreas, including Hilmo

714

0.87

0.51

2.0

1.8

2.50

12.18

iu/l

0.61

278

Major anomalies of jaw size

306

1.22

0.51

1.8

2.0

3.07

3.76

iu/l

0.37

128

Pneumonia due to other infectious organisms, not elsewhere classified

315

1.21

0.51

1.4

2.0

67.05

4.51

iu/l

0.45

118

Melanocytic naevi, other sites/unspecified

116

1047

1.11

0.51

1.9

2.1

2.59

8.95

iu/l

0.67

453

malignant neoplasm of female genital organs

239

2179

1.08

0.50

1.8

2.0

73.21

9.96

iu/l

0.44

889

Use of ropinirole

297

1.22

0.50

1.6

1.9

3.86

24.15

iu/l

0.51

117

Idiopathic pulmonary fibrosis

556

1.15

0.50

1.9

1.8

20.09

15.78

iu/l

0.08

192

Supplementary factors related to causes of morbidity and mortality classified elsewhere

445

4230

1.05

0.50

1.9

2.0

5.32

6.77

iu/l

0.21

200

1762

Golimumab

444

0.83

0.50

1.6

2.3

4.29

4.26

iu/l

0.00

195

Other and unspecified mononeuropathies, also in other diseases

270

1.23

0.50

1.9

2.0

4.23

5.21

iu/l

—

105

Family history of other conditions

198

1.27

0.50

2.7

2.2

4.61

3.99

iu/l

0.20

Azathioprine

195

1805

1.08

0.50

1.8

2.0

3.34

6.75

iu/l

0.58

778

Burn and corrosion of shoulder and upper limb, except wrist and hand

198

1.27

0.50

1.6

2.0

2.43

4.41

iu/l

—

Prophylactic surgery

110

1.38

0.49

1.9

2.1

6.67

5.20

iu/l

—

Focal epilepsy, strict definition

234

2181

1.07

0.49

1.8

2.0

2.99

6.37

iu/l

0.70

895

Use of levodopa decarboxylase inhibitor

128

1163

1.10

0.49

1.5

1.8

3.76

9.36

iu/l

0.48

403

Hereditary retinal dystrophy

145

1.32

0.49

2.3

2.0

7.13

4.96

iu/l

—

Spasmodic torticollis

381

1.19

0.49

1.9

2.0

151.77

18.62

iu/l

0.42

161

Tumor necrosis factor alpha inhibitors

207

2227

0.93

0.49

1.5

2.2

3.03

6.21

iu/l

0.75

1007

Alzheimer’s disease, strict definition

221

1915

0.93

0.49

1.6

1.7

33.16

13.31

iu/l

0.28

638

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

262

1.23

0.48

1.4

2.0

3.12

4.32

iu/l

—

100

Other hammer toe(s) (acquired)

225

1906

1.08

0.48

1.9

4.20

12.45

iu/l

0.77

749

Other injuries of spine and trunk, level unspecified

1.46

0.48

1.7

2.52

2.69

iu/l

—

Any dementia

390

2844

0.95

0.48

1.7

1.8

19.45

11.23

iu/l

0.20

143

958

Foreign body in ear

208

1.26

0.48

1.6

2.0

2.05

4.36

iu/l

—

Multiple delivery

139

1271

1.10

0.48

2.2

3.78

9.84

iu/l

0.55

557

Chronic suppurative otitis media, including avohilmo

832

1.12

0.48

1.8

2.1

3.70

10.34

iu/l

0.51

357

Ovarian hyperstimulation (induction)

281

1.22

0.48

1.8

2.4

1.72

3.67

iu/l

—

135

Non-Hodgkin lymphoma, all, including Hilmo

131

1194

1.10

0.48

1.8

1.9

6.66

9.01

iu/l

0.18

454

Psoriasis (vulgaris), strict definition

345

1.19

0.48

2.0

2.1

2.83

4.17

iu/l

1.11

143

Other and unspecified mental retardation

153

1.30

0.48

1.8

2.0

1.61

3.71

iu/l

—

Unequal limb length (acquired)

102

1.39

0.48

2.1

2.3

2.10

4.60

iu/l

—

Personal history of malignant neoplasm

127

1157

1.10

0.47

2.0

5.86

8.48

iu/l

0.22

490

Benign intracranial hypertension

155

1.30

0.47

1.6

2.3

2.08

4.78

iu/l

—

Early complications of trauma

429

1.17

0.47

1.9

2.1

2.20

16.75

iu/l

0.60

184

!Aliquae complicationes praecoces traumatis

429

1.17

0.47

1.9

2.1

2.20

16.75

iu/l

0.60

184

Atypical mycobacterium lung infection

1.42

0.47

2.0

1.8

2.17

76.22

iu/l

—

Systemic lupus erythematosus, unspecified

375

0.82

0.47

2.1

10.80

18.72

iu/l

—

158

Localized skin eruption due to drugs and medicaments

120

1.35

0.46

2.2

2.1

2.31

3.59

iu/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

110

1.36

0.46

2.2

2.0

3.42

3.96

iu/l

—

severe traumatic brain injury, does not include concussion

220

2054

1.07

0.46

1.6

1.9

4.41

6.85

iu/l

0.36

779

Hypothermia

129

1.33

0.46

2.8

1.9

5.76

5.77

iu/l

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

192

1785

1.08

0.46

2.0

2.3

3.09

3.78

iu/l

0.73

829

All dysplastic lesions of the vulva

590

1.14

0.46

2.3

2.1

2.66

13.18

iu/l

0.60

252

Pleural plaque with presence of asbestos

356

1.18

0.45

1.6

1.7

4.77

3.64

iu/l

0.28

110

Other and unspecified disease of Bartholin gland

363

0.82

0.45

1.7

2.1

3.87

20.08

iu/l

—

146

Benign neoplasm: Peripheral nerves and autonomic nervous system

147

1.30

0.45

1.2

2.1

3.54

4.25

iu/l

—

Personal history of risk-factors, not elsewhere classified

156

1.29

0.45

1.5

2.1

1.76

4.78

iu/l

—

147

1.30

0.45

1.8

1.6

58.65

50.97

iu/l

—

Scarlet fever, including avohilmo

112

1.35

0.45

2.3

2.2

2.21

4.88

iu/l

—

Mixed conductive and sensorineural hearing loss

138

1266

1.09

0.45

2.0

1.9

2.74

3.90

iu/l

2.07

490

Non-Hodgkin lymphoma, all

292

1.20

0.45

1.3

1.9

8.07

23.16

iu/l

—

119

Malignant neoplasm of rectum, including Hilmo

1022

0.90

0.45

1.8

6.00

9.87

iu/l

0.26

380

Viral agents as the cause of diseases classified to other chapters, including avohilmo

274

1.21

0.45

2.2

2.0

1.96

4.12

iu/l

2.93

105

D07AA Corticosteroids, weak (group I)

223

2083

1.07

0.45

2.1

2.2

3.59

6.33

iu/l

0.54

929

Poisoning by medicine, drug-induced

130

1.32

0.44

3.5

2.2

3.25

4.26

iu/l

—

Infliximab

252

0.79

0.44

1.6

2.3

2.85

4.01

iu/l

—

113

Attention to artificial openings

321

1.19

0.43

1.6

1.9

2.58

4.27

iu/l

1.98

118

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

616

3994

1.04

0.43

1.7

1.9

5.09

12.52

iu/l

0.77

193

1609

Hallux rigidus

174

1616

1.08

0.43

1.9

5.26

8.87

iu/l

0.34

645

Use of interferon beta-1a

294

1.20

0.43

3.2

2.2

5.62

4.33

iu/l

0.38

126

Congenital malformations of the urinary system

621

1.13

0.43

1.9

2.2

2.81

12.74

iu/l

0.59

266

Other immunodeficiencies

113

1.34

0.43

1.6

2.2

1.27

5.16

iu/l

—

Malignant neoplasm of prostate, including Hilmo

187

1025

1.08

0.43

1.6

1.7

4.04

14.10

iu/l

0.61

376

Prolapse and hernia of ovary and fallopian tube

346

1.18

0.43

2.3

1.6

3.56

4.11

iu/l

0.24

110

Other condition

186

1733

1.08

0.43

1.7

2.1

3.65

6.82

iu/l

0.51

762

Other sexually transmitted chlamydial diseases

944

0.90

0.43

2.5

2.3

4.13

3.73

iu/l

0.24

456

Gonococcal infection, including avohilmo

406

1.16

0.42

2.1

4.76

3.87

iu/l

0.32

170

Traumatic arthropathy

0.00

0.42

0.0

1.7

—

6.78

—

Urticaria due to cold and heat

1.37

0.42

1.9

2.14

5.42

iu/l

—

Malignant neoplasm of prostate

184

1012

1.08

0.42

1.6

1.7

3.98

14.23

iu/l

0.62

372

Toxic effect of carbon monoxide

149

1.28

0.42

2.2

1.9

8.44

5.35

iu/l

—

Injury of muscle and tendon at shoulder and upper arm level

421

4022

1.05

0.42

1.9

23.54

7.96

iu/l

0.37

159

1546

Lumbosacral spina bifida and hydrocephalus

0.00

0.42

0.0

2.2

—

3.35

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.00

0.42

0.0

2.4

—

4.16

—

Benign neoplasm: Scapula and long bones of upper limb

1.37

0.42

2.9

2.1

3.16

5.37

iu/l

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

0.42

0.0

1.8

—

1.80

—

Medial epicondylitis

444

1.15

0.42

1.8

2.1

2.32

4.22

iu/l

3.44

210

Adenocarcinoma and papillary adenocarcinoma of stomach

167

1.26

0.42

1.7

2.0

8.28

35.41

iu/l

—

Assault by other and unspecified firearm discharge

0.00

0.42

0.0

2.0

—

3.17

—

Other inherited muscular atrophy

0.00

0.42

0.0

2.2

—

3.84

—

Traumatic secondary and recurrent haemorrhage

0.00

0.41

0.0

2.2

—

2.95

—

Klinefelter syndrome, karyotype 47 XXY

0.00

0.41

0.0

2.0

—

4.93

—

Hypertrophy of (infrapatellar) fat pad

105

1.35

0.41

1.9

13.64

5.13

iu/l

—

Dialysis

323

1.18

0.41

1.4

2.1

2.33

4.82

iu/l

3.25

126

Secondary systemic amyloidosis

0.00

0.41

0.0

2.5

—

3.84

—

5-aminosalicylic acid

287

2717

1.06

0.41

2.3

2.0

3.30

5.82

iu/l

0.68

124

1185

Cicatricial pemphigoid

0.00

0.41

0.0

2.2

—

3.43

—

Other and unspecified injuries of ankle and foot

539

1.14

0.41

2.0

2.1

2.35

13.47

iu/l

0.61

243

Livedoid vasculitis

1.49

0.41

1.0

2.2

—

3.31

—

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

0.00

0.40

0.0

1.9

—

3.16

—

Scabies

511

1.14

0.40

2.1

2.0

133.27

3.75

iu/l

0.49

226

Malignant neoplasm of tongue, including Hilmo

195

1.24

0.40

1.3

2.1

1.70

30.81

iu/l

—

Hyperfunction of pituitary gland, other and/or unspecified

0.00

0.40

0.0

2.2

—

5.23

—

Congenital malformations of anterior segment of eye

1.38

0.40

1.3

2.3

1.80

5.50

iu/l

—

Other bursal cyst

141

1.28

0.40

1.9

1.7

2.55

4.97

iu/l

—

Other disorders of Eustachian tube

352

1.17

0.40

2.0

2.1

2.06

4.13

iu/l

3.26

148

Craniosynostosis EXCLUDE syndromes

0.00

0.40

0.0

2.2

—

3.15

—

Pleural plaque without asbestos

186

1.24

0.40

1.5

1.7

4.99

39.56

iu/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

205

0.78

0.40

2.2

2.1

2.76

31.26

iu/l

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

0.40

0.0

2.2

—

3.78

—

Other effects of reduced temperature

0.00

0.40

0.0

1.9

—

2.19

—

Dementia in Alzheimer disease

137

1239

0.92

0.39

1.6

1.7

3.10

18.08

iu/l

0.52

411

Malignant neoplasm of thymus, including Hilmo

1.44

0.39

1.0

1.7

—

5.53

—

Other and unspecified neuropathies

1.44

0.39

1.2

2.1

—

3.80

—

Other intracranial haemorrhages

205

1.22

0.39

1.6

1.7

3.55

5.36

iu/l

—

Benign neoplasm: Epididymis

0.00

0.39

0.0

2.0

—

5.22

—

Foreign body in genitourinary tract

124

1.30

0.39

1.8

2.1

1.32

4.43

iu/l

—

Other bursitis of hip

242

1.21

0.39

1.7

2.0

2.30

4.43

iu/l

2.07

113

Chronic lymphocytic leukaemia, helper endpoint

196

1.23

0.39

1.5

2.1

2.80

30.68

iu/l

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

196

1.23

0.39

1.5

2.1

2.80

30.68

iu/l

—

Chronic lymphocytic leukaemia

196

1.23

0.39

1.5

2.1

2.80

30.68

iu/l

—

Car occupant injured in noncollision transport accident

400

1.15

0.39

1.7

2.1

2.52

4.41

iu/l

2.01

174

Congenital deformities of hip

205

1.22

0.39

2.0

1.9

5.44

4.29

iu/l

0.28

Benign neoplasm: Skin of trunk

466

1.14

0.39

1.9

2.2

3.67

16.12

iu/l

0.52

193

Coronary artery bypass grafting

189

1496

0.94

0.39

1.5

1.7

56.40

8.79

iu/l

0.43

492

Prolonged pregnancy

291

2357

1.06

0.38

2.3

2.2

2.97

6.79

iu/l

0.77

128

1122

L02BG Aromatase inhibitors

454

4669

0.96

0.38

1.9

21.36

10.99

iu/l

0.25

184

1859

Caught, crushed, jammed or pinched in or between objects

569

0.88

0.38

2.1

4.41

4.26

iu/l

0.03

245

Atherosclerosis, excluding cerebral and coronary sclerosis

426

3204

1.04

0.38

1.7

1.8

4.08

12.32

iu/l

0.79

150

1113

Urethritis and urethral syndrome

252

1.20

0.38

2.5

2.1

3.69

25.51

iu/l

0.51

108

Procedures for purposes other than remedying health state

317

1.17

0.38

1.6

2.1

1.84

4.61

iu/l

—

134

Other disorders of pigmentation

514

1.13

0.38

2.6

2.0

135.72

14.41

iu/l

0.43

216

Embedded teeth, including avohilmo

145

1347

1.08

0.38

2.4

2.2

3.10

7.46

iu/l

0.58

610

Viral meningitis, including avohilmo

467

1.14

0.38

2.2

2.1

4.11

4.39

iu/l

0.07

199

6-mercaptopurine

401

1.15

0.38

1.8

2.1

2.15

4.19

iu/l

3.51

185

ILD, hospital admissions

147

1366

1.08

0.38

1.8

10.87

8.64

iu/l

0.10

500

Fracture of neck

533

1.13

0.38

1.9

4.97

14.78

iu/l

0.43

214

Congenital deformities of feet, including avohilmo

486

1.14

0.38

1.7

2.2

4.34

4.00

iu/l

0.09

216

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

439

1.14

0.38

1.9

2.2

3.05

4.04

iu/l

0.52

191

Puerperal sepsis

209

1968

1.06

0.38

2.1

3.64

10.43

iu/l

0.82

824

Localized scleroderma [morphea]

170

1.24

0.37

2.1

2.0

2.23

4.22

iu/l

—

Secondary thrombocytopenia

114

0.70

0.37

1.4

2.0

—

5.96

—

Evidence of alcohol involvement determined by level of intoxication

116

1.30

0.37

2.0

2.3

3.93

3.07

iu/l

—

Other deformities of toe(s)

402

1.15

0.37

2.3

2.0

7.82

4.34

iu/l

0.67

170

Retained placenta and membranes, without haemorrhage

201

1892

1.06

0.37

2.2

2.1

3.76

6.60

iu/l

0.49

817

Other/unspecified enthesopathies, not elsewhere classified

102

935

1.09

0.37

2.2

2.1

3.95

4.16

iu/l

0.09

405

Contact with other sharp object(s)

782

1.10

0.37

1.9

2.1

3.53

4.04

iu/l

0.19

351

Diseases caused by chlamydiae

135

0.73

0.37

3.3

2.2

4.00

4.28

iu/l

—

206

1.21

0.36

2.0

2.30

3.76

iu/l

1.03

Nonspecific lymphadenitis

725

1.11

0.36

2.1

3.42

4.02

iu/l

0.33

316

LeFortI or BSSO operation

545

0.88

0.36

2.0

2.2

3.02

4.19

iu/l

1.17

245

Contact with sharp object, undetermined intent

244

1.19

0.36

1.7

2.2

2.73

4.41

iu/l

—

110

Suppurative otitis media, unspecified

281

1.18

0.36

1.7

2.3

2.43

4.02

iu/l

1.95

126

Behavioural disorders

272

1.18

0.36

3.3

2.2

3.13

3.81

iu/l

0.36

124

Other congenital malformations of the digestive system

484

1.13

0.36

1.9

2.1

5.28

3.81

iu/l

0.38

204

Viral meningitis

450

1.14

0.36

2.1

4.11

4.39

iu/l

0.07

190

Use of other anti-dementia drugs

269

2054

1.05

0.36

1.5

1.7

3.11

16.22

iu/l

0.77

672

Use of memantine

269

2054

1.05

0.36

1.5

1.7

3.11

16.22

iu/l

0.77

672

Crohn's disease NAS

735

1.11

0.36

1.7

2.1

4.45

10.97

iu/l

0.44

329

Other, unspecified and serous retinal detachments

272

1.18

0.36

1.9

6.01

25.92

iu/l

0.43

106

Other and unspecified acne

171

1.24

0.36

1.7

2.1

3.04

4.38

iu/l

—

Oesophageal obstruction

263

1.18

0.36

1.7

1.8

2.19

28.34

iu/l

0.55

Carcinoma in situ of skin

793

1.10

0.36

1.7

1.9

2.97

11.52

iu/l

0.56

299

Burns and corrosions

169

1584

1.07

0.35

2.0

2.1

5.17

7.09

iu/l

0.22

701

L02BB Anti-androgens

441

1.14

0.35

1.3

1.6

8.28

3.72

iu/l

0.65

135

Ankyloglossia

200

0.79

0.35

3.3

2.3

2.88

3.37

iu/l

—

Pedestrian injured in collision with pedal cycle

310

1.17

0.35

2.4

2.2

3.41

21.15

iu/l

0.52

136

Congenital malformations of great arteries

195

1.21

0.35

2.8

2.1

2.10

3.72

iu/l

1.56

Allergic purpura

320

0.84

0.35

1.7

2.1

7.05

4.21

iu/l

0.54

136

Other fall from one level to another

286

2722

1.05

0.35

2.2

2.0

4.79

5.74

iu/l

0.18

131

1149

Malignant neoplasm of ureter, including Hilmo

1.40

0.35

1.3

1.8

—

120.01

—

Defects in the complement system

1.38

0.35

1.7

1.8

1.11

5.68

iu/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.38

0.35

1.5

2.0

3.62

5.83

iu/l

—

Use of rasagiline

190

1.22

0.35

1.3

1.8

4.76

35.46

iu/l

—

Viral conjunctivitis, including avohilmo

490

1.13

0.34

2.8

2.2

2.94

4.34

iu/l

1.32

208

Organic, including symptomatic, mental disorders

613

4170

1.03

0.34

1.7

1.8

15.41

8.61

iu/l

0.26

224

1504

Injury of muscle and tendon at ankle and foot level

265

0.83

0.34

1.8

2.0

3.30

4.10

iu/l

—

109

Other osteochondropathies

757

1.10

0.34

2.4

2.1

3.24

4.23

iu/l

0.82

330

Other and unspecified hydrocephalus

154

1.24

0.34

1.3

1.9

4.47

5.51

iu/l

—

Carcinoma in situ of vulva

109

1.30

0.34

1.4

1.9

1.05

4.14

iu/l

—

Chronic mastoiditis

200

1.20

0.34

1.6

1.8

2.01

35.84

iu/l

0.55

Exposure to other and unspecified inanimate mechanical forces

825

1.09

0.34

1.8

2.2

3.15

10.32

iu/l

0.59

369

Portal vein thrombosis

133

0.75

0.33

1.5

1.8

2.62

4.50

iu/l

—

Infections of breast associated with childbirth

596

1.11

0.33

2.7

2.2

5.43

3.81

iu/l

0.50

265

Hepatic failure, not elsewhere classified

340

1.15

0.33

2.2

1.9

1.71

21.57

iu/l

0.60

135

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

331

1.15

0.33

2.1

1.9

5.26

23.79

iu/l

0.46

119

Burns and corrosions of external body surface, specified by site

128

1192

1.08

0.33

1.9

2.1

5.68

8.21

iu/l

0.21

519

L04AC Interleukin inhibitors

778

1.10

0.33

1.7

2.2

2.61

4.06

iu/l

2.10

329

Pedestrian injured in transport accident

778

1.10

0.33

2.4

2.1

4.38

11.02

iu/l

0.44

319

Rare circulating lymphoid malignancy, including Hilmo

219

1.19

0.33

1.7

2.0

11.19

28.94

iu/l

0.31

Other and unspecified injuries of shoulder and upper arm

350

1.15

0.33

1.8

2.0

3.02

20.89

iu/l

0.54

139

Ascites

729

0.90

0.33

1.8

2.89

3.93

iu/l

1.10

290

Other interstitial pulmonary diseases

147

1377

1.07

0.32

1.8

10.87

8.64

iu/l

0.10

501

Carcinoma in situ of other and unspecified genital organs

263

0.83

0.32

1.5

2.0

2.02

26.36

iu/l

—

106

119

1.27

0.32

1.5

2.4

3.42

4.20

iu/l

—

Other disorders originating in the perinatal period

110

1.28

0.32

2.1

2.2

2.15

3.54

iu/l

—

Small cell lung cancer

137

1.24

0.32

1.5

2.1

3.20

41.24

iu/l

—

Small cell lung cancer, including Hilmo

137

1.24

0.32

1.5

2.1

3.20

41.24

iu/l

—

Allergic contact dermatitis due to drugs in contact with skin

241

0.83

0.32

1.6

2.0

2.27

4.15

iu/l

—

100

Carcinoma in situ of rectum

1.31

0.32

2.3

1.7

7.24

4.60

iu/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

183

1.21

0.32

2.4

1.8

2.57

4.26

iu/l

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

207

0.81

0.32

3.1

2.2

2.68

4.00

iu/l

—

Type of accident

406

3911

1.04

0.31

1.9

2.0

3.47

7.08

iu/l

0.87

180

1623

Use of galantamine

591

0.90

0.31

1.6

1.7

3.16

14.71

iu/l

0.52

209

Glomerulonephritis

103

954

1.08

0.31

2.3

2.1

73.76

9.82

iu/l

0.43

393

Other specified disorders of external ear

267

1.16

0.31

1.8

1.9

18.60

4.30

iu/l

—

Adalimumab

121

1296

0.93

0.31

1.5

2.1

3.50

7.79

iu/l

0.53

577

Other congenital malformations of ear

184

1.20

0.31

2.5

2.1

3.03

3.76

iu/l

—

Peripheral retinal degeneration

324

1.15

0.31

2.5

2.0

3.11

4.24

iu/l

0.74

129

Interstitial lung disease

147

1381

1.07

0.31

1.8

10.87

8.59

iu/l

0.10

506

Interstitial lung disease endpoints

147

1381

1.07

0.31

1.8

10.87

8.59

iu/l

0.10

506

Leisure time condition

234

2229

1.05

0.30

2.0

3.48

6.26

iu/l

0.56

109

928

Motor- or nonmotor-vehicle accident in traffic area

1.35

0.30

1.6

2.2

1.86

5.42

iu/l

—

Accessory breast

102

1.29

0.30

1.6

2.2

2.76

4.92

iu/l

—

Perioral dermatitis

334

1.14

0.30

2.1

3.07

3.69

iu/l

0.44

151

L02BX Other hormone antagonists and related agents

296

1.15

0.30

1.5

1.8

3.85

3.99

iu/l

0.03

Carcinoma in situ of skin of trunk

212

1.18

0.30

1.5

1.6

1.88

33.21

iu/l

—

Other and unspecified trigeminal disorders

166

1.21

0.30

1.5

2.0

3.09

4.07

iu/l

—

Fibrosis and cirrhosis of liver

754

1.09

0.30

1.9

2.0

5.11

12.10

iu/l

0.40

289

Methotrexate

188

1782

1.06

0.30

1.7

2.0

3.64

7.16

iu/l

0.55

731

UC patients in KELA-register (code 208), prior to 1994

391

1.13

0.30

2.3

1.9

3.94

3.95

iu/l

0.00

149

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

191

1810

1.06

0.30

2.0

3.44

6.88

iu/l

0.56

759

Myeloproliferative diseases (CML excluded)

724

0.91

0.30

1.3

2.0

2.87

12.20

iu/l

0.59

282

Moderate visual impairment, binocular

250

1.16

0.29

2.6

1.7

2.66

31.52

iu/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

909

1.08

0.29

2.0

2.2

2.59

4.00

iu/l

3.64

428

Bacterial, viral and other infectious agents, including avohilmo

106

987

1.08

0.29

1.8

2.1

3.53

9.19

iu/l

0.54

443

Acquired haemolytic anaemia

213

1.18

0.29

2.6

1.8

312.52

4.24

iu/l

—

Asymmetry of jaw

176

1.20

0.29

1.9

2.1

2.27

4.94

iu/l

—

Migraine with aura, drug-induced

130

1.24

0.29

1.4

1.8

6.22

4.45

iu/l

—

Routine general health check-up of defined subpopulation

260

1.16

0.29

1.8

2.3

3.50

4.70

iu/l

0.48

125

Calcific tendinitis of shoulder

679

1.09

0.29

1.7

2.1

5.77

4.42

iu/l

0.37

304

Other congenital malformations of skin, including avohilmo

112

1046

1.07

0.29

2.3

2.1

63.93

8.77

iu/l

0.44

454

Burn and corrosion of wrist and hand

408

0.88

0.29

1.9

2.1

3.45

4.11

iu/l

0.29

174

Chronic hepatitis NAS

121

1.25

0.29

1.5

1.9

3.51

4.76

iu/l

—

Traumatic subarachnoid haemorrhage

279

1.15

0.28

1.5

1.7

7.58

4.06

iu/l

—

103

Other retinal artery occlusion

167

1.20

0.28

2.0

1.7

2.98

38.45

iu/l

—

Cholangitis (primary sclerosing, PSC)

574

1.10

0.28

1.4

2.0

2.15

4.13

iu/l

4.06

221

Polycythaemia vera

251

1.16

0.28

1.4

2.1

3.54

25.74

iu/l

0.51

106

Other acute skin changes due to ultraviolet radiation

317

1.14

0.28

2.5

2.0

2.73

4.10

iu/l

1.49

131

Scabies, including avohilmo

217

2069

1.05

0.28

2.0

2.1

37.31

6.23

iu/l

0.44

930

Schizotypal disorder

242

1.16

0.28

1.5

2.2

1.84

4.37

iu/l

2.75

107

L01XX Other antineoplastic agents

491

0.89

0.28

1.3

1.9

3.20

16.60

iu/l

0.55

186

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

280

1.15

0.28

1.8

2.1

3.26

4.21

iu/l

0.47

131

Diastasis of muscle

122

1.24

0.27

3.1

2.3

2.42

5.33

iu/l

—

Tularaemia, including avohilmo

196

1.18

0.27

2.6

2.1

3.86

4.28

iu/l

—

Traumatic ischaemia of muscle

122

1.24

0.27

2.8

1.9

2.48

4.75

iu/l

—

Other specified disorders of kidney and ureter

309

1.14

0.27

2.0

6.06

22.80

iu/l

0.43

126

Other Crohn's disease

817

1.08

0.27

1.6

2.2

2.13

3.78

iu/l

4.85

363

Tibial collateral bursitis [Pellegrini-Stieda]

113

1.25

0.27

1.6

2.0

2.60

4.94

iu/l

—

Neuroendocrine tumor and carcinoma of small intestine

113

1.25

0.27

2.1

1.8

2.20

46.59

iu/l

—

Corns and callosities

692

1.09

0.26

1.9

2.1

3.03

12.40

iu/l

0.58

278

Acute poliomyelitis

104

1.26

0.26

1.9

1.7

5.02

3.61

iu/l

—

Superficial injury of neck

234

1.16

0.26

2.6

2.2

1.57

4.41

iu/l

—

104

Congenital vesicoureteral reflux

1.29

0.26

1.4

2.2

1.76

5.57

iu/l

—

Congenital deformities of hip, including avohilmo

243

1.16

0.26

1.9

5.16

4.32

iu/l

0.22

Tuberculosis, IBD comorbidity

531

0.90

0.26

1.5

1.9

2.30

15.74

iu/l

0.59

196

Hypertensive Renal Disease

234

1.16

0.26

1.7

1.8

2.90

3.40

iu/l

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

0.69

0.26

1.2

1.8

—

4.69

—

Malignant neoplasm of colon

137

1450

0.94

0.26

1.7

1.9

5.30

8.15

iu/l

0.28

538

Malignant immunoproliferative diseases

0.70

0.26

1.0

1.7

—

4.32

—

Abscess of Bartholin gland

415

0.89

0.26

1.9

2.3

3.29

4.08

iu/l

0.50

189

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

141

1.21

0.26

2.2

2.1

2.87

4.81

iu/l

0.96

Juvenile rheumatoid arthirtis

291

1.14

0.26

1.8

2.1

3.91

5.02

iu/l

0.45

140

Panniculitis affecting regions of neck and back

394

0.89

0.26

1.5

2.1

1.87

18.53

iu/l

0.62

165

Respiratory tuberculosis, not confirmed, including avohilmo

267

0.86

0.26

1.7

1.8

2.37

27.12

iu/l

0.54

100

Vulvovaginal ulceration/inflammation in other diseases

121

1140

1.06

0.25

1.8

2.2

3.03

8.48

iu/l

0.64

516

Bacterial meningitis

330

0.88

0.25

1.7

2.0

2.42

20.39

iu/l

0.55

140

Haemorrhagic and haematological disorders of fetus and newborn

144

1.20

0.25

2.4

1.8

2.98

3.35

iu/l

—

Spontaneous rupture of synovium and tendon

907

1.07

0.25

1.9

2.0

3.73

4.19

iu/l

0.21

381

Desensitization to allergens

747

0.92

0.25

1.9

2.1

3.04

3.81

iu/l

0.90

350

Acute poliomyelitis, including avohilmo

105

1.24

0.25

1.9

1.7

5.02

3.60

iu/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

676

1.08

0.25

2.3

2.1

3.47

3.92

iu/l

0.32

281

Small cell lung cancer, helper endpoint

142

1.20

0.24

1.5

1.8

3.20

4.87

iu/l

—

Polycystic kidney disease

255

0.86

0.24

1.9

2.98

4.38

iu/l

—

100

Other melanin hyperpigmentation

217

1.16

0.24

2.4

1.8

2.46

4.05

iu/l

—

Ulcerative rectosigmoiditis

921

0.93

0.24

2.4

2.1

3.74

9.79

iu/l

0.52

398

Foreign body in alimentary tract

532

1.09

0.24

1.5

2.1

2.93

14.21

iu/l

0.57

227

conjunctival degenerations and deposits

208

1.16

0.24

1.8

1.9

7.76

4.47

iu/l

—

Exclusion endpoint for supernumerary teeth

158

0.82

0.24

1.5

2.3

2.26

3.93

iu/l

—

Other demyelinating diseases of the central nervous system

475

1.10

0.24

2.0

2.2

7.30

3.90

iu/l

0.94

206

Multiple myeloma, including Hilmo

341

1.12

0.23

1.8

1.9

3.34

21.05

iu/l

0.51

134

Maxillary retrognathism

199

1.16

0.23

1.7

2.3

3.50

4.71

iu/l

0.29

IBD patients in KELA-register

310

2996

1.04

0.23

2.0

2.1

3.35

5.47

iu/l

0.62

121

1319

Muscle strain

389

1.11

0.23

1.7

2.2

2.74

4.33

iu/l

1.80

182

Disorders of continuity of bone

132

1251

1.06

0.23

1.9

2.0

4.40

8.21

iu/l

0.41

548

Other abnormal auditory perceptions

143

1.20

0.23

3.4

2.1

5.83

5.03

iu/l

—

Viral agents as the cause of diseases classified to other chapters

218

1.15

0.23

2.2

1.9

2.17

4.52

iu/l

2.25

Open wounds involving multiple body regions

1.33

0.23

1.0

2.3

—

3.41

—

Benign neoplasm of bone and articular cartilage

107

1008

1.06

0.23

1.8

2.1

4.28

9.10

iu/l

0.43

440

Crohn's disease of large intestine

578

0.91

0.23

1.8

2.2

3.44

3.89

iu/l

0.23

247

Foreign body on external eye

129

1361

0.95

0.23

1.6

2.0

3.69

3.73

iu/l

0.02

574

Tooth agenesis EXCLUDE clefts and syndromes

504

0.91

0.23

2.6

2.1

2.57

3.87

iu/l

0.89

235

Other acute viral hepatitis

134

1.20

0.23

1.2

2.0

2.26

4.90

iu/l

—

Erythema multiforme

228

1.14

0.23

1.6

2.1

3.73

4.40

iu/l

—

Pyogenic granuloma

181

1.17

0.22

1.6

2.0

3.43

4.41

iu/l

—

Maxillary hypoplasia

1.26

0.22

3.2

2.6

1.64

3.11

iu/l

—

Amputation of toe

515

1.09

0.22

1.9

1.8

8.72

16.38

iu/l

0.24

189

Diseases caused by chlamydiae, including avohilmo

189

0.84

0.22

2.9

2.3

6.33

4.87

iu/l

—

Other assisted single delivery

219

1.15

0.22

2.1

2.2

2.52

3.66

iu/l

—

107

Cutaneous lupus erythematosus

257

1.13

0.22

1.9

2.0

5.67

26.30

iu/l

0.46

106

therapeutic use

276

1.13

0.22

1.7

1.9

6.34

25.96

iu/l

—

107

Striae atrophicae

144

1.19

0.22

2.0

2.2

2.07

4.19

iu/l

—

Caries in Clefts patients

135

0.81

0.22

1.3

2.3

3.06

4.05

iu/l

—

Other and unspecified medical devices associated with adverse incidents

1.23

0.22

1.6

2.0

—

3.87

—

Rubella [German measles]

210

0.86

0.22

1.4

1.9

4.86

4.35

iu/l

—

Rubella [German measles], including avohilmo

210

0.86

0.22

1.4

1.9

4.86

4.35

iu/l

—

Accidental poisoning by and exposure to alcohol

191

1.16

0.22

1.6

2.1

2.29

4.38

iu/l

—

Ulcerative ileocolitis

439

1.10

0.22

1.8

2.0

3.57

4.02

iu/l

0.18

183

Biological medication for rheuma

239

2479

0.96

0.22

1.6

2.1

2.88

5.97

iu/l

0.83

1110

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.00

0.21

0.0

2.3

—

2.77

—

Malignant neoplasm of peripheral nerves and autonomic nervous system

0.00

0.21

0.0

2.7

—

8.72

—

Brain mixed glioma

0.00

0.21

0.0

2.2

—

4.08

—

Pneumococcal septicemia

294

0.88

0.21

1.9

2.0

4.07

4.14

iu/l

—

113

Benign neoplasm: Cornea

0.00

0.21

0.0

2.3

—

4.51

—

Amyloidosis of skin

0.00

0.21

0.0

2.8

—

4.54

—

Pinta [carate], including avohilmo

0.00

0.21

0.0

2.0

—

3.10

—

Discharge of firework

0.00

0.21

0.0

2.3

—

2.75

—

Other recurrent vertebral subluxation

0.00

0.21

0.0

1.8

—

3.16

—

Carcinoma in situ of cervix uteri

177

1846

0.96

0.21

2.5

2.3

61.35

6.46

iu/l

0.47

845

Hereditary spastic paraplegia

0.00

0.21

0.0

2.0

—

3.50

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

0.21

0.0

2.5

—

2.96

—

Bacterial, viral and other infectious agents

895

1.06

0.21

1.8

2.1

2.90

9.61

iu/l

0.60

399

Miliary tuberculosis

0.00

0.21

0.0

2.1

—

2.80

—

Benign neoplasm: Penis

0.00

0.21

0.0

2.3

—

6.40

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.21

0.0

2.3

—

4.73

—

Respiratory tuberculosis, not confirmed

262

0.88

0.21

1.7

1.8

2.37

27.37

iu/l

0.54

Intentional self-harm by crashing of motor vehicle

0.00

0.21

0.0

1.6

—

2.49

—

Hereditary choroidal dystrophy

0.00

0.21

0.0

2.1

—

2.99

—

Sequelae of injuries of head

527

1.08

0.21

1.7

2.1

3.53

3.99

iu/l

0.22

216

Benign lipomatous neoplasm of spermatic cord

0.00

0.21

0.0

2.5

—

5.42

—

Accident to watercraft causing drowning and submersion

0.00

0.21

0.0

2.2

—

2.60

—

Traumatic amputation of lower leg

0.00

0.21

0.0

2.2

—

3.02

—

Other other unspecified disorders of the circulatory system

335

0.89

0.21

1.7

1.9

85.86

22.92

iu/l

0.33

126

Bradycardia, unspecified, drug-induced

0.00

0.21

0.0

2.2

—

1.87

—

Molar incisor enamel hypoplasia

469

0.91

0.21

2.3

2.2

2.38

3.84

iu/l

1.78

211

ILD, hospital admissions 1, main diag only

129

1228

1.05

0.20

1.6

1.9

12.08

9.19

iu/l

0.11

452

Osteomalacia

1.26

0.20

2.4

2.0

2.30

4.89

iu/l

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

687

0.93

0.20

1.5

2.0

3.13

12.35

iu/l

0.55

274

Lichen nitidus

0.00

0.20

0.0

2.2

—

3.27

—

Neonatal aspiration syndromes

0.00

0.20

0.0

1.5

—

1.97

—

Cryoglobulinemia

0.00

0.20

0.0

2.9

—

4.47

—

Intentional self-harm by other and unspecified firearm discharge

0.00

0.20

0.0

1.6

—

6.32

—

Rheumatic heart disease, other

0.00

0.20

0.0

2.2

—

1.83

—

Other nonautoimmune haemolytic anaemias

0.00

0.20

0.0

2.4

—

2.49

—

Fracture of spine, level unspecified

0.00

0.20

0.0

2.4

—

2.75

—

Carcinoma in situ of skin, other sites/unspecified

108

1.21

0.20

1.7

2.63

65.65

iu/l

—

Meningitis

509

1.08

0.20

1.6

2.1

2.61

14.91

iu/l

0.58

213

Inguinal hernia, unilateral

250

1.12

0.20

1.9

284.03

4.25

iu/l

0.46

Inguinal of femoral hernia, unilateral

250

1.12

0.20

1.9

284.03

4.25

iu/l

0.46

Femoral hernia, unilateral

250

1.12

0.20

1.9

284.03

4.25

iu/l

0.46

Burn and corrosion of head and neck

197

0.86

0.20

1.5

2.1

2.88

4.46

iu/l

0.58

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

210

2024

1.04

0.19

2.0

3.25

6.47

iu/l

0.61

856

Prominent ears

146

1.17

0.19

2.5

2.3

2.97

3.51

iu/l

—

Amyloidosis

146

1.17

0.19

1.3

1.8

2.50

3.49

iu/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

327

1.10

0.19

1.8

2.0

2.64

22.84

iu/l

—

125

Malignant neoplasm of other and unspecified female genital organs

203

1.14

0.19

1.9

3.35

35.82

iu/l

—

Amyloidosis, other/unspecified

118

1.19

0.19

1.4

1.7

2.50

3.83

iu/l

—

Infective bursitis

222

1.13

0.19

2.0

1.9

1.95

4.26

iu/l

2.45

Benign neoplasm: Other and unspecified parts of small intestine

137

1.17

0.19

1.8

2.15

4.04

iu/l

—

Multiple myeloma and malignant plasma cell neoplasms

366

1.09

0.19

1.8

1.9

3.37

20.32

iu/l

0.52

142

Lesion of plantar nerve

725

1.06

0.18

2.4

2.0

4.74

12.39

iu/l

0.45

285

Juvenile osteochondrosis

376

1.09

0.18

2.5

2.1

3.77

4.01

iu/l

0.08

171

Aneurysms, operations, SAH

193

1862

1.04

0.18

2.0

1.9

3.38

3.99

iu/l

0.64

746

Extreme obesity with alveolar hypoventilation

415

1.09

0.18

2.1

2.2

376.03

4.30

iu/l

0.47

169

Reactive arthropathies, FINNGEN

784

1.06

0.18

2.1

5.27

3.94

iu/l

0.31

334

Other obstetric trauma

833

1.06

0.18

2.6

2.2

4.15

3.73

iu/l

0.14

394

Bilateral sagittal split ramus osteotomy operation

456

0.92

0.18

2.0

2.3

3.09

4.36

iu/l

1.09

206

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

185

1.14

0.18

1.3

2.2

11.06

3.74

iu/l

—

Benign neoplasm: Long bones of lower limb

367

1.09

0.18

1.7

2.1

4.60

3.88

iu/l

0.12

156

Focal epilepsy, mode (most common among epilepsy diagnosis)

218

2108

1.03

0.18

1.9

2.0

3.09

6.45

iu/l

0.67

870

Liquid cancers

328

3021

1.03

0.18

1.7

2.0

5.36

6.37

iu/l

0.18

106

1212

Tuberculosis, wide, including avohilmo

559

0.93

0.18

1.5

1.9

2.36

14.88

iu/l

0.60

212

Arthropod-borne viral fevers and viral haemorrhagic fevers

949

0.95

0.18

2.2

2.1

3.22

9.82

iu/l

0.57

394

Malignant neoplasm of cervix uteri, including Hilmo

331

0.90

0.18

1.8

2.1

4.62

20.92

iu/l

0.48

139

Personal history of allergy to drugs, medicaments and biological substances

138

1.16

0.17

2.1

2.0

1.30

5.38

iu/l

—

Follicular lymphoma, hilmo

358

1.09

0.17

1.7

1.9

7.40

20.25

iu/l

0.35

141

Delayed milestone in childhood

137

0.85

0.17

1.5

2.1

1.65

4.28

iu/l

—

Ulcerative proctitis

733

0.94

0.17

2.8

2.2

2.70

3.81

iu/l

1.77

328

Benign neoplasm: Brain, supratentorial

157

1.15

0.17

2.3

2.1

3.70

4.96

iu/l

—

Acute myeloid leukaemia and myelodysplastic syndromes

138

1.16

0.17

1.3

2.0

2.67

38.19

iu/l

—

Mild mental retardation

262

1.11

0.17

2.0

2.1

2.37

4.61

iu/l

1.84

108

Palatinal maxillary operation

110

1.19

0.17

2.0

1.9

2.53

3.80

iu/l

—

Other benign neoplasms of connective and other soft tissue

121

1158

1.05

0.17

2.0

3.40

8.78

iu/l

0.58

485

Exposure to smoke, fire and flames

205

1.12

0.17

2.3

2.1

2.17

4.58

iu/l

—

Pterygium

205

1.12

0.17

1.6

1.9

3.07

4.16

iu/l

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

129

1.17

0.17

1.7

4.28

5.12

iu/l

—

Injury of nerves at wrist and hand level

392

0.92

0.17

1.6

2.0

3.58

3.98

iu/l

0.15

170

Cleft lip, lip and palate or palate

194

0.87

0.17

1.5

2.2

6.84

4.19

iu/l

—

Social disorders starting during childhood or adolescence

101

1.20

0.17

1.4

2.4

1.34

5.51

iu/l

—

Endometroid carcinoma of ovary, including Hilmo

101

1.20

0.17

2.0

1.8

2.70

59.11

iu/l

—

SLE, strict definition

422

0.92

0.16

2.0

2.1

9.36

17.17

iu/l

0.25

179

SLE, ICD10

422

0.92

0.16

2.0

2.1

9.36

17.17

iu/l

0.25

179

Other congenital malformations of tongue, mouth and pharynx

161

0.86

0.16

3.1

2.1

2.77

3.71

iu/l

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

360

1.09

0.16

1.7

2.2

2.34

3.99

iu/l

—

154

Disorders of acoustic nerve

254

1.11

0.16

1.5

2.0

3.75

4.63

iu/l

0.26

102

Infection due to other mycobacteria

130

0.84

0.16

2.3

1.7

3.07

53.15

iu/l

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

193

0.88

0.16

2.1

2.01

4.52

iu/l

—

Gingival hyperplasia

370

1.08

0.16

2.0

1.97

18.70

iu/l

0.58

156

Open wound of hip and thigh

341

1.09

0.16

1.4

2.0

3.46

4.31

iu/l

0.26

143

Tuberculosis, wide

545

0.93

0.15

1.5

1.9

2.33

15.26

iu/l

0.60

206

Systemic atrophies primarily affecting the central nervous system

328

0.91

0.15

1.9

5.55

21.83

iu/l

0.45

132

Lesion of lateral popliteal nerve

458

1.07

0.15

1.7

2.1

6.29

16.66

iu/l

0.40

195

Focal brain injury

487

1.07

0.15

1.5

1.8

5.89

4.07

iu/l

0.21

182

Benign neoplasm of other and unspecified sites

332

1.09

0.15

1.9

4.55

4.12

iu/l

0.13

137

HSIL lesion of the vulva

226

1.11

0.15

2.7

1.9

2.69

29.62

iu/l

0.54

Cyst of Bartholin Gland

585

0.94

0.15

1.8

2.2

2.98

12.58

iu/l

0.56

264

Benign neoplasm: Short bones of upper limb

161

0.87

0.15

1.9

2.1

6.16

5.03

iu/l

—

Benign neoplasm: other/unspecified salivary gland

226

1.11

0.15

1.2

1.8

2.34

4.10

iu/l

—

Congenital deformities of feet

317

0.91

0.15

1.5

2.1

2.77

4.30

iu/l

—

140

Dislocation, sprain and strain of joint and ligaments of hip

342

1.08

0.15

1.9

1.8

2.85

22.01

iu/l

0.55

130

Exposure to other and unspecified animate mechanical forces

410

1.08

0.15

2.0

2.1

2.33

3.93

iu/l

2.57

183

Malignant neoplasm of ovary, including Hilmo

830

0.95

0.15

1.8

2.0

3.59

11.11

iu/l

0.54

329

Hypoplasia of dental enamel , including avohilmo

453

0.93

0.15

2.3

2.2

2.43

3.88

iu/l

1.67

205

Certolizumab pegol

265

1.10

0.15

1.6

2.3

1.81

3.79

iu/l

3.16

118

Perforation of tympanic membrane

115

1105

1.04

0.14

2.1

14.20

8.80

iu/l

0.22

464

Hypertrophy of breast

287

2939

0.98

0.14

2.2

2.1

3.84

16.43

iu/l

1.13

121

1307

Other congenital malformations of the digestive system, including avohilmo

562

1.06

0.14

1.9

2.1

4.94

13.32

iu/l

0.41

243

Chondromalacia

304

1.09

0.14

2.3

2.1

16.04

4.17

iu/l

0.46

127

Other obstructive and reflux uropathy

469

1.07

0.14

2.4

2.3

3.79

4.35

iu/l

0.24

207

Status post-ami

224

1652

1.03

0.14

1.7

48.39

8.16

iu/l

0.43

547

Burns and corrosions of multiple and unspecified body regions

227

1.10

0.14

1.7

2.2

4.18

4.37

iu/l

—

Benign neoplasm: Skin of scalp and neck

256

1.10

0.14

1.5

2.0

4.75

4.23

iu/l

—

106

Carcinoma in situ of breast, intraductal

125

1205

1.04

0.14

1.8

2.0

4.16

8.64

iu/l

0.46

490

Benign neoplasm: Skin, unspecified

431

1.07

0.14

1.7

2.1

4.52

4.05

iu/l

0.16

188

Extracorporeal dialysis

509

1.06

0.14

2.3

2.0

8.12

4.25

iu/l

0.31

209

Systemic sclerosis, icd10

274

0.91

0.14

1.6

2.0

3.11

24.47

iu/l

—

115

Glaucoma, exfoliation

930

1.04

0.14

1.6

1.7

2.65

10.65

iu/l

0.60

332

Other spirochaetal diseases, including avohilmo

476

4843

0.98

0.13

1.8

2.0

4.07

12.05

iu/l

1.08

153

2006

Neonatal jaundice from other and unspecified causes

109

1.16

0.13

2.2

1.8

3.12

3.56

iu/l

—

Colorectal neuroendocrine tumor and carcinoma

151

1.13

0.13

1.8

1.9

3.29

40.85

iu/l

—

Open wound of ankle and foot

118

1138

1.04

0.13

1.9

2.0

4.33

8.62

iu/l

0.42

487

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

159

0.88

0.13

1.7

2.0

3.73

38.58

iu/l

—

Alcohol abuse counselling and surveillance

159

0.88

0.13

1.4

2.0

1.95

4.55

iu/l

—

Calcific tendinitis

1.18

0.13

2.9

2.0

2.83

5.02

iu/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

218

2236

0.97

0.13

2.1

3.18

6.21

iu/l

0.69

984

Spirochaetal infections, other/unspecified, including avohilmo

470

4779

0.98

0.13

1.8

2.0

4.11

12.15

iu/l

1.08

150

1986

Normal-pressure hydrocephalus

335

1.08

0.13

1.8

1.7

4.46

22.44

iu/l

0.48

126

Contact with heat and hot substances

579

1.05

0.13

1.7

2.1

2.80

13.02

iu/l

0.58

253

Endometriosis of intestine

248

1.09

0.13

2.7

2.2

4.91

4.34

iu/l

0.16

126

Cystic kidney disease

314

0.92

0.13

2.2

2.0

3.21

4.34

iu/l

—

129

Care involving dialysis

687

1.05

0.13

2.2

2.0

6.82

4.17

iu/l

0.31

263

Respiratory and cardiovascular disorders specific to the perinatal period

188

0.90

0.12

1.9

1.79

4.10

iu/l

—

Postpartum haemorrhage due to retained placenta

252

2464

1.02

0.12

2.2

2.3

3.51

6.63

iu/l

0.60

118

1153

Keratoconus

229

1.09

0.12

2.7

2.1

3.17

4.31

iu/l

0.63

Ulcerative colitis (strict definition, require KELA)

204

2092

0.97

0.12

2.1

3.27

6.41

iu/l

0.65

915

Crowding of teeth, including avohilmo

135

1082

1.03

0.12

2.0

2.2

4.05

3.56

iu/l

0.20

487

Unspecified event, undetermined intent

268

1.08

0.12

2.1

2.03

4.07

iu/l

—

112

Open wound of abdomen, lower back and pelvis

313

0.92

0.12

2.4

2.0

2.57

4.42

iu/l

1.81

136

Campylobacter enteritis

278

1.08

0.12

1.7

2.1

2.12

4.37

iu/l

—

112

Primary angle-closure glaucoma

356

1.07

0.12

1.6

1.8

3.27

20.11

iu/l

0.51

140

Torticollis

191

1.10

0.12

1.4

2.0

2.28

4.49

iu/l

—

CR(E)ST syndrome

168

0.89

0.12

1.6

1.9

1.62

4.02

iu/l

—

Other and unspecified mononeuropathies of lower limb

288

1.08

0.12

1.9

2.0

1.94

24.77

iu/l

—

115

Hypertrophy of breast in women and men

307

3129

0.98

0.11

2.1

3.68

15.72

iu/l

1.15

130

1385

Lichen sclerosus et atrophicus

166

1616

1.03

0.11

1.8

2.0

4.26

7.22

iu/l

0.39

666

Other lack of coordination

143

1.12

0.11

1.8

2.40

5.25

iu/l

—

Any dementia, excluding more controls

364

2542

0.98

0.11

1.7

1.8

20.44

4.18

iu/l

0.46

135

870

Ill-defined and unknown causes of mortality

761

0.96

0.11

1.4

1.8

4.49

12.31

iu/l

0.44

275

Circumscribed brain atrophy

153

1.11

0.11

1.6

1.8

7.90

5.04

iu/l

—

Acute peritonitis

557

0.95

0.11

1.7

2.0

3.62

14.38

iu/l

0.53

228

Myeloproliferative diseases

791

0.96

0.11

1.3

2.0

2.82

11.53

iu/l

0.59

302

Inflammatory bowel disease, strict (require KELA)

310

3045

1.02

0.11

2.0

2.1

3.35

5.59

iu/l

0.67

121

1332

Other spirochaetal diseases

472

4787

0.99

0.10

1.8

2.0

4.07

12.14

iu/l

1.09

153

1985

Peroneal tendinitis

202

1.09

0.10

1.7

2.1

3.39

4.76

iu/l

—

Malignant neoplasm of cervix uteri

249

0.92

0.10

1.5

2.1

3.41

25.16

iu/l

0.52

111

Lyme disease

468

4744

0.99

0.10

1.8

2.0

4.11

12.23

iu/l

1.08

150

1968

Lyme disease, including avohilmo

468

4744

0.99

0.10

1.8

2.0

4.11

12.23

iu/l

1.08

150

1968

Lymphoid leukaemia

433

0.95

0.10

1.6

1.9

8.30

18.04

iu/l

0.30

165

Injury of blood vessels at neck level

1.17

0.10

2.0

2.1

—

4.52

—

Tuberculosis

427

1.05

0.10

1.6

1.8

2.65

19.22

iu/l

0.56

154

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

187

0.91

0.10

1.6

1.7

2.46

36.12

iu/l

—

Benign neoplasm: Larynx

238

0.92

0.09

2.7

1.9

4.49

4.81

iu/l

—

Other noninflammatory disorders of cervix uteri

644

1.04

0.09

2.3

1.9

4.97

4.01

iu/l

0.40

271

Disorder of the sleep-wake schedule

207

0.92

0.09

1.8

2.2

1.43

5.27

iu/l

—

Scissor bite

286

0.93

0.09

1.8

2.0

2002.98

4.02

iu/l

—

120

Gender identity disorders

174

1.09

0.09

1.7

2.2

3.61

3.72

iu/l

—

Tuberculosis of other organs

145

0.89

0.09

1.5

1.8

2.32

43.81

iu/l

—

Myeloid leukaemia

213

1.08

0.09

1.5

1.8

2.25

32.06

iu/l

—

Struck by thrown, projected or falling objec

527

1.04

0.09

1.9

2.1

4.50

13.79

iu/l

0.45

233

Panniculitis, unspecified

1.14

0.09

2.6

2.0

3.37

5.55

iu/l

—

Distal bite

445

1.05

0.09

1.8

2.0

2.72

4.19

iu/l

1.50

188

Complications of genitourinary prosthetic devices, implants and grafts

278

0.93

0.09

2.2

2.1

4.91

24.40

iu/l

0.48

117

Pyogenic arthritis

614

0.96

0.09

1.7

2.0

3.99

3.92

iu/l

0.03

248

Contact with other hot fluids

339

0.94

0.08

1.8

2.1

3.45

4.13

iu/l

—

143

Tarsal tunnel syndrome

107

1.13

0.08

2.0

1.7

5.02

3.96

iu/l

—

Blood alcohol or alcohol intoxication level

253

1.07

0.08

2.1

2.2

32.52

4.14

iu/l

0.49

110

Systemic sclerosis

267

0.93

0.08

1.6

1.9

3.11

25.44

iu/l

—

110

Pneumonia derived septicemia

318

0.94

0.08

1.8

1.9

3.83

3.80

iu/l

0.01

118

Other specific arthropathies, wide

224

1.07

0.08

1.6

1.9

5.06

4.94

iu/l

—

103

Kidney transplant status

489

1.04

0.08

2.3

2.1

2.59

4.22

iu/l

1.69

203

Primary_lymphoid and hematopoietic malignant neoplasms

253

2490

1.02

0.08

1.8

1.9

6.04

6.31

iu/l

0.04

941

Thrombocytopenia, unspecified

716

1.03

0.08

2.2

2.0

15.28

11.88

iu/l

0.09

291

Cerebral palsy

195

0.92

0.08

2.3

2.1

3.23

4.29

iu/l

—

Burn and corrosion of hip and lower limb, except ankle and foot

244

1.07

0.08

2.4

2.1

17.61

4.23

iu/l

—

Other sexually transmitted chlamydial diseases, including avohilmo

157

1602

0.98

0.08

2.3

3.54

3.59

iu/l

0.03

747

Degeneration of the brain due to alcohol

127

1.10

0.08

1.8

1.9

7.88

4.65

iu/l

—

Gout due to impairment of renal function

1.03

0.08

1.1

1.7

—

3.46

—

Other superficial injuries of ankle and foot

0.81

0.07

1.0

2.0

—

2.90

—

Alzheimer’s disease (Late onset)

207

1732

0.98

0.07

1.6

1.7

35.88

14.49

iu/l

0.28

567

Toxic effect of contact with venomous animals

471

1.04

0.07

2.5

2.0

4.83

4.13

iu/l

0.21

202

Recurrent dislocation and subluxation of joint

797

1.03

0.07

2.0

2.2

2.55

3.91

iu/l

2.99

373

Other salmonella infections

353

1.05

0.07

1.9

2.0

3.66

21.16

iu/l

0.52

138

Undefined dementia

717

1.03

0.07

1.4

1.7

3.51

13.04

iu/l

0.51

250

Lack of expected normal physiological development

180

1.07

0.07

1.7

2.2

2.90

4.37

iu/l

—

Need for immunization against other single viral diseases

163

0.92

0.07

2.3

1.9

5.47

4.21

iu/l

—

Benign neoplasm: Cranial nerves

265

1.06

0.07

1.5

1.9

3.75

4.61

iu/l

0.25

102

Other osteochondrodysplasias

1.13

0.07

1.3

2.0

2.40

5.49

iu/l

—

Labour and delivery complicated by umbilical cord complications

729

1.03

0.07

2.2

2.1

3.59

3.68

iu/l

0.05

333

Disorder of external ear, unspecified

334

1.05

0.06

1.9

12.24

20.80

iu/l

0.19

139

Other disorders of central nervous system

128

1.10

0.06

1.4

1.9

2.60

5.20

iu/l

—

Degeneration of nervous system due to alcohol

128

1.10

0.06

1.8

1.9

7.88

4.59

iu/l

—

Anxious personality disorder

244

0.94

0.06

2.5

2.3

2.58

4.56

iu/l

1.40

106

Other dialysis

246

1.06

0.06

1.5

2.2

2.48

4.67

iu/l

—

Benign neoplasm of other and unspecified female genital organs

548

0.97

0.06

2.6

2.0

3.82

14.50

iu/l

0.50

218

Clubfoot

109

1.10

0.06

2.2

1.9

2.14

5.41

iu/l

—

Calculus of lower urinary tract

325

1.05

0.06

1.8

2.16

4.14

iu/l

2.81

113

LSIL lesion of the vagina

207

1.07

0.06

2.0

2.70

4.43

iu/l

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

158

1.08

0.06

2.3

2.2

2.98

5.35

iu/l

—

Unspecified dementia

691

1.03

0.06

1.4

1.7

3.51

3.61

iu/l

0.06

231

Cholesteatoma of middle ear

444

1.04

0.06

1.9

2.0

2.99

16.77

iu/l

0.54

180

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

227

1.06

0.06

1.6

1.8

4.37

30.08

iu/l

—

Serous carcinoma of ovary, including Hilmo

405

0.96

0.05

2.0

1.9

4.96

19.61

iu/l

0.47

151

Benign neoplasm: Skin of upper limb, including shoulder

192

0.94

0.05

1.8

2.0

7.33

3.76

iu/l

—

Open bite that required surgery (Lefort1 or BSSO)

141

0.92

0.05

2.7

2.2

2.21

4.41

iu/l

—

Other diseases caused by chlamydiae

141

0.92

0.05

3.2

2.2

3.79

4.92

iu/l

—

Use of selegiline

334

0.96

0.05

1.6

1.9

6.36

22.37

iu/l

—

128

Benign neoplasm: Vulva

267

1.05

0.05

3.0

2.0

4.17

25.75

iu/l

—

106

Osteomyelitis

536

0.97

0.05

1.7

1.9

8.74

15.06

iu/l

0.22

216

Benign neoplasm: Vagina

151

0.92

0.05

1.8

1.9

3.53

4.16

iu/l

—

Carcinoma in situ of breast, other/unspecified

151

0.93

0.05

1.7

1.8

4.45

3.70

iu/l

—

IgA nephropathy (IgA glomerulonephritis)

208

1.06

0.05

1.4

2.1

2.61

4.77

iu/l

—

Monoarthritis, not elsewhere classified

455

1.03

0.05

1.7

2.0

4.77

4.15

iu/l

0.26

191

Malignant neoplasm of breast, HER-negative

299

2842

1.01

0.05

1.8

2.0

3.89

14.96

iu/l

0.89

109

1186

Injury of other and unspecified intrathoracic organs

554

1.03

0.05

1.5

1.9

6.41

14.79

iu/l

0.35

215

Unspecified abortion

697

0.97

0.05

2.1

2.2

2.88

4.47

iu/l

2.18

330

Reactive arthropathies

100

981

1.02

0.05

2.1

62.74

3.80

iu/l

0.50

425

Bicornuate uterus

120

1.09

0.05

1.2

2.3

1.88

4.74

iu/l

—

Other ulcerative colitis

656

0.97

0.05

2.6

2.2

3.14

12.02

iu/l

0.55

282

Pedestrian injured in other and unspecified transport accidents

120

1.09

0.05

1.2

1.9

3.66

4.94

iu/l

—

Obstructed labour due to maternal pelvic abnormality

229

2315

0.99

0.05

1.8

2.0

33.60

14.14

iu/l

0.27

103

973

Systemic sclerosis (FG)

262

0.95

0.04

1.6

2.0

3.11

4.67

iu/l

—

115

Spirochaetal infections, other/unspecified

102

1002

1.02

0.04

1.7

2.0

3.89

9.60

iu/l

0.49

412

Motorcycle rider injured in other and unspecified transport accidents

585

1.03

0.04

1.9

2.0

2.67

3.81

iu/l

1.19

261

All dysplastic lesions of the vagina

373

0.96

0.04

2.0

2.1

2.71

18.75

iu/l

0.59

164

Other/unspecified reactive arthropathies

734

1.02

0.04

2.1

4.55

11.75

iu/l

0.44

302

Fitting and adjustment of other devices

427

3786

0.99

0.04

1.7

1.9

4.41

6.75

iu/l

0.51

149

1445

Infection due to other mycobacteria, including avohilmo

140

0.93

0.04

2.1

1.9

2.93

47.76

iu/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

417

1.03

0.04

1.7

2.1

4.47

4.01

iu/l

0.09

174

Other ill-defined and unspecified causes of mortality

695

1.02

0.04

1.4

1.8

4.62

13.13

iu/l

0.44

253

Childhood allergy (age < 16)

242

1976

1.01

0.04

2.2

2.3

202.64

3.20

iu/l

0.50

101

908

Anogenital herpesviral [herpes simplex] infection

964

1.02

0.04

2.0

2.2

2.15

3.86

iu/l

4.03

454

Alcohol withdrawal state with delirium

497

1.03

0.04

1.7

1.9

2.58

4.23

iu/l

1.74

203

Male infertility

281

0.96

0.04

1.5

1.9

3.30

3.29

iu/l

0.00

117

Other osteochondrodysplasias, including avohilmo

121

1.08

0.03

1.4

1.9

2.40

4.74

iu/l

—

Iliotibial band syndrome

129

0.93

0.03

1.8

2.0

3.23

5.22

iu/l

—

Dysplastic lesion of unknown severity of the cervix uteri

169

0.94

0.03

1.9

2.2

2.06

4.48

iu/l

—

Burns and corrosions confined to eye and internal organs

280

0.96

0.03

2.1

3.07

4.14

iu/l

0.88

119

Malignant neoplasm of ovary

618

1.02

0.03

2.0

4.13

13.70

iu/l

0.50

244

Follow-up care involving plastic surgery

479

1.02

0.03

1.9

2.0

9.54

4.39

iu/l

0.94

199

Crossbite

798

1.02

0.03

2.2

2.1

3.70

3.84

iu/l

0.07

343

Respiratory tuberculosis

370

0.97

0.03

1.5

1.8

2.29

20.90

iu/l

0.58

140

Respiratory tuberculosis, confirmed and not-confirmed

370

0.97

0.03

1.5

1.8

2.29

20.90

iu/l

0.58

140

Etanercept

852

0.99

0.02

1.5

2.1

3.65

10.27

iu/l

0.52

367

Pathological resorption of teeth

410

0.97

0.02

1.9

2.2

3.08

17.81

iu/l

0.55

169

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

201

2025

0.99

0.02

2.1

3.28

6.52

iu/l

0.65

883

Myocardial infarction, unclassifiable

168

1488

1.01

0.02

1.7

3.04

8.42

iu/l

0.59

491

Tuberculosis of other organs, strict, including avohilmo

162

1.05

0.02

1.5

1.8

2.47

37.90

iu/l

—

Ulcerative enterocolitis

331

1.03

0.02

3.4

2.2

4.76

4.23

iu/l

0.14

139

Other/unspecified soft tissue disorders related to use, overuse and pressure

351

1.03

0.02

1.4

2.1

4.17

4.77

iu/l

0.10

161

Primary Sclerosing Cholangitis, IBD and UDCA required

218

0.96

0.02

1.3

2.1

2.32

4.24

iu/l

—

Systemic lupus erythematosus

441

1.02

0.02

2.0

2.1

7.80

16.89

iu/l

0.31

183

Other salmonella infections, including avohilmo

459

0.98

0.02

2.1

6.00

16.59

iu/l

0.39

188

Laparoscopic right hemicolectomy

501

1.02

0.02

1.9

3.99

15.83

iu/l

0.48

191

Alcoholic gastritis

1.08

0.02

2.9

1.9

3.02

5.54

iu/l

—

Cystic kidney disease, including avohilmo

348

0.98

0.01

2.2

2.0

3.34

4.15

iu/l

—

145

Prepatellar bursitis

368

0.98

0.01

1.6

2.1

5.21

4.52

iu/l

0.08

158

Deep bite

143

1264

0.99

0.01

1.9

2.1

3.48

7.97

iu/l

0.52

537

Injury of urinary and pelvic organs

183

1.04

0.01

1.8

2.0

1.96

4.66

iu/l

—

Maternal care for known or suspected disproportion

638

0.99

0.01

2.5

2.2

3.08

3.86

iu/l

0.68

312

Malignant neoplasm of oesophagus, including Hilmo

227

0.97

0.01

1.8

1.9

3.58

28.89

iu/l

—

Hydrocephalus

662

1.01

0.01

1.8

4.77

3.95

iu/l

0.30

248

Alcohol-induced acute pancreatitis

243

1.03

0.01

1.8

1.9

1.32

4.92

iu/l

—

Transient global amnesia

938

0.99

0.01

2.3

1.9

4.99

4.02

iu/l

0.40

355

Contusion of toe(s) without damage to nail

353

1.02

0.01

1.6

2.0

2.84

4.23

iu/l

0.90

150

Preparatory care for dialysis

353

1.02

0.01

1.7

1.9

12.89

20.86

iu/l

0.18

140

Malignant neoplasm of breast, ER-negative, including Hilmo

327

3049

1.00

0.01

1.9

2.0

3.94

14.27

iu/l

0.89

121

1267

Non-follicular lymphoma

817

0.99

0.01

1.9

9.05

11.96

iu/l

0.14

300

Short stature, not elsewhere classified

235

1.03

0.01

2.2

2.3

1.65

3.38

iu/l

2.94

107

Other and unspecified injuries of neck

114

1.05

0.00

2.8

2.0

2.01

5.37

iu/l

—

Tooth eruption problems

235

2261

1.00

0.00

2.4

2.3

3.29

5.68

iu/l

0.53

130

1040

Injury of nerves at forearm level

126

0.95

0.00

2.1

2.2

2.35

4.51

iu/l

—

Contact with other hot metals

134

1.05

0.00

1.6

2.0

2.60

5.49

iu/l

—

Inflammation of lacrimal passages (acute and unspecified)

174

1.04

0.00

3.7

1.8

2.79

4.56

iu/l

—

Communicating hydrocephalus

176

0.97

0.00

2.2

1.8

1.97

4.86

iu/l

—

Assault by unspecified means

234

1.03

0.00

1.8

2.2

3.55

4.00

iu/l

—

102

Burn and corrosion confined to eye and adnexa

236

0.97

0.00

2.2

2.1

3.05

4.25

iu/l

—

Exposure to other specified electric current

266

0.98

0.00

2.4

2.2

5.15

3.87

iu/l

—

117

Abnormal spermatozoa

736

0.99

0.00

1.5

1.7

4.24

3.45

iu/l

0.26

242

Ulcerative colitis (strict definition, all Crohn cases excluded)

174

1746

1.00

0.00

2.2

2.1

3.00

6.88

iu/l

0.68

759

Sulfasalazine

384

3834

1.00

0.00

1.9

2.0

3.03

10.24

iu/l

0.82

153

1609

Traumatic amputation of wrist and hand

291

1.00

0.00

1.8

1.9

2.87

4.66

iu/l

—

110

Spinal enthesopathy

170

1.00

0.00

1.7

1.6

3.00

44.68

iu/l

—

Overjet

289

1.00

0.00

2.3

2.0

2.98

4.25

iu/l

—

119

Mature T/NK-cell lymphomas, hilmo

1.04

0.00

1.4

1.8

2.74

4.64

iu/l

—

Family history of other specific disorders

175

0.97

0.00

2.8

2.2

2.32

3.95

iu/l

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

146

1.03

0.00

1.7

1.9

4.53

41.04

iu/l

—

Pedestrian injured in collision with car, pick-up truck or van

264

0.98

0.00

1.9

2.0

6.36

25.04

iu/l

0.42

110

Venous complications and haemorrhoids in pregnancy

274

0.98

0.00

1.6

2.5

2.48

3.86

iu/l

—

128

Chorioretinal inflammation

296

1.01

0.00

2.0

2.56

23.23

iu/l

0.55

121

Pyoderma

173

0.98

0.00

2.0

3.40

4.47

iu/l

—

Disorders of puberty

183

0.98

0.00

1.7

2.2

3.10

3.32

iu/l

—

Chronic nephritic syndrome

334

0.99

0.00

1.4

2.0

1.98

4.23

iu/l

3.66

137

Mandibular retrognathia AND surgery (BSSO)

346

1.01

0.00

1.9

2.3

2.94

4.39

iu/l

1.28

158

Other diseases caused by chlamydiae, including avohilmo

193

0.98

0.00

2.8

2.3

5.56

4.87

iu/l

—

1.02

0.00

2.7

2.1

1.80

5.75

iu/l

—

Malignant neoplasm of rectosigmoid junction

108

1.02

0.00

2.1

1.9

2.59

51.14

iu/l

—

Cirrhosis of liver, NAS

464

0.99

0.00

1.7

2.0

3.38

16.90

iu/l

0.53

181

Endovascular or surgical operations to intracerebral aneurysms

624

0.99

0.00

2.0

2.68

4.37

iu/l

2.97

257

Acute epiglottitis

152

0.99

0.00

2.3

1.9

5.37

3.92

iu/l

—

Other specified/unspecified deforming dorsopathies

188

1.01

0.00

4.8

2.0

2.50

34.58

iu/l

—

Disorders of puberty, all

208

1.01

0.00

1.7

2.1

3.10

3.86

iu/l

—

Mumps, including avohilmo

252

0.99

0.00

2.0

1.9

3.26

4.12

iu/l

0.36

Contact with machinery

837

1.00

0.00

1.7

1.9

96.08

3.90

iu/l

0.48

329

Other bursitis of knee

111

0.99

0.00

1.9

8.00

5.00

iu/l

—

Respiratory distress of newborn

102

1.00

0.00

2.3

1.9

2.12

3.49

iu/l

—

Unspecified threat to breathing

119

1.01

0.00

1.5

2.0

2.18

5.22

iu/l

—

Abscess of external ear

141

0.99

0.00

2.2

2.1

3.91

4.14

iu/l

—

Benign neoplasm: Other/unspecified site

141

0.99

0.00

2.3

2.1

3.63

3.89

iu/l

—

Evidence of alcohol involvement determined by blood alcohol level

141

0.99

0.00

2.5

2.0

47.92

5.09

iu/l

—

Other congenital malformations of female genitalia

139

1.01

0.00

1.9

2.2

2.33

4.41

iu/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

782

1.00

0.00

2.1

3.34

11.13

iu/l

0.56

330

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

878

1.00

0.00

2.0

2.1

3.78

10.24

iu/l

0.50

366

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

147

1.02

0.00

1.5

2.1

2.20

40.88

iu/l

—

Tuberculosis of other organs, strict

159

1.01

0.00

1.4

1.8

2.40

38.42

iu/l

—

Injury of intra-abdominal organs

239

1.00

0.00

1.6

2.0

5.71

4.38

iu/l

0.15

106

Mumps

247

1.01

0.00

2.0

1.9

3.26

4.11

iu/l

0.35

Cleft palate

137

1.02

0.00

1.2

2.2

2.93

4.26

iu/l

—

Pedal cyclist injured in collision with motor vehicle

367

1.01

0.00

2.2

2.0

4.62

4.15

iu/l

0.08

157

Essential (haemorrhagic) thrombocythaemia

357

1.01

0.00

1.2

2.1

2.36

20.54

iu/l

0.57

142

Malignant neoplasm of colon, including Hilmo

180

1788

1.00

0.00

1.6

1.9

5.05

8.69

iu/l

0.46

673

Effects of other external causes

325

0.98

0.00

1.9

2.2

4.28

3.88

iu/l

0.10

148

Calculus of urinary tract in diseases classified elsewhere

0.00

0.0

3.4

—

3.27

—

Melanoma in situ of eyelid, including canthus

0.00

0.0

1.3

—

Intrauterine hypoxia

0.00

0.0

1.0

—

Exposure to uncontrolled fire in building or structure

1.00

-0.00

1.8

2.0

—

6.67

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

0.92

-0.00

1.2

1.9

—

3.58

—

Calcaneal spur

130

1.00

-0.00

1.7

2.1

3.84

5.16

iu/l

—

Exposure to noise

0.00

-0.00

0.0

2.8

—

3.15

—

Mental and behavioural disorders due to hallucinogens

0.87

-0.00

1.2

2.2

—

5.22

—

Other accidental hanging and strangulation

0.00

-0.00

0.0

3.1

—

2.21

—

Unicornuate uterus

1.02

-0.00

1.6

2.4

—

5.41

—

Congenital pneumonia

0.00

-0.00

0.0

2.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Thyrotropin receptor Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS